data_1t4z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t4z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 ' N ' HD21 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.7 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.605 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.428 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.8 m-20 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 41' ' ' ALA . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.607 ' OE2' ' O ' ' A' ' 37' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.638 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.638 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.3 pt20 -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.477 ' N ' HD11 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 86' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.587 HH12 ' CG2' ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.587 ' CG2' HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.819 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.819 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' N ' HD21 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.452 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.2 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 50' ' ' ILE . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' OG1' ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.692 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 40' ' ' GLU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 18' ' ' PHE . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.6 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.401 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.453 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' N ' HD21 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 17.5 mm100 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.812 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.812 ' H ' ' HG ' ' A' ' 82' ' ' SER . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.482 HG22 HD13 ' A' ' 84' ' ' ILE . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.476 HE22 ' HA ' ' A' ' 81' ' ' LEU . 2.6 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.442 ' CZ3' HD13 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 74' ' ' GLY . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.501 ' CG2' ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.817 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.817 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.752 ' CB ' ' HE ' ' A' ' 22' ' ' ARG . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 82.5 m-20 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.657 HE21 ' CD2' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.657 ' CD2' HE21 ' A' ' 55' ' ' GLN . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.62 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' N ' HD12 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' N ' HD22 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.838 HE22 ' HE1' ' A' ' 97' ' ' TRP . 25.3 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.431 ' CG2' HH12 ' A' ' 78' ' ' ARG . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.591 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.3 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.838 ' HE1' HE22 ' A' ' 79' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.763 0.316 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.48 ' N ' HD11 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.605 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.549 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.421 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.477 ' HZ2' HG13 ' A' ' 29' ' ' VAL . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.0 m-20 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.683 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' A' ' 18' ' ' PHE . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.625 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.621 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.421 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.522 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' HD12 ' A' ' 15' ' ' LEU . 20.0 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.618 ' O ' ' OG1' ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.552 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.552 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.506 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.406 ' NE ' HG23 ' A' ' 87' ' ' THR . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.3 m-20 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.603 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.603 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 2.6 pt20 -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.483 ' H ' HD13 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.66 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.66 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.439 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.494 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.496 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.496 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 86' ' ' LEU . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.406 HG23 ' NE ' ' A' ' 31' ' ' ARG . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.557 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.577 ' OG ' ' CG1' ' A' ' 19' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 41' ' ' ALA . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.427 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.718 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.718 HE21 ' C ' ' A' ' 51' ' ' ASN . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.474 ' NH1' ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.467 ' N ' HD11 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.402 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.402 ' N ' HD21 ' A' ' 70' ' ' LEU . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.728 ' CB ' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.705 ' C ' ' H ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.407 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.56 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.649 0.262 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.471 HE21 HD13 ' A' ' 73' ' ' ILE . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.478 ' CE1' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.469 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.568 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.568 ' CG2' ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.686 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.2 m-20 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 40' ' ' GLU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.519 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.519 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD21 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.471 HD13 HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.552 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 24.3 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.489 ' HG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.54 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 94' ' ' LEU . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.549 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.552 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.678 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' HD11 ' A' ' 15' ' ' LEU . 23.6 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.582 ' O ' ' OG1' ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.6 m-20 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 40' ' ' GLU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.63 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 3.1 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.64 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' CG1' HD11 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.636 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' N ' ' HG ' ' A' ' 77' ' ' SER . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.793 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 17.0 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 70' ' ' LEU . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.4 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 86' ' ' LEU . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.675 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 98.2 mm-40 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.793 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.53 0.205 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.474 ' N ' HD12 ' A' ' 15' ' ' LEU . 24.8 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.434 ' NH2' ' CB ' ' A' ' 67' ' ' THR . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.678 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.5 m-20 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 ' O ' ' C ' ' A' ' 40' ' ' GLU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 39' ' ' VAL . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.439 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.8 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' N ' HD12 ' A' ' 58' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.684 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.684 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' N ' HD12 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.462 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 ' CB ' ' NH2' ' A' ' 22' ' ' ARG . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.439 ' N ' HD21 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.77 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.77 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.9 mm-40 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.412 0.148 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.483 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.467 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.602 ' O ' ' OG1' ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.555 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 93.0 m-20 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 41' ' ' ALA . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.443 ' N ' HD21 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.497 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 18' ' ' PHE . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.418 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.432 ' N ' HD21 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.683 ' CB ' ' NZ ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 77' ' ' SER . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.426 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.779 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HG ' ' A' ' 82' ' ' SER . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.604 ' NE2' ' OD1' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.608 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.507 ' NE2' HE22 ' A' ' 79' ' ' GLN . 25.5 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.746 0.308 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' HD11 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.698 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 78.0 m-20 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 41' ' ' ALA . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 39' ' ' VAL . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 50' ' ' ILE . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.551 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.551 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' N ' HD22 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 4.1 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.459 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.462 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.816 0.341 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 16' ' ' GLN . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.48 ' N ' HD12 ' A' ' 15' ' ' LEU . 22.0 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 88.3 m-20 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 ' H ' ' A' ' 45' ' ' ILE . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.442 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.9 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 18' ' ' PHE . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.629 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 ' CG1' HD11 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.518 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.437 ' HG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 1.2 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.437 HD13 ' CH2' ' A' ' 97' ' ' TRP . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.507 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' N ' HD11 ' A' ' 15' ' ' LEU . 25.6 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.613 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.673 ' HG ' ' N ' ' A' ' 26' ' ' GLN . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.673 ' N ' ' HG ' ' A' ' 25' ' ' SER . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.69 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.1 mm100 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.9 m-20 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.701 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.442 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' HE22 ' A' ' 55' ' ' GLN . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.642 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' N ' HD11 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.479 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 81' ' ' LEU . 1.7 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.483 ' N ' HD12 ' A' ' 15' ' ' LEU . 26.7 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.571 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.461 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.461 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.692 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 1.7 m120 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.593 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.628 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.648 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.648 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.456 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HZ1' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.527 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.7 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 22.9 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 HD22 ' NE2' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.456 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.618 ' O ' ' N ' ' A' ' 90' ' ' LEU . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.461 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.461 ' N ' ' HG1' ' A' ' 87' ' ' THR . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.454 ' NE2' HD22 ' A' ' 81' ' ' LEU . 10.0 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.7 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.6 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' NH2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 HD23 ' NH2' ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.516 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.4 m-20 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 35' ' ' ILE . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' GLU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.627 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.627 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.531 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 53' ' ' ALA . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.449 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.627 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 63' ' ' ARG . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.495 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.495 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.574 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.664 0.268 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.472 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' CD2' HG21 ' A' ' 29' ' ' VAL . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' HG23 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.9 m-20 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 40' ' ' GLU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.461 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB3' ' HG ' ' A' ' 25' ' ' SER . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.486 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HH21 ' A' ' 78' ' ' ARG . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.648 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.4 HG23 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.412 HD12 ' CH2' ' A' ' 97' ' ' TRP . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.559 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.613 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.7 m-20 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' GLU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 47' ' ' LEU . 17.1 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.475 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 71' ' ' VAL . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.517 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.794 HE22 ' HE1' ' A' ' 97' ' ' TRP . 28.4 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.65 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.7 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.619 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.794 ' HE1' HE22 ' A' ' 79' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 15' ' ' LEU . 21.3 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.578 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.0 m-20 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.444 HD11 ' NE2' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.42 ' NE2' HG23 ' A' ' 50' ' ' ILE . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.497 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' N ' HD21 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HZ2' ' HA2' ' A' ' 74' ' ' GLY . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.49 ' HA2' ' HZ2' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.767 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.767 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.473 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.473 ' N ' ' HG1' ' A' ' 87' ' ' THR . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 93' ' ' GLN . 3.8 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.475 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.479 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.479 ' N ' HD11 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.447 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.2 mm100 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.557 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.702 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.7 m-20 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 43' ' ' VAL . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 50' ' ' ILE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.1 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.645 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.645 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.455 ' N ' HD12 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.755 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.769 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.769 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.537 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.463 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.751 0.31 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.462 ' N ' HD11 ' A' ' 15' ' ' LEU . 24.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.602 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.759 HH21 ' HG ' ' A' ' 25' ' ' SER . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.759 ' HG ' HH21 ' A' ' 22' ' ' ARG . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 28' ' ' ILE . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.679 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.681 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.408 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.493 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.495 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.705 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.761 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.705 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' N ' HD11 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.464 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 71' ' ' VAL . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HD22 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.761 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 84' ' ' ILE . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.9 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.568 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.478 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.489 ' N ' HD11 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.606 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.8 m-20 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 15' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.468 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.796 ' N ' ' NE2' ' A' ' 55' ' ' GLN . 13.3 m120 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.796 ' NE2' ' N ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' N ' ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD21 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.667 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 54.2 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.425 ' N ' ' HG1' ' A' ' 87' ' ' THR . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 1.5 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.667 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.749 0.309 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 16' ' ' GLN . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.473 ' N ' HD11 ' A' ' 15' ' ' LEU . 22.3 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.588 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.565 HH22 ' HG1' ' A' ' 67' ' ' THR . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.6 m-20 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.431 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.431 ' N ' HD21 ' A' ' 47' ' ' LEU . 3.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.676 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.463 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.565 ' HG1' HH22 ' A' ' 22' ' ' ARG . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB2' ' HG ' ' A' ' 82' ' ' SER . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.42 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.419 ' N ' ' HG ' ' A' ' 77' ' ' SER . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 52.9 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.463 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.476 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.652 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.479 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.616 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.616 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 2.8 mm100 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 80.6 m-20 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 35' ' ' ILE . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ALA . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.584 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.691 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.449 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.634 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.466 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' N ' HD22 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.61 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.716 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 15' ' ' LEU . 20.5 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 50' ' ' ILE . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.62 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.62 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 26' ' ' GLN . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.649 ' N ' ' HG ' ' A' ' 25' ' ' SER . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 39' ' ' VAL . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.527 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.446 HG21 ' N ' ' A' ' 53' ' ' ALA . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' H ' HD13 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.484 ' N ' HD12 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.484 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HZ3' ' HA2' ' A' ' 74' ' ' GLY . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' ' HZ3' ' A' ' 72' ' ' LYS . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 4.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.56 0.219 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' NH1' ' O ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' HZ1' ' A' ' 33' ' ' LYS . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HZ1' HG13 ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 40' ' ' GLU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.429 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.706 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.706 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 2.7 pm0 -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.473 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 86' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD22 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.599 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.729 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.729 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.9 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 89.1 mm-40 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -96.91 153.65 17.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -106.64 139.12 41.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.459 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 tp -95.94 -47.67 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.33 66.82 75.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.374 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.75 141.9 15.21 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.434 2.089 . . . . 0.0 112.386 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -104.73 132.2 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.65 43.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.5 pt? -84.6 148.74 26.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 133.26 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.923 0.392 . . . . 0.0 110.974 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -93.1 151.15 40.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.291 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.479 HD21 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 ' N ' HD21 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.7 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.605 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.428 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.8 m-20 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 41' ' ' ALA . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.607 ' OE2' ' O ' ' A' ' 37' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.638 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.638 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.3 pt20 -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 HD11 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' N ' HD11 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 86' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.411 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.41 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.587 HH12 ' CG2' ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.587 ' CG2' HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.819 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.819 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.489 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.474 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.79 -42.49 24.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 101' ' ' GLN . 69.3 t -69.49 -51.24 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.598 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 48.51 35.85 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.727 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.453 ' H ' HG12 ' A' ' 99' ' ' VAL . 55.1 mt-30 -106.46 125.93 51.62 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.597 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -96.71 -3.28 42.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.41 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.33 -170.94 42.39 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 105' ' ' PHE . 73.5 mt -104.68 129.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 110.562 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.506 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.1 t80 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.703 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -133.5 -97.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -64.85 155.39 34.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.387 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.5 OUTLIER -117.18 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.75 159.89 29.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.533 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' O ' ' C ' ' A' ' 7' ' ' GLN . 2.6 Cg_endo -48.12 144.78 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.796 2.331 . . . . 0.0 111.699 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' C ' ' O ' ' A' ' 6' ' ' PRO . 30.1 mt-30 -5.36 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.567 0.542 . . . . 0.0 111.365 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.62 122.22 19.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.588 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.748 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.07 145.01 26.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.836 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' A' ' 9' ' ' LEU . . . -68.08 -163.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.328 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -88.28 118.08 69.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.49 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' N ' HD21 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.452 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.2 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CE1' HD13 ' A' ' 50' ' ' ILE . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' OG1' ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.456 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.692 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 40' ' ' GLU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' CE1' ' A' ' 18' ' ' PHE . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.6 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.401 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.453 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' N ' HD21 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 17.5 mm100 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.812 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.812 ' H ' ' HG ' ' A' ' 82' ' ' SER . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.482 HG22 HD13 ' A' ' 84' ' ' ILE . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.476 HE22 ' HA ' ' A' ' 81' ' ' LEU . 2.6 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 90' ' ' LEU . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.442 ' CZ3' HD13 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.1 -35.41 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.61 -44.47 98.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.179 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 101' ' ' GLN . 82.0 mt-30 54.46 50.08 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 100' ' ' GLN . 88.8 mt-30 -36.83 165.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.54 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.6 -36.02 75.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.22 177.04 30.94 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.452 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.31 134.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 110.667 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.502 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 p -64.8 162.59 15.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t 67.59 4.24 3.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.4 tp -99.68 134.91 41.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.173 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.49 156.17 36.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.676 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -49.05 156.36 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.042 2.495 . . . . 0.0 111.802 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.34 138.92 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.77 152.01 19.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.752 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -82.93 160.48 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.722 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 134.78 53.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.933 0.397 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 149.15 38.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.755 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.484 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 74' ' ' GLY . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' C ' ' CD1' ' A' ' 15' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.501 ' CG2' ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.817 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.817 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.752 ' CB ' ' HE ' ' A' ' 22' ' ' ARG . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 82.5 m-20 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.48 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.657 HE21 ' CD2' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.657 ' CD2' HE21 ' A' ' 55' ' ' GLN . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.62 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' N ' HD12 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' N ' HD22 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' NZ ' ' CD1' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.431 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.838 HE22 ' HE1' ' A' ' 97' ' ' TRP . 25.3 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.431 ' CG2' HH12 ' A' ' 78' ' ' ARG . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.591 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.533 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.3 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.838 ' HE1' HE22 ' A' ' 79' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.54 -40.68 56.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.4 t -63.69 -43.0 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 52.54 29.62 7.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -152.49 163.84 38.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 57.32 -144.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 54.94 5.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 tp -96.13 135.21 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 110.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.457 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' H3 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . 31.2 m -57.33 -38.34 73.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.708 0.289 . . . . 0.0 110.9 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -72.11 148.96 45.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 tp -89.67 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.85 58.28 0.4 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -45.34 146.05 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.767 2.312 . . . . 0.0 111.87 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 8' ' ' ALA . 58.0 tp60 -65.17 143.64 57.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 27.69 76.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.673 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.87 138.25 32.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.02 43.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.335 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -81.8 147.07 57.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.396 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' N ' HD11 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.454 ' CE1' HD11 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.605 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.549 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.477 ' HZ2' HG13 ' A' ' 29' ' ' VAL . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.0 m-20 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.683 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.454 HD11 ' CE1' ' A' ' 18' ' ' PHE . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.473 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.625 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.621 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.421 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.527 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt -90.18 -25.15 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 95' ' ' PRO . 25.5 t -86.74 32.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 101' ' ' GLN . 74.1 mt-30 -57.87 142.78 44.84 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 102' ' ' GLU . 75.1 mt-30 -158.19 -93.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.313 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 101' ' ' GLN . 66.4 mm-40 30.38 40.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.962 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -86.33 151.84 24.87 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.13 125.76 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.0 t80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.617 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.701 ' C ' ' H ' ' A' ' 4' ' ' LEU . 6.2 p -80.06 -0.39 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.773 0.32 . . . . 0.0 110.383 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.28 -14.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.701 ' H ' ' C ' ' A' ' 2' ' ' SER . 12.0 tp -60.6 -39.8 89.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -122.47 80.49 46.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.822 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.34 151.79 76.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.648 2.232 . . . . 0.0 112.015 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 9' ' ' LEU . 37.1 tt0 -101.77 131.41 48.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.225 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . -16.77 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.761 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -85.06 138.75 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.23 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 146.31 54.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -89.66 146.25 35.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.334 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.522 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' HD12 ' A' ' 15' ' ' LEU . 20.0 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.618 ' O ' ' OG1' ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.618 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.552 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.552 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.506 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.406 ' NE ' HG23 ' A' ' 87' ' ' THR . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.3 m-20 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.603 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.603 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 2.6 pt20 -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.483 ' H ' HD13 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.66 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.66 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.439 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.494 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.496 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.496 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 86' ' ' LEU . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.406 HG23 ' NE ' ' A' ' 31' ' ' ARG . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.557 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.38 -45.1 41.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.0 -39.07 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 101' ' ' GLN . 95.1 mt-30 58.6 30.73 20.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.301 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 100' ' ' GLN . 92.7 mt-30 37.77 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.764 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.557 ' O ' ' C ' ' A' ' 103' ' ' GLY . 62.5 mm-40 -92.19 139.16 30.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 27.76 -127.22 0.07 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.03 134.21 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 110.311 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.515 ' OXT' ' CD2' ' A' ' 105' ' ' PHE . 84.5 t80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.441 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -83.44 -1.4 53.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.349 . . . . 0.0 110.651 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.7 m -85.0 168.09 15.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.532 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -86.6 115.9 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -163.6 101.7 0.95 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.421 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -67.18 57.58 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.995 1.797 . . . . 0.0 111.877 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' SER . 98.3 mt-30 -87.71 131.93 34.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -164.54 34.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.794 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 pp -84.77 137.99 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 156.85 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.252 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.38 161.87 58.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.312 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.577 ' OG ' ' CG1' ' A' ' 19' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 41' ' ' ALA . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.427 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.547 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.718 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.718 HE21 ' C ' ' A' ' 51' ' ' ASN . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.474 ' NH1' ' HG2' ' A' ' 63' ' ' ARG . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.467 ' N ' HD11 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.402 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' N ' HD21 ' A' ' 70' ' ' LEU . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.728 ' CB ' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.457 HD11 HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.705 ' C ' ' H ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.705 ' H ' ' C ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.407 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.56 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.3 -40.02 81.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 89.3 t -74.1 -41.01 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.267 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.99 34.5 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.37 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.31 143.33 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.2 0.524 . . . . 0.0 111.23 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 103' ' ' GLY . 91.4 mt-10 -96.13 143.98 26.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.305 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . 53.89 151.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -110.66 136.81 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.983 0.42 . . . . 0.0 111.305 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.525 179.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 1' ' ' GLY . 33.2 m -58.38 -125.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.455 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' LEU . 73.5 m -79.55 7.02 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.5 tp 46.5 102.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.78 152.89 95.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.191 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.16 140.65 19.29 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.45 2.1 . . . . 0.0 111.536 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.27 135.84 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.702 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 142.59 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.79 115.48 24.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.645 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 148.31 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -85.69 141.1 35.88 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.383 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.471 HE21 HD13 ' A' ' 73' ' ' ILE . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.478 ' CE1' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.568 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.568 ' CG2' ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.686 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.2 m-20 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 40' ' ' GLU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.44 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.519 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.519 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.529 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG23 ' HG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.469 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD21 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.471 HD13 HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.552 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 24.3 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.489 ' HG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.54 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 94' ' ' LEU . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.549 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 100' ' ' GLN . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.552 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.37 -41.7 63.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -76.0 -41.14 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.381 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' GLN . 99.2 mm-40 62.6 49.0 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.714 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 101' ' ' GLN . 0.8 OUTLIER -58.26 -34.45 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 50.18 18.37 0.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.72 158.24 28.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.579 ' C ' ' CG ' ' A' ' 105' ' ' PHE . 26.9 pt -116.36 153.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 110.722 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -64.67 160.58 19.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 110.646 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -143.83 -96.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.1 tp -81.28 52.4 1.81 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.125 0.488 . . . . 0.0 110.126 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 158.31 84.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.016 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -47.92 176.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 123.31 2.673 . . . . 0.0 112.103 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.27 151.19 47.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.77 142.37 2.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.2 -170.79 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.273 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.56 157.98 30.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -85.64 147.5 46.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.678 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.457 ' N ' HD11 ' A' ' 15' ' ' LEU . 23.6 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.582 ' O ' ' OG1' ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.6 m-20 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 40' ' ' GLU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.63 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 3.1 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.64 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' CG1' HD11 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.636 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.636 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.419 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' N ' ' HG ' ' A' ' 77' ' ' SER . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.793 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 17.0 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' N ' ' A' ' 70' ' ' LEU . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 86' ' ' LEU . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.675 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 98.2 mm-40 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.793 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt -75.74 -37.31 59.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.6 -46.88 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.03 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 48.99 60.78 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.87 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.72 124.42 20.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.146 0.498 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 103' ' ' GLY . 43.1 mt-10 -99.1 131.28 45.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.957 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 30.62 -125.2 0.16 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' PHE . 15.7 tt -117.84 137.12 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -77.62 7.68 5.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 t -130.89 51.18 2.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.774 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.1 tt -60.25 -37.04 79.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.013 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.64 166.04 12.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.35 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -76.98 -71.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.442 2.095 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -97.57 153.26 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.402 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.45 138.89 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.684 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -85.41 152.97 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.063 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.93 144.37 55.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.397 . . . . 0.0 110.268 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -86.02 140.9 35.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.474 ' N ' HD12 ' A' ' 15' ' ' LEU . 24.8 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' NH2' ' CB ' ' A' ' 67' ' ' THR . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.678 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.5 m-20 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 ' O ' ' C ' ' A' ' 40' ' ' GLU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 39' ' ' VAL . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.439 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.8 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' N ' HD12 ' A' ' 58' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.684 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.684 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' N ' HD12 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 ' CB ' ' NH2' ' A' ' 22' ' ' ARG . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HD3' ' CZ ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.439 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.439 ' N ' HD21 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.77 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.77 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.455 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.9 mm-40 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.15 -37.2 85.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.07 -48.62 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.251 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 62.64 39.36 11.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.332 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.583 ' O ' ' O ' ' A' ' 102' ' ' GLU . 83.5 mt-30 -148.12 -94.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.27 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 101' ' ' GLN . 80.4 mm-40 25.57 -148.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 125.76 0.02 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.448 HD13 HG21 ' A' ' 104' ' ' ILE . 61.1 mt -103.34 136.13 37.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.344 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.9 t80 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.5 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 3' ' ' SER . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.673 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 40.1 14.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.665 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 1' ' ' GLY . 57.4 p 31.51 29.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.673 ' N ' ' O ' ' A' ' 2' ' ' SER . 29.4 tp -90.86 115.33 27.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.746 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -168.66 67.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.08 137.82 70.13 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.198 1.932 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.663 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 39.1 tt0 -94.33 -74.71 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.83 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 7' ' ' GLN . . . 128.27 100.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.888 0.742 . . . . 0.0 109.899 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 120.83 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.29 157.82 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.178 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.12 135.78 36.75 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.739 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.483 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.467 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.602 ' O ' ' OG1' ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.455 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.555 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.444 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 93.0 m-20 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 41' ' ' ALA . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.443 ' N ' HD21 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.467 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.497 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 HG21 ' CD2' ' A' ' 18' ' ' PHE . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.418 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.471 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.432 ' N ' HD21 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.683 ' CB ' ' NZ ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 77' ' ' SER . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.779 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.779 ' H ' ' HG ' ' A' ' 82' ' ' SER . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' H ' ' C ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 90' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.604 ' NE2' ' OD1' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.608 ' C ' ' CD1' ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' N ' HD12 ' A' ' 90' ' ' LEU . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.507 ' NE2' HE22 ' A' ' 79' ' ' GLN . 25.5 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.541 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.0 mt -77.27 -36.83 54.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.548 ' O ' ' C ' ' A' ' 100' ' ' GLN . 55.1 t -64.01 -44.97 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.878 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' C ' ' O ' ' A' ' 99' ' ' VAL . 75.9 mm-40 21.23 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -114.43 -70.42 0.8 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.791 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -70.54 150.5 46.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.02 48.64 0.65 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 105' ' ' PHE . 11.0 pt -102.97 141.74 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.399 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.638 ' HG ' ' H ' ' A' ' 3' ' ' SER . 7.3 t 46.45 -173.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.788 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.638 ' H ' ' HG ' ' A' ' 2' ' ' SER . 0.7 OUTLIER -167.58 142.03 3.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.464 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.482 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 3.3 tm? -57.36 -34.0 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.45 83.55 16.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.47 150.32 63.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.6 2.2 . . . . 0.0 112.05 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 60.36 39.69 18.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.62 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.07 -158.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.905 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.89 144.21 29.37 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.181 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.64 147.14 52.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.77 147.9 47.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.596 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' N ' HD11 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.448 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.698 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 78.0 m-20 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 41' ' ' ALA . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' C ' ' O ' ' A' ' 39' ' ' VAL . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 50' ' ' ILE . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.551 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.551 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' N ' HD22 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 4.1 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.459 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.462 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.23 -40.63 82.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 95' ' ' PRO . 78.3 t -67.53 -38.98 81.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.303 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 61.07 67.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.646 ' O ' ' N ' ' A' ' 103' ' ' GLY . 94.5 mt-30 -77.3 2.71 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.25 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 59.45 -60.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.698 0.285 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . 100.98 1.18 54.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.96 138.21 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.745 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.573 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -110.24 138.81 46.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 0.0 111.107 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -85.57 169.79 13.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.7 tp -88.83 131.55 35.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.482 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.2 89.46 52.24 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.401 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 3.0 Cg_exo -73.03 -167.81 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.765 2.31 . . . . 0.0 111.168 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.1 -6.76 41.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.144 0.497 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.39 44.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -83.9 91.07 7.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.178 0.514 . . . . 0.0 110.04 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.67 167.57 12.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -146.53 147.45 30.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.371 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 16' ' ' GLN . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' N ' HD12 ' A' ' 15' ' ' LEU . 22.0 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 88.3 m-20 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 ' H ' ' A' ' 45' ' ' ILE . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.442 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.9 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 18' ' ' PHE . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.629 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 ' CG1' HD11 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG23 ' HG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.518 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.437 ' HG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 1.2 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.437 HD13 ' CH2' ' A' ' 97' ' ' TRP . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.48 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.507 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.46 -33.06 74.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.599 ' O ' ' C ' ' A' ' 100' ' ' GLN . 77.3 t -65.87 -39.34 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.1 mm-40 -12.51 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.21 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 102' ' ' GLU . 85.3 mt-30 -73.59 7.56 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 101' ' ' GLN . 95.9 mt-10 31.42 47.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.845 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.89 -127.95 4.62 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 105' ' ' PHE . 13.4 tt -113.43 133.27 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.57 ' C ' ' O ' ' A' ' 104' ' ' ILE . 66.3 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.2 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 3' ' ' SER . 59.6 p -95.24 -90.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.63 ' N ' ' OG ' ' A' ' 2' ' ' SER . 55.2 p -73.02 161.24 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.357 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.1 tp -125.11 -95.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.573 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.82 146.25 99.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.577 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.5 Cg_endo -51.78 143.85 36.95 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.474 2.116 . . . . 0.0 112.23 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.647 ' C ' ' H ' ' A' ' 9' ' ' LEU . 24.1 mt-30 23.02 -80.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.109 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.701 ' N ' ' O ' ' A' ' 6' ' ' PRO . . . 47.27 5.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.985 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.647 ' H ' ' C ' ' A' ' 7' ' ' GLN . 1.5 pp -85.07 143.71 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 0.0 110.791 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.14 162.93 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.155 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -85.16 114.21 54.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.516 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' N ' HD11 ' A' ' 15' ' ' LEU . 25.6 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.613 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.673 ' HG ' ' N ' ' A' ' 26' ' ' GLN . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.673 ' N ' ' HG ' ' A' ' 25' ' ' SER . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.69 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.1 mm100 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.9 m-20 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.701 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.442 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' HA ' HE22 ' A' ' 55' ' ' GLN . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.642 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.642 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' N ' HD11 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.479 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.401 HE22 ' HA ' ' A' ' 81' ' ' LEU . 1.7 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -67.49 -41.15 84.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.85 -36.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.075 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 101' ' ' GLN . 95.9 mt-30 60.71 111.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.173 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.706 ' C ' ' H ' ' A' ' 103' ' ' GLY . 94.9 mm-40 38.78 -134.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.364 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 59.78 -33.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.706 ' H ' ' C ' ' A' ' 101' ' ' GLN . . . -56.72 -27.99 56.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.74 135.91 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.643 0.259 . . . . 0.0 110.385 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 85.7 t80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.606 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.557 ' C ' ' O ' ' A' ' 1' ' ' GLY . 22.6 t 23.32 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 4' ' ' LEU . 8.5 p -69.22 162.15 27.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' C ' ' O ' ' A' ' 3' ' ' SER . 11.6 tp 18.12 -131.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.066 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.533 ' H ' ' CG ' ' A' ' 4' ' ' LEU . 11.7 m -138.51 88.41 14.5 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.77 143.48 74.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -86.54 7.51 25.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.037 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 68.21 99.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.526 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.52 147.24 26.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.85 146.02 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -86.35 145.17 39.39 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.808 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' N ' HD22 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.483 ' N ' HD12 ' A' ' 15' ' ' LEU . 26.7 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.571 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.461 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.461 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.692 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 1.7 m120 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.593 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.628 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.648 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.648 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.456 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' N ' HD22 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HZ1' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.527 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.7 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 22.9 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 HD22 ' NE2' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.456 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.618 ' O ' ' N ' ' A' ' 90' ' ' LEU . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.461 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.461 ' N ' ' HG1' ' A' ' 87' ' ' THR . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.454 ' NE2' HD22 ' A' ' 81' ' ' LEU . 10.0 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.618 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.7 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.06 -31.02 71.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.657 ' O ' ' N ' ' A' ' 101' ' ' GLN . 71.9 t -63.28 -16.12 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.46 43.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.737 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 99' ' ' VAL . 90.7 mt-30 -91.04 137.74 32.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.372 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -89.91 156.62 18.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.296 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.81 102.54 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.484 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 105' ' ' PHE . 30.7 mm -101.3 127.94 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.517 ' C ' ' O ' ' A' ' 104' ' ' ILE . 81.5 m-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.457 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -67.57 168.48 10.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.539 0.209 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p 176.33 -0.51 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.478 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.8 tt -93.49 134.78 35.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -115.77 98.69 51.47 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.03 16.42 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.674 2.25 . . . . 0.0 113.675 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 5' ' ' SER . 65.1 tt0 -60.05 150.58 28.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 146.05 44.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.967 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.747 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.95 162.18 17.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.87 170.21 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.343 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -150.85 149.22 24.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.927 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' N ' HD22 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.6 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.6 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' NH2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 HD23 ' NH2' ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.516 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.4 m-20 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD11 HG23 ' A' ' 35' ' ' ILE . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 40' ' ' GLU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.627 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.531 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.449 HG23 ' N ' ' A' ' 53' ' ' ALA . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.449 ' N ' HG23 ' A' ' 52' ' ' VAL . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.627 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 63' ' ' ARG . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.495 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.495 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.6 mt -82.91 -40.47 20.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 100' ' ' GLN . 77.9 t -66.85 -49.58 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.874 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 99' ' ' VAL . 92.5 mt-30 37.84 49.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.558 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 103' ' ' GLY . 26.0 mt-30 59.79 -102.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.083 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 52.5 -71.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -45.81 175.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.53 ' O ' ' C ' ' A' ' 105' ' ' PHE . 74.1 mt -99.22 134.74 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' C ' ' O ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.877 -1.058 . . . . 0.0 110.824 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.62 ' OG ' ' N ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -153.67 -162.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 0.0 110.371 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.62 ' N ' ' OG ' ' A' ' 2' ' ' SER . 25.6 p -56.46 -19.65 16.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp 39.39 -91.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.04 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -96.48 162.17 24.33 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.382 . . . . 0.0 110.688 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -45.37 150.81 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.025 2.483 . . . . 0.0 112.035 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -82.2 156.56 24.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.615 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.5 132.39 48.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.731 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.4 pt? -85.96 156.2 20.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.45 149.77 47.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -82.72 148.93 59.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.414 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' N ' HD21 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.472 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' CD2' HG21 ' A' ' 29' ' ' VAL . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.47 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.597 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.4 ' NE ' HG23 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.9 m-20 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' O ' ' C ' ' A' ' 40' ' ' GLU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.461 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HB3' ' HG ' ' A' ' 25' ' ' SER . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.486 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG13 HH21 ' A' ' 78' ' ' ARG . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.648 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.4 HG23 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.412 HD12 ' CH2' ' A' ' 97' ' ' TRP . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.468 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.559 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt -87.1 -12.75 46.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' A' ' 101' ' ' GLN . 61.2 t -108.87 15.89 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.6 mt-30 -32.19 90.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.768 0.318 . . . . 0.0 111.135 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 102' ' ' GLU . 94.2 mt-30 -153.18 -14.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 101' ' ' GLN . 52.2 mp0 35.01 -160.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.083 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.74 72.81 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.82 128.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 44.6 p90 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.526 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.444 ' H1 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 59.4 p -61.36 -81.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.707 0.289 . . . . 0.0 110.528 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -90.97 125.67 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.121 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.536 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 3.2 tm? -65.87 -42.34 90.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.009 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.31 159.13 30.27 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.45 138.49 65.71 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.636 2.224 . . . . 0.0 111.559 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 8' ' ' ALA . 61.2 tp60 -139.73 42.97 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.159 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' O ' ' O ' ' A' ' 7' ' ' GLN . . . 41.25 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.18 143.87 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 145.8 55.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.65 145.28 41.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.267 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 HD22 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.613 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.457 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.7 m-20 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 40' ' ' GLU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.457 ' N ' HD21 ' A' ' 47' ' ' LEU . 17.1 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.614 ' C ' ' CD1' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.587 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.587 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.475 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 71' ' ' VAL . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' N ' HD22 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.517 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.794 HE22 ' HE1' ' A' ' 97' ' ' TRP . 28.4 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.65 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.7 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.619 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.794 ' HE1' HE22 ' A' ' 79' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt -75.2 -32.38 61.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 101' ' ' GLN . 97.2 t -66.37 -48.28 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.274 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' VAL . 77.4 mt-30 29.92 38.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 99' ' ' VAL . 8.3 mm-40 -122.06 0.66 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.938 0.399 . . . . 0.0 110.322 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 54.6 mp0 -55.53 143.98 27.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.63 11.84 4.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.588 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 105' ' ' PHE . 10.2 tt -114.16 131.06 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 104' ' ' ILE . 59.2 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m -85.51 2.89 42.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.651 0.262 . . . . 0.0 111.019 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -66.85 165.32 15.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -53.62 -39.48 64.96 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.72 172.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.49 -79.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.188 1.925 . . . . 0.0 112.31 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.71 151.1 25.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.16 175.41 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.271 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.769 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -81.61 150.51 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.06 142.96 55.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.775 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.93 149.83 46.48 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.128 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 15' ' ' LEU . 21.3 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.578 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.578 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.0 m-20 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.555 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.444 HD11 ' NE2' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.42 ' NE2' HG23 ' A' ' 50' ' ' ILE . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 63' ' ' ARG . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.497 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' N ' HD21 ' A' ' 86' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' N ' HD21 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HZ2' ' HA2' ' A' ' 74' ' ' GLY . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.49 ' HA2' ' HZ2' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.767 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.767 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.473 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.473 ' N ' ' HG1' ' A' ' 87' ' ' THR . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 93' ' ' GLN . 3.8 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.489 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 100' ' ' GLN . 79.7 mt -93.03 -32.8 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.608 ' O ' ' O ' ' A' ' 102' ' ' GLU . 84.0 t -65.02 8.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.837 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 98' ' ' LEU . 89.3 mt-30 -38.96 154.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 62.76 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.41 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 99' ' ' VAL . 96.2 mt-10 -57.97 146.6 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.771 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.9 18.41 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.5 mt -105.21 137.21 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 1.2 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -110.18 145.65 36.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 p -68.06 160.39 28.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.592 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.8 tp -178.23 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.228 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 7' ' ' GLN . 1.7 p -130.36 77.13 76.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.393 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.82 39.19 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.651 2.234 . . . . 0.0 111.483 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.57 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 84.0 mt-30 -77.23 -2.15 33.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.4 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.419 ' HB2' ' H ' ' A' ' 9' ' ' LEU . . . 63.56 -86.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.238 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.419 ' H ' ' HB2' ' A' ' 8' ' ' ALA . 0.9 OUTLIER -83.89 173.73 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.45 -167.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.57 ' OE1' ' OE1' ' A' ' 7' ' ' GLN . 4.1 mm100 -86.4 119.09 71.27 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.475 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.479 ' N ' HD11 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.572 ' O ' ' OG1' ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.557 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.2 mm100 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.557 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.702 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.7 m-20 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 43' ' ' VAL . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.499 HD11 HG21 ' A' ' 50' ' ' ILE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.1 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.645 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.645 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.455 ' N ' HD12 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.755 ' HG ' ' N ' ' A' ' 78' ' ' ARG . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.769 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.769 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.537 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.585 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.463 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.95 -37.24 78.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.97 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.297 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 57.27 106.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.807 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.25 156.88 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.88 -30.75 67.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.65 36.99 41.34 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.9 tt -111.69 135.83 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.78 0.324 . . . . 0.0 110.962 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.51 179.553 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -89.95 6.17 43.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.289 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 4' ' ' LEU . 39.1 p -79.77 -1.27 37.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.297 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 3' ' ' SER . 24.1 tp 54.19 144.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.6 m -91.24 137.45 26.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.69 140.29 84.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.01 1.807 . . . . 0.0 111.68 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 46.46 82.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.01 47.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.782 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.86 144.64 26.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.15 -169.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -85.09 143.44 39.71 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.937 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' C ' ' CD2' ' A' ' 13' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.462 ' N ' HD11 ' A' ' 15' ' ' LEU . 24.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.602 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.759 HH21 ' HG ' ' A' ' 25' ' ' SER . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.759 ' HG ' HH21 ' A' ' 22' ' ' ARG . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 HD13 HG23 ' A' ' 28' ' ' ILE . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.679 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' O ' ' CG1' ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.681 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.408 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.493 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.495 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.705 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.761 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.705 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' N ' HD11 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.464 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 71' ' ' VAL . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HD22 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.761 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 84' ' ' ILE . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.9 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.568 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 100' ' ' GLN . 26.2 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.478 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.35 -33.87 76.7 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.03 -22.73 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 96' ' ' GLN . 25.2 mt-30 63.13 47.89 3.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.447 ' O ' ' O ' ' A' ' 102' ' ' GLU . 96.1 mm-40 -101.53 147.56 26.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.4 mm-40 56.3 114.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.464 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.2 122.54 0.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.63 157.32 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.796 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.694 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 1' ' ' GLY . 21.6 m -57.69 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.463 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.2 p -64.42 164.17 11.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.27 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.4 tp 52.56 78.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.027 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 m -121.87 81.0 41.81 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.003 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.51 -166.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.923 1.748 . . . . 0.0 111.274 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -67.13 138.47 57.1 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.75 41.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.704 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -84.17 155.6 22.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.482 -179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 175.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.804 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -83.23 137.23 42.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.489 ' N ' HD11 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CZ ' HD13 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.606 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.8 m-20 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 15' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.468 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.796 ' N ' ' NE2' ' A' ' 55' ' ' GLN . 13.3 m120 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.796 ' NE2' ' N ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.508 ' CD1' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.621 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' O ' ' N ' ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.621 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.631 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' HD21 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.667 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 54.2 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.489 ' HG ' ' H ' ' A' ' 83' ' ' GLY . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 ' HG1' ' N ' ' A' ' 88' ' ' ASP . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.425 ' N ' ' HG1' ' A' ' 87' ' ' THR . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 1.5 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.667 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -68.79 -37.77 79.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 100' ' ' GLN . 55.6 t -64.26 -43.26 97.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.583 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' VAL . 53.7 mt-30 57.59 131.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 102' ' ' GLU . 88.8 mt-30 57.27 -154.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.1 mm-40 57.05 158.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -109.57 2.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -95.46 123.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.747 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 3' ' ' SER . 27.1 t -132.09 -117.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.505 ' N ' ' OG ' ' A' ' 2' ' ' SER . 91.4 p -80.31 -1.01 39.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.34 107.98 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.07 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.95 86.73 0.73 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.778 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.45 -5.36 16.49 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.68 2.254 . . . . 0.0 111.699 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -76.34 6.07 6.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.49 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.47 117.53 15.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.444 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.75 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.44 148.06 25.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 9' ' ' LEU . . . -66.8 175.73 2.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.277 -178.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -82.4 143.89 48.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.619 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 16' ' ' GLN . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.473 ' N ' HD11 ' A' ' 15' ' ' LEU . 22.3 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' CZ ' ' CD1' ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.588 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.565 HH22 ' HG1' ' A' ' 67' ' ' THR . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.429 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.6 m-20 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.431 HD21 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.431 ' N ' HD21 ' A' ' 47' ' ' LEU . 3.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.481 ' CD1' ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.676 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.599 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.463 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.565 ' HG1' HH22 ' A' ' 22' ' ' ARG . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' HB2' ' HG ' ' A' ' 82' ' ' SER . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 81' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.515 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.419 ' N ' ' HG ' ' A' ' 77' ' ' SER . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 52.9 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.463 ' OG ' ' CG2' ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.476 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.652 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.9 mt -68.17 -31.67 71.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.612 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 81.4 t -72.55 3.06 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -81.74 20.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.162 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -89.34 -4.74 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.107 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.612 ' OE1' ' O ' ' A' ' 99' ' ' VAL . 62.0 mp0 -99.37 172.16 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -52.44 -146.5 0.0 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.77 136.28 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.753 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.532 179.911 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -82.82 -1.18 51.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.454 ' HG ' ' HG3' ' A' ' 7' ' ' GLN . 8.1 t -179.34 101.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.74 -41.3 90.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.234 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -99.9 142.49 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.597 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 2.6 Cg_endo -52.21 140.97 50.48 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.248 1.965 . . . . 0.0 111.696 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.454 ' HG3' ' HG ' ' A' ' 3' ' ' SER . 43.7 mt-30 -103.33 -12.47 17.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.196 179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.69 46.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.979 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.597 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -82.3 134.52 35.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.038 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.83 -175.79 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.562 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -86.11 126.32 65.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' N ' HD21 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.479 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' O ' ' OG1' ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.616 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.616 ' CG2' ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 2.8 mm100 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 80.6 m-20 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 35' ' ' ILE . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 41' ' ' ALA . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.584 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.691 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.634 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.634 ' H ' ' C ' ' A' ' 62' ' ' TYR . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.466 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 71' ' ' VAL . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' N ' HD22 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.61 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.473 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.96 -29.5 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.613 ' O ' ' N ' ' A' ' 101' ' ' GLN . 17.9 t -102.06 30.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.008 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.473 HE21 ' HA ' ' A' ' 97' ' ' TRP . 80.1 mm-40 -62.92 53.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.613 ' N ' ' O ' ' A' ' 99' ' ' VAL . 94.2 mt-30 -85.54 -0.44 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.472 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -101.39 140.14 36.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.062 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.06 -18.15 8.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.9 mt -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.664 0.269 . . . . 0.0 110.337 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.649 179.953 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 t -150.56 57.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.71 0.29 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -69.53 -4.4 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.051 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -102.06 131.24 48.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -123.03 80.81 51.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.221 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.92 -4.78 15.3 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.352 2.701 . . . . 0.0 113.3 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -67.71 124.77 24.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.659 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.81 130.44 34.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.28 158.63 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.94 136.34 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.365 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -91.38 145.75 32.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.076 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.716 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.454 ' N ' HD12 ' A' ' 15' ' ' LEU . 20.5 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 50' ' ' ILE . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.62 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.62 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 26' ' ' GLN . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.649 ' N ' ' HG ' ' A' ' 25' ' ' SER . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.501 ' C ' ' O ' ' A' ' 39' ' ' VAL . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG2' ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.527 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.446 HG21 ' N ' ' A' ' 53' ' ' ALA . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 52' ' ' VAL . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' H ' HD13 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.663 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.663 ' H ' ' C ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.484 ' N ' HD12 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.484 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 86' ' ' LEU . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HZ3' ' HA2' ' A' ' 74' ' ' GLY . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' ' HZ3' ' A' ' 72' ' ' LYS . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.493 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.549 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 4.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 100' ' ' GLN . 26.3 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.82 -36.23 72.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.88 -41.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.544 179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 96' ' ' GLN . 67.5 mm-40 64.11 63.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.625 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -73.18 17.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.867 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 100' ' ' GLN . 95.5 mt-10 -53.18 144.81 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.988 0.423 . . . . 0.0 110.96 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.26 176.91 17.68 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 105' ' ' PHE . 17.5 tt -112.26 125.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.509 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.4 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 3' ' ' SER . 19.5 t -106.56 138.37 42.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.666 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 2' ' ' SER . 93.8 p 16.73 95.54 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.411 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 tt -80.13 -6.89 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.424 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.32 80.8 71.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.274 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.24 149.75 64.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.877 2.385 . . . . 0.0 112.806 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 65.38 79.7 0.24 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.771 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.35 53.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.341 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.26 -169.97 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.359 -179.419 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.36 153.84 40.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.99 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -87.42 138.36 32.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 HD21 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.425 ' CZ ' HD11 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' NH1' ' O ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' HZ1' ' A' ' 33' ' ' LYS . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' HZ1' HG13 ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 40' ' ' GLU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CB ' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.429 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.564 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.706 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.706 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 2.7 pm0 -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.473 ' O ' ' NH1' ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' O ' ' CD1' ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 86' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' N ' HD22 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.599 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.729 ' HG ' ' N ' ' A' ' 83' ' ' GLY . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.729 ' N ' ' HG ' ' A' ' 82' ' ' SER . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.9 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 89.1 mm-40 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' O ' ' CG2' ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' GLN . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.02 -40.46 65.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 95' ' ' PRO . 65.4 t -70.7 -34.91 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.083 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 96' ' ' GLN . 95.2 mt-30 58.83 -163.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.94 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 54.87 81.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.353 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 -49.62 144.62 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 110.503 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -36.53 167.08 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 HD13 HG22 ' A' ' 104' ' ' ILE . 72.5 mt -95.24 133.12 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.147 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.621 -179.484 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.891 ' N ' HD13 ' A' ' 15' ' ' LEU . 74.4 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 69' ' ' ALA . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' C ' HG23 ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.597 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 32' ' ' VAL . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.53 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 28' ' ' ILE . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.3 m120 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.584 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.587 ' OE1' HG23 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HD12 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.771 HG23 ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.706 HH12 HG23 ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG23 HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 93' ' ' GLN . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.771 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.599 ' HG3' HD21 ' A' ' 81' ' ' LEU . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 39' ' ' VAL . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.871 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.871 ' N ' HD13 ' A' ' 15' ' ' LEU . 73.0 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 69' ' ' ALA . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.566 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 25' ' ' SER . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.1 m120 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 39' ' ' VAL . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.757 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 HD22 ' A' ' 13' ' ' LEU . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.623 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.695 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.876 ' N ' HD23 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HE2' HD11 ' A' ' 13' ' ' LEU . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.718 ' O ' ' NE2' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.718 ' NE2' ' O ' ' A' ' 78' ' ' ARG . 40.2 mm-40 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 71' ' ' VAL . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.642 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 HG21 ' A' ' 28' ' ' ILE . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CH2' HD12 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.894 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 70' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.858 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.6 ' CD2' HG22 ' A' ' 29' ' ' VAL . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.544 HG23 ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.835 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.835 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.791 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.658 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.544 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 28' ' ' ILE . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.1 m120 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 36' ' ' LEU . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.679 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.793 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.798 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.943 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.865 ' N ' HD13 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.618 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.836 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.443 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 71' ' ' VAL . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.461 HD11 ' HZ2' ' A' ' 97' ' ' TRP . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.618 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 28' ' ' ILE . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 11.0 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.677 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.763 0.316 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.745 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 68' ' ' PRO . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.552 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.45 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.552 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 25.1 m120 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.741 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.678 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.759 HG23 ' NE2' ' A' ' 55' ' ' GLN . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 50' ' ' ILE . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.758 ' H ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.881 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.695 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.853 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.62 HG13 HG22 ' A' ' 71' ' ' VAL . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' LEU . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.695 ' OG ' HG23 ' A' ' 66' ' ' VAL . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 8.2 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.873 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 68.9 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.685 ' C ' HG23 ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.567 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.983 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.553 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.7 m120 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.866 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' N ' HD23 ' A' ' 47' ' ' LEU . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.547 HD11 ' CD ' ' A' ' 16' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' A' ' 53' ' ' ALA . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 67' ' ' THR . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' OD1' ' A' ' 51' ' ' ASN . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.637 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.776 ' H ' HD12 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 65' ' ' VAL . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.772 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.537 HG21 HG11 ' A' ' 52' ' ' VAL . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.845 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.792 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.445 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.507 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HG13 ' A' ' 71' ' ' VAL . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 93' ' ' GLN . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.645 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.932 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CG ' HD22 ' A' ' 81' ' ' LEU . 4.7 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.662 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 39' ' ' VAL . 50.9 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.904 ' N ' HD13 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 25' ' ' SER . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 25' ' ' SER . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.764 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG12 HD13 ' A' ' 13' ' ' LEU . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.988 HG22 ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.757 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 67' ' ' THR . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.988 ' NE2' HG22 ' A' ' 50' ' ' ILE . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 64' ' ' LEU . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.717 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 52' ' ' VAL . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 80' ' ' VAL . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.464 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 42.7 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 93' ' ' GLN . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.717 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.479 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.467 ' HB3' HD22 ' A' ' 81' ' ' LEU . 1.9 tt0 -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.675 ' HG3' HD21 ' A' ' 81' ' ' LEU . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.649 0.262 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.885 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.888 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.485 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.996 ' O ' HG23 ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 86' ' ' LEU . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.549 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 28' ' ' ILE . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.549 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 21.6 m120 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.68 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.71 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.653 HG23 HD22 ' A' ' 13' ' ' LEU . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.686 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.777 HG23 ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.777 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.867 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 71' ' ' VAL . 79.2 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.75 HG13 HG22 ' A' ' 71' ' ' VAL . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.51 ' OG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.904 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 28' ' ' ILE . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 98' ' ' LEU . 89.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.2 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.622 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.649 ' C ' HG23 ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.649 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.921 ' O ' HG23 ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 68' ' ' PRO . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.547 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 22.3 m120 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' HD23 ' A' ' 47' ' ' LEU . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.851 ' ND2' ' HB3' ' A' ' 53' ' ' ALA . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 18' ' ' PHE . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.851 ' HB3' ' ND2' ' A' ' 51' ' ' ASN . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.936 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' CG1' HD12 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.769 ' N ' HD23 ' A' ' 70' ' ' LEU . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' NH1' ' CE1' ' A' ' 62' ' ' TYR . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.688 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 58.3 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 71' ' ' VAL . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 66' ' ' VAL . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.72 ' HB3' HD22 ' A' ' 81' ' ' LEU . 4.6 tt0 -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.688 ' NE2' ' OE1' ' A' ' 79' ' ' GLN . 30.2 mm100 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.53 0.205 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 80.2 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 69' ' ' ALA . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.951 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.409 HD12 ' HG2' ' A' ' 68' ' ' PRO . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.531 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD2' HG21 ' A' ' 87' ' ' THR . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.6 m120 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.719 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 HD22 ' A' ' 13' ' ' LEU . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.515 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.695 HD11 ' OE1' ' A' ' 16' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG11 HG21 ' A' ' 67' ' ' THR . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.2 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 64' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.654 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.768 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.736 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.734 HG21 HG11 ' A' ' 52' ' ' VAL . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.79 ' N ' HD23 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.563 ' O ' HG13 ' A' ' 71' ' ' VAL . 70.0 mm-40 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 71' ' ' VAL . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.736 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.694 HD23 ' HB2' ' A' ' 70' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 31' ' ' ARG . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 28.4 mm100 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.412 0.148 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.881 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.915 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' CD2' HG22 ' A' ' 29' ' ' VAL . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.993 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 32' ' ' VAL . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG23 ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 87' ' ' THR . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 13.9 m120 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.907 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 36' ' ' LEU . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 13' ' ' LEU . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 35.4 t-20 -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.686 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 64' ' ' LEU . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.817 ' N ' HD13 ' A' ' 64' ' ' LEU . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.715 ' N ' HD23 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.727 ' CB ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.521 HH12 HG21 ' A' ' 80' ' ' VAL . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 31' ' ' ARG . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.874 ' HB3' HD22 ' A' ' 81' ' ' LEU . 5.0 mt-30 -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 39' ' ' VAL . 95.0 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.746 0.308 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.889 HD11 HD21 ' A' ' 70' ' ' LEU . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.874 ' N ' HD13 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 29' ' ' VAL . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HE2' HD12 ' A' ' 58' ' ' LEU . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.599 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.599 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.615 HD13 HD13 ' A' ' 86' ' ' LEU . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 25' ' ' SER . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.548 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.548 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 30.6 m120 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.805 HG11 HD21 ' A' ' 94' ' ' LEU . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 58' ' ' LEU . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.51 HD21 ' HG3' ' A' ' 55' ' ' GLN . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.789 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.677 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.892 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.678 ' O ' HG13 ' A' ' 71' ' ' VAL . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.441 HD11 ' CH2' ' A' ' 97' ' ' TRP . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.677 ' OG ' HG23 ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 93' ' ' GLN . 25.7 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.805 HD21 HG11 ' A' ' 39' ' ' VAL . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.816 0.341 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.933 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.933 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.903 ' N ' HD13 ' A' ' 15' ' ' LEU . 76.7 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' A' ' 29' ' ' VAL . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' C ' HG23 ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.974 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.649 HD12 ' HG2' ' A' ' 68' ' ' PRO . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HB3' HG21 ' A' ' 87' ' ' THR . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 14.5 m120 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.888 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 13.6 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 18' ' ' PHE . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.897 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.803 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.649 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.508 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 93' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 31' ' ' ARG . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 4.4 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 36' ' ' LEU . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.507 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.907 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.907 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 15' ' ' LEU . 82.7 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' CD2' HG22 ' A' ' 29' ' ' VAL . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 25' ' ' SER . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.626 ' C ' HG23 ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 29' ' ' VAL . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 68' ' ' PRO . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.55 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 10.7 mm-40 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 20.0 m120 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LEU . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 13' ' ' LEU . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.654 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.572 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.678 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.711 ' H ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.773 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.815 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.631 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 71' ' ' VAL . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD22 ' CD ' ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.773 ' OG ' HG23 ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.526 ' CD ' HD22 ' A' ' 81' ' ' LEU . 6.6 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 98' ' ' LEU . 89.4 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.914 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.6 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.84 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.413 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.705 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.555 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.705 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 13.2 m-20 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.549 ' O ' HG12 ' A' ' 39' ' ' VAL . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.899 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.576 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 15' ' ' LEU . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.871 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.546 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.546 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.518 ' OE1' ' OE1' ' A' ' 93' ' ' GLN . 74.3 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.668 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 82' ' ' SER . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.861 ' HB3' HD22 ' A' ' 81' ' ' LEU . 34.6 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.911 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.918 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.446 HH21 HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 HH21 ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' VAL . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.553 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.666 ' HD3' HG21 ' A' ' 87' ' ' THR . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 28' ' ' ILE . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.1 m120 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.594 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 36' ' ' LEU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.632 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.858 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HD2' ' A' ' 18' ' ' PHE . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.91 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.778 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.694 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.685 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HE3' HD11 ' A' ' 13' ' ' LEU . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG13 HG22 ' A' ' 71' ' ' VAL . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 89' ' ' GLN . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.856 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 31' ' ' ARG . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 39' ' ' VAL . 79.6 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.664 0.268 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.908 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 69' ' ' ALA . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.6 ' C ' HG23 ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 68' ' ' PRO . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.541 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NE ' HG21 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' ILE . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.3 m120 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.903 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 13' ' ' LEU . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 18' ' ' PHE . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.623 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.71 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.707 ' N ' HD23 ' A' ' 70' ' ' LEU . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 71' ' ' VAL . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.623 ' OG ' HG23 ' A' ' 66' ' ' VAL . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.886 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.44 HG21 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.407 ' CD ' HD22 ' A' ' 81' ' ' LEU . 21.9 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.559 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.955 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.942 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.597 ' HD2' HG12 ' A' ' 52' ' ' VAL . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 68' ' ' PRO . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.544 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.9 m120 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 13' ' ' LEU . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.652 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.8 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 18' ' ' PHE . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 65' ' ' VAL . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.715 HG23 ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 52' ' ' VAL . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.955 HD21 HD11 ' A' ' 15' ' ' LEU . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.832 ' N ' HD23 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' O ' HG13 ' A' ' 71' ' ' VAL . 93.2 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 71' ' ' VAL . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 93' ' ' GLN . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 66' ' ' VAL . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.704 ' HB3' HD22 ' A' ' 81' ' ' LEU . 3.8 tt0 -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.73 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.619 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.911 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.866 ' N ' HD13 ' A' ' 15' ' ' LEU . 72.2 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.639 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 17' ' ' LEU . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.554 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 21.7 m120 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.68 HD11 ' OE1' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 50' ' ' ILE . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 55' ' ' GLN . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.793 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.689 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.639 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.911 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' CA ' ' HZ3' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' VAL . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.689 ' OG ' HG23 ' A' ' 66' ' ' VAL . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' GLN . 20.5 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 98' ' ' LEU . 79.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.88 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 70' ' ' LEU . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 29' ' ' VAL . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.596 ' C ' HG23 ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.999 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 68' ' ' PRO . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.552 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 28' ' ' ILE . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.552 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.5 m120 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 HD22 ' A' ' 13' ' ' LEU . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' CE1' ' A' ' 18' ' ' PHE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 67' ' ' THR . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.7 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.795 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG23 ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 52' ' ' VAL . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 15' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.808 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.787 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.787 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.691 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 83' ' ' GLY . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 82' ' ' SER . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.421 ' CD ' HD22 ' A' ' 81' ' ' LEU . 4.3 tt0 -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.751 0.31 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.864 ' N ' HD13 ' A' ' 15' ' ' LEU . 80.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.649 ' CD2' HG22 ' A' ' 29' ' ' VAL . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 58' ' ' LEU . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.617 ' C ' HG23 ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.961 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.558 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' ILE . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 22.4 m120 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.019 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.019 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.628 HG23 HD22 ' A' ' 13' ' ' LEU . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 58' ' ' LEU . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' HD21 ' A' ' 58' ' ' LEU . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.917 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.917 ' N ' HD12 ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.665 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.777 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.731 ' N ' HD13 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.489 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.863 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.777 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.745 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.683 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 82' ' ' SER . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 15.3 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.568 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.955 ' N ' HD23 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.69 ' CD2' HG22 ' A' ' 29' ' ' VAL . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.97 ' O ' HG23 ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.753 HD13 HD13 ' A' ' 86' ' ' LEU . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.1 m120 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.695 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG23 HD22 ' A' ' 13' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.639 ' N ' HD23 ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.45 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.646 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 73.6 m-20 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.737 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.75 ' H ' HD12 ' A' ' 58' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.917 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.724 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.895 ' N ' HD23 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.812 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 50.3 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 71' ' ' VAL . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.681 ' OG ' HG23 ' A' ' 66' ' ' VAL . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.924 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 6.9 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 39' ' ' VAL . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.812 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.749 0.309 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.923 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.869 ' N ' HD13 ' A' ' 15' ' ' LEU . 76.1 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 86' ' ' LEU . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.535 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 28' ' ' ILE . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.6 m120 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.89 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.89 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.711 HG23 HD22 ' A' ' 13' ' ' LEU . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.621 ' N ' HD23 ' A' ' 47' ' ' LEU . 8.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.812 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 67' ' ' THR . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.849 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 52' ' ' VAL . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 15' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.812 HG22 HG13 ' A' ' 80' ' ' VAL . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.499 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.504 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 43.0 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG13 HG22 ' A' ' 71' ' ' VAL . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 39' ' ' VAL . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.505 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.912 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.884 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 69' ' ' ALA . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.604 ' C ' HG23 ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.511 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 84' ' ' ILE . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . 1.003 ' O ' HG23 ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 32' ' ' VAL . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 43.9 mm-40 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' ILE . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.2 m120 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.517 ' N ' HD22 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.732 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.732 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.721 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 65' ' ' VAL . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.893 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' OG ' ' A' ' 82' ' ' SER . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.651 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.755 ' N ' HD23 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 13' ' ' LEU . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 71' ' ' VAL . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.775 HD21 ' HG3' ' A' ' 93' ' ' GLN . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 66' ' ' VAL . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.475 HG22 HD21 ' A' ' 24' ' ' LEU . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.447 ' HB3' HD22 ' A' ' 81' ' ' LEU . 5.2 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.775 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 94' ' ' LEU . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.906 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 72.7 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.445 ' HE1' HD13 ' A' ' 58' ' ' LEU . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.61 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.541 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 23.0 m120 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.609 ' N ' HD23 ' A' ' 47' ' ' LEU . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.842 HG23 ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 59' ' ' VAL . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.842 ' NE2' HG23 ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.782 ' N ' HD12 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.776 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.797 ' N ' HD23 ' A' ' 70' ' ' LEU . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.696 ' HE2' HD11 ' A' ' 13' ' ' LEU . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 71' ' ' VAL . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' HG23 ' A' ' 66' ' ' VAL . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.731 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 93' ' ' GLN . 23.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.56 0.219 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.909 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.592 ' C ' HG23 ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.474 HH22 ' CB ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 29' ' ' VAL . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 68' ' ' PRO . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 25' ' ' SER . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' NZ ' ' CG1' ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.8 m120 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.75 ' OE1' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.819 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.474 ' CB ' HH22 ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.774 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.603 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.603 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 71' ' ' VAL . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 83' ' ' GLY . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.808 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' GLN . 9.0 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' GLN . 25.8 mm100 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -96.91 153.65 17.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -106.64 139.12 41.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.459 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 tp -95.94 -47.67 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.33 66.82 75.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.374 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.75 141.9 15.21 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.434 2.089 . . . . 0.0 112.386 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -104.73 132.2 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.65 43.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.5 pt? -84.6 148.74 26.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 133.26 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.923 0.392 . . . . 0.0 110.974 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -93.1 151.15 40.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.291 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.891 ' N ' HD13 ' A' ' 15' ' ' LEU . 74.4 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 69' ' ' ALA . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' C ' HG23 ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.597 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 32' ' ' VAL . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.53 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 28' ' ' ILE . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.3 m120 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.584 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.608 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.587 ' OE1' HG23 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HD12 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.771 HG23 ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.706 HH12 HG23 ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG23 HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 93' ' ' GLN . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.771 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.599 ' HG3' HD21 ' A' ' 81' ' ' LEU . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 39' ' ' VAL . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.79 -42.49 24.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 101' ' ' GLN . 69.3 t -69.49 -51.24 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.598 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 29.9 mm-40 48.51 35.85 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.727 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.555 ' H ' HG12 ' A' ' 99' ' ' VAL . 55.1 mt-30 -106.46 125.93 51.62 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.597 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -96.71 -3.28 42.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.41 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.33 -170.94 42.39 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 105' ' ' PHE . 73.5 mt -104.68 129.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 110.562 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.506 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.1 t80 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.703 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -133.5 -97.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -64.85 155.39 34.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.387 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.615 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -117.18 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.75 159.89 29.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.533 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' O ' ' C ' ' A' ' 7' ' ' GLN . 2.6 Cg_endo -48.12 144.78 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.796 2.331 . . . . 0.0 111.699 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' C ' ' O ' ' A' ' 6' ' ' PRO . 30.1 mt-30 -5.36 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.567 0.542 . . . . 0.0 111.365 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.62 122.22 19.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.588 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.838 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.07 145.01 26.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.836 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.725 ' O ' HD22 ' A' ' 9' ' ' LEU . . . -68.08 -163.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.328 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -88.28 118.08 69.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.49 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.871 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.871 ' N ' HD13 ' A' ' 15' ' ' LEU . 73.0 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 69' ' ' ALA . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.566 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 25' ' ' SER . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.1 m120 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 39' ' ' VAL . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.757 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 HD22 ' A' ' 13' ' ' LEU . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.623 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.695 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.876 ' N ' HD23 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HE2' HD11 ' A' ' 13' ' ' LEU . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.718 ' O ' ' NE2' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.718 ' NE2' ' O ' ' A' ' 78' ' ' ARG . 40.2 mm-40 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 71' ' ' VAL . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.642 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 HG21 ' A' ' 28' ' ' ILE . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CH2' HD12 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.1 -35.41 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.61 -44.47 98.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.179 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 101' ' ' GLN . 82.0 mt-30 54.46 50.08 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 100' ' ' GLN . 88.8 mt-30 -36.83 165.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.54 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.6 -36.02 75.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.22 177.04 30.94 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.452 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.31 134.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 110.667 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.502 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 p -64.8 162.59 15.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t 67.59 4.24 3.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.4 tp -99.68 134.91 41.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.173 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.49 156.17 36.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.676 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -49.05 156.36 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.042 2.495 . . . . 0.0 111.802 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.34 138.92 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.77 152.01 19.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.031 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -82.93 160.48 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.722 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 134.78 53.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.933 0.397 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -91.67 149.15 38.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.755 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.894 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 70' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.858 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.6 ' CD2' HG22 ' A' ' 29' ' ' VAL . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.544 HG23 ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.835 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.835 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.791 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.658 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.544 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 28' ' ' ILE . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.1 m120 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 36' ' ' LEU . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.793 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.798 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.577 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.943 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.865 ' N ' HD13 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.618 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.836 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.443 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 71' ' ' VAL . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.461 HD11 ' HZ2' ' A' ' 97' ' ' TRP . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.618 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 28' ' ' ILE . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 11.0 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.677 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.54 -40.68 56.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 95' ' ' PRO . 76.4 t -63.69 -43.0 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 89.3 mt-30 52.54 29.62 7.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -152.49 163.84 38.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 57.32 -144.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 54.94 5.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 tp -96.13 135.21 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 110.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.457 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 m -57.33 -38.34 73.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.708 0.289 . . . . 0.0 110.9 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -72.11 148.96 45.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 tp -89.67 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.85 58.28 0.4 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -45.34 146.05 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.767 2.312 . . . . 0.0 111.87 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 8' ' ' ALA . 58.0 tp60 -65.17 143.64 57.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 27.69 76.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.673 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -85.87 138.25 32.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.02 43.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.335 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -81.8 147.07 57.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.396 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.745 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 68' ' ' PRO . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.552 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.45 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.552 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 25.1 m120 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.741 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.678 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.759 HG23 ' NE2' ' A' ' 55' ' ' GLN . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 50' ' ' ILE . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.758 ' H ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.881 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.695 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.853 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.62 HG13 HG22 ' A' ' 71' ' ' VAL . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' LEU . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.695 ' OG ' HG23 ' A' ' 66' ' ' VAL . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 8.2 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.904 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt -90.18 -25.15 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 95' ' ' PRO . 25.5 t -86.74 32.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 74.1 mt-30 -57.87 142.78 44.84 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 102' ' ' GLU . 75.1 mt-30 -158.19 -93.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.313 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 101' ' ' GLN . 66.4 mm-40 30.38 40.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.962 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -86.33 151.84 24.87 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.13 125.76 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.0 t80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.617 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.675 ' C ' ' H ' ' A' ' 4' ' ' LEU . 6.2 p -80.06 -0.39 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.773 0.32 . . . . 0.0 110.383 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.28 -14.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.675 ' H ' ' C ' ' A' ' 2' ' ' SER . 12.0 tp -60.6 -39.8 89.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -122.47 80.49 46.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.822 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.34 151.79 76.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.648 2.232 . . . . 0.0 112.015 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 9' ' ' LEU . 37.1 tt0 -101.77 131.41 48.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.225 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . -16.77 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.056 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -85.06 138.75 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.23 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 146.31 54.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -89.66 146.25 35.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.334 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.873 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 68.9 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.685 ' C ' HG23 ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.567 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.983 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.553 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.7 m120 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.866 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' N ' HD23 ' A' ' 47' ' ' LEU . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.547 HD11 ' CD ' ' A' ' 16' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' A' ' 53' ' ' ALA . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 67' ' ' THR . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' OD1' ' A' ' 51' ' ' ASN . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.637 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.776 ' H ' HD12 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 65' ' ' VAL . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.772 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.537 HG21 HG11 ' A' ' 52' ' ' VAL . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.845 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.792 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.445 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.507 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HG13 ' A' ' 71' ' ' VAL . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 93' ' ' GLN . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.645 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.932 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CG ' HD22 ' A' ' 81' ' ' LEU . 4.7 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.662 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 39' ' ' VAL . 50.9 mt -75.38 -45.1 41.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 95' ' ' PRO . 92.7 t -64.0 -39.07 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 101' ' ' GLN . 95.1 mt-30 58.6 30.73 20.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.301 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 100' ' ' GLN . 92.7 mt-30 37.77 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.764 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.557 ' O ' ' C ' ' A' ' 103' ' ' GLY . 62.5 mm-40 -92.19 139.16 30.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 27.76 -127.22 0.07 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.03 134.21 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 110.311 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.515 ' OXT' ' CD2' ' A' ' 105' ' ' PHE . 84.5 t80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.441 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -83.44 -1.4 53.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.349 . . . . 0.0 110.651 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.7 m -85.0 168.09 15.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -86.6 115.9 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.731 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -163.6 101.7 0.95 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.421 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -67.18 57.58 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.995 1.797 . . . . 0.0 111.877 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' SER . 98.3 mt-30 -87.71 131.93 34.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -164.54 34.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.794 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.1 pp -84.77 137.99 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 156.85 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.252 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.38 161.87 58.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.312 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.904 ' N ' HD13 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 25' ' ' SER . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 25' ' ' SER . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.764 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG12 HD13 ' A' ' 13' ' ' LEU . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.988 HG22 ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.757 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 67' ' ' THR . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.988 ' NE2' HG22 ' A' ' 50' ' ' ILE . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 64' ' ' LEU . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.717 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 52' ' ' VAL . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 80' ' ' VAL . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.464 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 42.7 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 93' ' ' GLN . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.717 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.479 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.467 ' HB3' HD22 ' A' ' 81' ' ' LEU . 1.9 tt0 -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.675 ' HG3' HD21 ' A' ' 81' ' ' LEU . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.3 -40.02 81.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 101' ' ' GLN . 89.3 t -74.1 -41.01 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.267 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 60.99 34.5 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.37 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' HG12 ' A' ' 99' ' ' VAL . 95.5 mt-30 -138.31 143.33 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.2 0.524 . . . . 0.0 111.23 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 103' ' ' GLY . 91.4 mt-10 -96.13 143.98 26.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.305 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . 53.89 151.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -110.66 136.81 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.983 0.42 . . . . 0.0 111.305 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.525 179.616 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 1' ' ' GLY . 33.2 m -58.38 -125.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.455 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' LEU . 73.5 m -79.55 7.02 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.5 tp 46.5 102.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.78 152.89 95.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.191 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.16 140.65 19.29 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.45 2.1 . . . . 0.0 111.536 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.27 135.84 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.702 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 142.59 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -86.79 115.48 24.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.645 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 148.31 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -85.69 141.1 35.88 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.383 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.885 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.888 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.485 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.996 ' O ' HG23 ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 86' ' ' LEU . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.549 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 28' ' ' ILE . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.549 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 21.6 m120 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.68 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.71 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.653 HG23 HD22 ' A' ' 13' ' ' LEU . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.686 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.777 HG23 ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.777 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.867 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.445 ' O ' HG13 ' A' ' 71' ' ' VAL . 79.2 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.75 HG13 HG22 ' A' ' 71' ' ' VAL . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.51 ' OG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.904 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 28' ' ' ILE . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.493 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 100' ' ' GLN . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.493 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 98' ' ' LEU . 89.7 mt -73.37 -41.7 63.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.486 HG11 ' NE2' ' A' ' 101' ' ' GLN . 71.6 t -76.0 -41.14 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.381 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' GLN . 29.3 mm100 62.6 49.0 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.714 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.486 ' NE2' HG11 ' A' ' 99' ' ' VAL . 31.5 mm-40 -58.26 -34.45 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.93 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 50.18 18.37 0.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.72 158.24 28.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.579 ' C ' ' CG ' ' A' ' 105' ' ' PHE . 26.9 pt -116.36 153.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 110.722 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -64.67 160.58 19.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 110.646 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -143.83 -96.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 4' ' ' LEU . 29.1 tp -81.28 52.4 1.81 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.125 0.488 . . . . 0.0 110.126 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 158.31 84.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.016 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -47.92 176.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 123.31 2.673 . . . . 0.0 112.103 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.27 151.19 47.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.77 142.37 2.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.2 -170.79 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.273 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.56 157.98 30.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -85.64 147.5 46.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.2 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.622 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.649 ' C ' HG23 ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.649 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.921 ' O ' HG23 ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 68' ' ' PRO . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 22.3 m120 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' HD23 ' A' ' 47' ' ' LEU . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.851 ' ND2' ' HB3' ' A' ' 53' ' ' ALA . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 18' ' ' PHE . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.851 ' HB3' ' ND2' ' A' ' 51' ' ' ASN . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.936 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' CG1' HD12 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.769 ' N ' HD23 ' A' ' 70' ' ' LEU . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' NH1' ' CE1' ' A' ' 62' ' ' TYR . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.688 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 58.3 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 71' ' ' VAL . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 66' ' ' VAL . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.72 ' HB3' HD22 ' A' ' 81' ' ' LEU . 4.6 tt0 -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.688 ' NE2' ' OE1' ' A' ' 79' ' ' GLN . 30.2 mm100 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.743 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt -75.74 -37.31 59.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 95' ' ' PRO . 58.4 t -66.6 -46.88 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.03 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 86.6 mt-30 48.99 60.78 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.87 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.72 124.42 20.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.146 0.498 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 103' ' ' GLY . 43.1 mt-10 -99.1 131.28 45.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.957 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 30.62 -125.2 0.16 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' PHE . 15.7 tt -117.84 137.12 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -77.62 7.68 5.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 t -130.89 51.18 2.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.774 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 4' ' ' LEU . 9.1 tt -60.25 -37.04 79.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.64 166.04 12.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.35 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -76.98 -71.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.442 2.095 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -97.57 153.26 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.402 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.45 138.89 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.684 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -85.41 152.97 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.063 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.93 144.37 55.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.397 . . . . 0.0 110.268 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -86.02 140.9 35.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 80.2 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 69' ' ' ALA . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.951 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.409 HD12 ' HG2' ' A' ' 68' ' ' PRO . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.531 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD2' HG21 ' A' ' 87' ' ' THR . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.6 m120 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.719 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 HD22 ' A' ' 13' ' ' LEU . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.515 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.695 HD11 ' OE1' ' A' ' 16' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG11 HG21 ' A' ' 67' ' ' THR . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.2 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 64' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.654 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.768 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.736 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.734 HG21 HG11 ' A' ' 52' ' ' VAL . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.79 ' N ' HD23 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.563 ' O ' HG13 ' A' ' 71' ' ' VAL . 70.0 mm-40 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 71' ' ' VAL . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.736 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.694 HD23 ' HB2' ' A' ' 70' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 31' ' ' ARG . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 28.4 mm100 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.15 -37.2 85.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.07 -48.62 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.251 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 62.64 39.36 11.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.332 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.583 ' O ' ' O ' ' A' ' 102' ' ' GLU . 83.5 mt-30 -148.12 -94.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.27 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 101' ' ' GLN . 80.4 mm-40 25.57 -148.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 125.76 0.02 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 105' ' ' PHE . 61.1 mt -103.34 136.13 37.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.344 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.9 t80 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.5 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 3' ' ' SER . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.673 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 40.1 14.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.665 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 1' ' ' GLY . 57.4 p 31.51 29.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.673 ' N ' ' O ' ' A' ' 2' ' ' SER . 29.4 tp -90.86 115.33 27.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.746 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -168.66 67.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.08 137.82 70.13 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.198 1.932 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.663 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 39.1 tt0 -94.33 -74.71 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.83 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 7' ' ' GLN . . . 128.27 100.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.888 0.742 . . . . 0.0 109.899 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 120.83 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.29 157.82 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.178 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -86.12 135.78 36.75 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.739 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.881 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.915 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' CD2' HG22 ' A' ' 29' ' ' VAL . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.993 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 32' ' ' VAL . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG23 ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 87' ' ' THR . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 13.9 m120 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.907 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 36' ' ' LEU . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 13' ' ' LEU . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 35.4 t-20 -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.686 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 64' ' ' LEU . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.817 ' N ' HD13 ' A' ' 64' ' ' LEU . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.715 ' N ' HD23 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.727 ' CB ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.521 HH12 HG21 ' A' ' 80' ' ' VAL . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 31' ' ' ARG . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.874 ' HB3' HD22 ' A' ' 81' ' ' LEU . 5.0 mt-30 -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 39' ' ' VAL . 95.0 mt -77.27 -36.83 54.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 95' ' ' PRO . 55.1 t -64.01 -44.97 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.878 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' C ' ' O ' ' A' ' 99' ' ' VAL . 75.9 mm-40 21.23 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 99' ' ' VAL . 95.1 mt-30 -114.43 -70.42 0.8 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.791 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -70.54 150.5 46.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.02 48.64 0.65 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 105' ' ' PHE . 11.0 pt -102.97 141.74 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.399 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' GLY . 7.3 t 46.45 -173.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.788 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.58 142.03 3.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.464 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.782 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.3 tm? -57.36 -34.0 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.45 83.55 16.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.47 150.32 63.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.6 2.2 . . . . 0.0 112.05 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 60.36 39.69 18.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.62 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.07 -158.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.905 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.89 144.21 29.37 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.181 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.64 147.14 52.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.77 147.9 47.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.596 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.889 HD11 HD21 ' A' ' 70' ' ' LEU . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.874 ' N ' HD13 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 29' ' ' VAL . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HE2' HD12 ' A' ' 58' ' ' LEU . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.599 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.599 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.615 HD13 HD13 ' A' ' 86' ' ' LEU . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 25' ' ' SER . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.548 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.548 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 30.6 m120 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.805 HG11 HD21 ' A' ' 94' ' ' LEU . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 58' ' ' LEU . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.51 HD21 ' HG3' ' A' ' 55' ' ' GLN . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.789 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.677 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.892 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.678 ' O ' HG13 ' A' ' 71' ' ' VAL . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.441 HD11 ' CH2' ' A' ' 97' ' ' TRP . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.677 ' OG ' HG23 ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 93' ' ' GLN . 25.7 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.805 HD21 HG11 ' A' ' 39' ' ' VAL . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.79 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.23 -40.63 82.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 95' ' ' PRO . 78.3 t -67.53 -38.98 81.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.303 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 61.07 67.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.668 ' O ' ' N ' ' A' ' 103' ' ' GLY . 94.5 mt-30 -77.3 2.71 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.25 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 59.45 -60.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.698 0.285 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . 100.98 1.18 54.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.96 138.21 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.745 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.573 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -110.24 138.81 46.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 0.0 111.107 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -85.57 169.79 13.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.7 tp -88.83 131.55 35.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.482 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.2 89.46 52.24 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.401 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 3.0 Cg_exo -73.03 -167.81 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.765 2.31 . . . . 0.0 111.168 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.1 -6.76 41.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.144 0.497 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.39 44.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -83.9 91.07 7.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.178 0.514 . . . . 0.0 110.04 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.67 167.57 12.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -146.53 147.45 30.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.371 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.933 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.933 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.903 ' N ' HD13 ' A' ' 15' ' ' LEU . 76.7 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' A' ' 29' ' ' VAL . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' C ' HG23 ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.974 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.649 HD12 ' HG2' ' A' ' 68' ' ' PRO . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HB3' HG21 ' A' ' 87' ' ' THR . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 14.5 m120 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.888 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 13.6 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 18' ' ' PHE . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.897 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.803 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.649 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 93' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 31' ' ' ARG . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 4.4 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 36' ' ' LEU . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.46 -33.06 74.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 95' ' ' PRO . 77.3 t -65.87 -39.34 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.1 mm-40 -12.51 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.21 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 102' ' ' GLU . 85.3 mt-30 -73.59 7.56 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 101' ' ' GLN . 95.9 mt-10 31.42 47.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.845 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.89 -127.95 4.62 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 105' ' ' PHE . 13.4 tt -113.43 133.27 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.57 ' C ' ' O ' ' A' ' 104' ' ' ILE . 66.3 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.2 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 3' ' ' SER . 59.6 p -95.24 -90.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.63 ' N ' ' OG ' ' A' ' 2' ' ' SER . 55.2 p -73.02 161.24 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.357 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.1 tp -125.11 -95.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.573 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.82 146.25 99.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.577 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.5 Cg_endo -51.78 143.85 36.95 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.474 2.116 . . . . 0.0 112.23 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' LEU . 78.6 mt-30 23.02 -80.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.109 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.701 ' N ' ' O ' ' A' ' 6' ' ' PRO . . . 47.27 5.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.985 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' GLN . 1.5 pp -85.07 143.71 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 0.0 110.791 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.14 162.93 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.155 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -85.16 114.21 54.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.516 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.907 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.907 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 15' ' ' LEU . 82.7 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' CD2' HG22 ' A' ' 29' ' ' VAL . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 25' ' ' SER . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.626 ' C ' HG23 ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 29' ' ' VAL . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 68' ' ' PRO . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 10.7 mm-40 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.55 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 20.0 m120 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LEU . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 13' ' ' LEU . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.654 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.585 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.572 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.678 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.711 ' H ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.773 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.815 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.631 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 71' ' ' VAL . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD22 ' CD ' ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.773 ' OG ' HG23 ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.526 ' CD ' HD22 ' A' ' 81' ' ' LEU . 6.6 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 98' ' ' LEU . 89.4 mt -67.49 -41.15 84.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.85 -36.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.075 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 101' ' ' GLN . 95.9 mt-30 60.71 111.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.173 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 103' ' ' GLY . 94.9 mm-40 38.78 -134.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.364 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 59.78 -33.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -56.72 -27.99 56.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.74 135.91 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.643 0.259 . . . . 0.0 110.385 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 85.7 t80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.606 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.557 ' C ' ' O ' ' A' ' 1' ' ' GLY . 22.6 t 23.32 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 4' ' ' LEU . 8.5 p -69.22 162.15 27.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' C ' ' O ' ' A' ' 3' ' ' SER . 11.6 tp 18.12 -131.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.066 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.489 ' H ' ' CG ' ' A' ' 4' ' ' LEU . 11.7 m -138.51 88.41 14.5 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.77 143.48 74.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 81.4 mm-40 -86.54 7.51 25.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.037 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 7' ' ' GLN . . . 68.21 99.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.526 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -85.52 147.24 26.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.85 146.02 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -86.35 145.17 39.39 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.808 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.914 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.6 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.84 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.413 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.705 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.555 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.705 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 13.2 m-20 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.549 ' O ' HG12 ' A' ' 39' ' ' VAL . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.899 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.576 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 15' ' ' LEU . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.871 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.546 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.546 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.518 ' OE1' ' OE1' ' A' ' 93' ' ' GLN . 74.3 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.668 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 82' ' ' SER . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.861 ' HB3' HD22 ' A' ' 81' ' ' LEU . 34.6 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.5 m-20 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.548 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.06 -31.02 71.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 95' ' ' PRO . 71.9 t -63.28 -16.12 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.46 43.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.737 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 99' ' ' VAL . 90.7 mt-30 -91.04 137.74 32.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.372 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -89.91 156.62 18.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.296 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.81 102.54 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.484 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 105' ' ' PHE . 30.7 mm -101.3 127.94 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.517 ' C ' ' O ' ' A' ' 104' ' ' ILE . 81.5 m-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.457 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -67.57 168.48 10.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.539 0.209 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p 176.33 -0.51 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.478 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 5' ' ' SER . 6.8 tt -93.49 134.78 35.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -115.77 98.69 51.47 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.03 16.42 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.674 2.25 . . . . 0.0 113.675 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.05 150.58 28.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 146.05 44.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.967 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.028 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.95 162.18 17.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.87 170.21 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.343 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -150.85 149.22 24.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.927 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.911 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.918 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.446 HH21 HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 HH21 ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' VAL . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.553 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.666 ' HD3' HG21 ' A' ' 87' ' ' THR . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 28' ' ' ILE . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.1 m120 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.594 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 36' ' ' LEU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.632 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.858 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HD2' ' A' ' 18' ' ' PHE . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.91 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.778 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.694 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.685 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HE3' HD11 ' A' ' 13' ' ' LEU . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG13 HG22 ' A' ' 71' ' ' VAL . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 89' ' ' GLN . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.856 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 31' ' ' ARG . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 39' ' ' VAL . 79.6 mt -82.91 -40.47 20.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 95' ' ' PRO . 77.9 t -66.85 -49.58 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.874 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 99' ' ' VAL . 92.5 mt-30 37.84 49.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.558 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 103' ' ' GLY . 82.5 mt-30 59.79 -102.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.083 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 52.5 -71.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -45.81 175.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.53 ' O ' ' C ' ' A' ' 105' ' ' PHE . 74.1 mt -99.22 134.74 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' C ' ' O ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.877 -1.058 . . . . 0.0 110.824 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.62 ' OG ' ' N ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -153.67 -162.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 0.0 110.371 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.62 ' N ' ' OG ' ' A' ' 2' ' ' SER . 25.6 p -56.46 -19.65 16.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp 39.39 -91.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.04 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -96.48 162.17 24.33 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.382 . . . . 0.0 110.688 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -45.37 150.81 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.025 2.483 . . . . 0.0 112.035 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -82.2 156.56 24.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.615 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.5 132.39 48.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.044 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.4 pt? -85.96 156.2 20.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.45 149.77 47.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -82.72 148.93 59.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.414 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.908 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 69' ' ' ALA . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.6 ' C ' HG23 ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 68' ' ' PRO . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.541 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NE ' HG21 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' ILE . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.3 m120 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.903 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 13' ' ' LEU . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 18' ' ' PHE . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.71 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.707 ' N ' HD23 ' A' ' 70' ' ' LEU . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 71' ' ' VAL . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.407 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.623 ' OG ' HG23 ' A' ' 66' ' ' VAL . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.886 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.44 HG21 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.407 ' CD ' HD22 ' A' ' 81' ' ' LEU . 21.9 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt -87.1 -12.75 46.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 99' ' ' VAL . 61.2 t -108.87 15.89 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.6 mt-30 -32.19 90.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.768 0.318 . . . . 0.0 111.135 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 102' ' ' GLU . 94.2 mt-30 -153.18 -14.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 101' ' ' GLN . 52.2 mp0 35.01 -160.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.083 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.74 72.81 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.82 128.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 44.6 p90 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.526 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 p -61.36 -81.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.707 0.289 . . . . 0.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -90.97 125.67 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.121 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.825 ' C ' HD13 ' A' ' 4' ' ' LEU . 3.2 tm? -65.87 -42.34 90.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.009 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.31 159.13 30.27 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.45 138.49 65.71 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.636 2.224 . . . . 0.0 111.559 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 8' ' ' ALA . 61.2 tp60 -139.73 42.97 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.159 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' O ' ' O ' ' A' ' 7' ' ' GLN . . . 41.25 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.18 143.87 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 145.8 55.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.65 145.28 41.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.267 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.955 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.942 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.597 ' HD2' HG12 ' A' ' 52' ' ' VAL . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 68' ' ' PRO . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.544 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.9 m120 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 13' ' ' LEU . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.652 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.8 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 18' ' ' PHE . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 65' ' ' VAL . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.715 HG23 ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 52' ' ' VAL . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.955 HD21 HD11 ' A' ' 15' ' ' LEU . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.832 ' N ' HD23 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' O ' HG13 ' A' ' 71' ' ' VAL . 93.2 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 71' ' ' VAL . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 93' ' ' GLN . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 66' ' ' VAL . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.704 ' HB3' HD22 ' A' ' 81' ' ' LEU . 3.8 tt0 -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.73 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.688 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt -75.2 -32.38 61.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 95' ' ' PRO . 97.2 t -66.37 -48.28 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.274 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' VAL . 77.4 mt-30 29.92 38.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.599 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.3 mm-40 -122.06 0.66 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.938 0.399 . . . . 0.0 110.322 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.547 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 54.6 mp0 -55.53 143.98 27.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.63 11.84 4.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.588 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 105' ' ' PHE . 10.2 tt -114.16 131.06 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 104' ' ' ILE . 59.2 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m -85.51 2.89 42.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.651 0.262 . . . . 0.0 111.019 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -66.85 165.32 15.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -53.62 -39.48 64.96 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.72 172.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.49 -79.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.188 1.925 . . . . 0.0 112.31 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -106.71 151.1 25.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.16 175.41 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.271 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.051 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -81.61 150.51 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.06 142.96 55.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.775 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.93 149.83 46.48 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.128 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.911 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.866 ' N ' HD13 ' A' ' 15' ' ' LEU . 72.2 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.639 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 17' ' ' LEU . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.554 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 21.7 m120 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.68 HD11 ' OE1' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 50' ' ' ILE . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 55' ' ' GLN . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.793 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.689 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.639 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.911 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' CA ' ' HZ3' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' VAL . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.689 ' OG ' HG23 ' A' ' 66' ' ' VAL . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' GLN . 20.5 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 100' ' ' GLN . 79.7 mt -93.03 -32.8 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.741 ' O ' HG12 ' A' ' 99' ' ' VAL . 84.0 t -65.02 8.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.837 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 98' ' ' LEU . 89.3 mt-30 -38.96 154.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 62.76 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.41 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 99' ' ' VAL . 96.2 mt-10 -57.97 146.6 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.771 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.9 18.41 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.5 mt -105.21 137.21 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 1.2 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -110.18 145.65 36.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 p -68.06 160.39 28.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.592 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.8 tp -178.23 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.228 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 p -130.36 77.13 76.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.82 39.19 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.651 2.234 . . . . 0.0 111.483 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.716 ' NE2' ' OE1' ' A' ' 11' ' ' GLN . 23.3 mt-30 -77.23 -2.15 33.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.4 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.56 -86.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.238 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -83.89 173.73 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -65.45 -167.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.716 ' OE1' ' NE2' ' A' ' 7' ' ' GLN . 4.1 mm100 -86.4 119.09 71.27 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.88 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 70' ' ' LEU . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 29' ' ' VAL . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.596 ' C ' HG23 ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.999 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 68' ' ' PRO . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.552 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 28' ' ' ILE . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.552 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.5 m120 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 HD22 ' A' ' 13' ' ' LEU . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' CE1' ' A' ' 18' ' ' PHE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 67' ' ' THR . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.7 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.795 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG23 ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 52' ' ' VAL . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 15' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.808 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.787 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.787 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.691 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 83' ' ' GLY . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 82' ' ' SER . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.421 ' CD ' HD22 ' A' ' 81' ' ' LEU . 4.3 tt0 -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.95 -37.24 78.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 95' ' ' PRO . 90.4 t -68.97 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 57.27 106.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.807 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -91.25 156.88 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.88 -30.75 67.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.65 36.99 41.34 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.9 tt -111.69 135.83 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.78 0.324 . . . . 0.0 110.962 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.51 179.553 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -89.95 6.17 43.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.289 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 4' ' ' LEU . 39.1 p -79.77 -1.27 37.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.297 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 3' ' ' SER . 24.1 tp 54.19 144.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.6 m -91.24 137.45 26.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.69 140.29 84.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.01 1.807 . . . . 0.0 111.68 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 46.46 82.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.01 47.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.782 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.86 144.64 26.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.15 -169.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -85.09 143.44 39.71 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.937 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.864 ' N ' HD13 ' A' ' 15' ' ' LEU . 80.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.649 ' CD2' HG22 ' A' ' 29' ' ' VAL . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 58' ' ' LEU . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.617 ' C ' HG23 ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.961 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.558 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' ILE . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.558 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 22.4 m120 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.019 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.019 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.628 HG23 HD22 ' A' ' 13' ' ' LEU . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 58' ' ' LEU . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' HD21 ' A' ' 58' ' ' LEU . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.917 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.917 ' N ' HD12 ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.665 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.777 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.731 ' N ' HD13 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.489 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.863 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.777 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.745 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.683 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 82' ' ' SER . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 15.3 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 100' ' ' GLN . 83.6 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.35 -33.87 76.7 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 95' ' ' PRO . 21.3 t -87.03 -22.73 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.582 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 96' ' ' GLN . 84.6 mt-30 63.13 47.89 3.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.58 ' HG2' HG12 ' A' ' 99' ' ' VAL . 96.1 mm-40 -101.53 147.56 26.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.4 mm-40 56.3 114.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.464 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.2 122.54 0.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.63 157.32 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.796 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.694 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 1' ' ' GLY . 21.6 m -57.69 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.463 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.2 p -64.42 164.17 11.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.27 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.4 tp 52.56 78.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.027 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 m -121.87 81.0 41.81 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.003 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.51 -166.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.923 1.748 . . . . 0.0 111.274 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -67.13 138.47 57.1 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.75 41.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.053 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -84.17 155.6 22.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.482 -179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 175.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.804 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -83.23 137.23 42.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.955 ' N ' HD23 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.69 ' CD2' HG22 ' A' ' 29' ' ' VAL . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.97 ' O ' HG23 ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.753 HD13 HD13 ' A' ' 86' ' ' LEU . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 24.1 m120 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.695 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG23 HD22 ' A' ' 13' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.639 ' N ' HD23 ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.45 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.646 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 73.6 m-20 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.737 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.75 ' H ' HD12 ' A' ' 58' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.917 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.724 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.895 ' N ' HD23 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.812 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 50.3 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 71' ' ' VAL . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.681 ' OG ' HG23 ' A' ' 66' ' ' VAL . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.924 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 6.9 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 39' ' ' VAL . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.812 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -68.79 -37.77 79.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 100' ' ' GLN . 55.6 t -64.26 -43.26 97.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.583 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' VAL . 53.7 mt-30 57.59 131.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 102' ' ' GLU . 88.8 mt-30 57.27 -154.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.1 mm-40 57.05 158.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -109.57 2.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -95.46 123.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.747 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 3' ' ' SER . 27.1 t -132.09 -117.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.505 ' N ' ' OG ' ' A' ' 2' ' ' SER . 91.4 p -80.31 -1.01 39.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.34 107.98 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.07 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.95 86.73 0.73 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.778 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.45 -5.36 16.49 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.68 2.254 . . . . 0.0 111.699 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -76.34 6.07 6.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.49 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.47 117.53 15.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.444 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.842 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.44 148.06 25.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD22 ' A' ' 9' ' ' LEU . . . -66.8 175.73 2.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.277 -178.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -82.4 143.89 48.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.619 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.923 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.869 ' N ' HD13 ' A' ' 15' ' ' LEU . 76.1 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 86' ' ' LEU . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 28' ' ' ILE . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.535 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 20.6 m120 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.89 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.89 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.711 HG23 HD22 ' A' ' 13' ' ' LEU . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.621 ' N ' HD23 ' A' ' 47' ' ' LEU . 8.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.812 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 67' ' ' THR . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.849 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 52' ' ' VAL . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 15' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.812 HG22 HG13 ' A' ' 80' ' ' VAL . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.499 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.504 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 43.0 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG13 HG22 ' A' ' 71' ' ' VAL . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 39' ' ' VAL . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.505 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 101' ' ' GLN . 26.9 mt -68.17 -31.67 71.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 99' ' ' VAL . 81.4 t -72.55 3.06 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -81.74 20.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.162 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 98' ' ' LEU . 90.2 mm-40 -89.34 -4.74 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.612 ' OE1' ' O ' ' A' ' 99' ' ' VAL . 62.0 mp0 -99.37 172.16 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -52.44 -146.5 0.0 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.77 136.28 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.753 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.532 179.911 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -82.82 -1.18 51.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -179.34 101.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.74 -41.3 90.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.234 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -99.9 142.49 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.597 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 2.6 Cg_endo -52.21 140.97 50.48 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.248 1.965 . . . . 0.0 111.696 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -103.33 -12.47 17.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.196 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.69 46.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.979 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.597 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -82.3 134.52 35.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.038 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.83 -175.79 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.562 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -86.11 126.32 65.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.912 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.884 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 69' ' ' ALA . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.604 ' C ' HG23 ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.511 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 84' ' ' ILE . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . 1.003 ' O ' HG23 ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 32' ' ' VAL . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.547 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 43.9 mm-40 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' ILE . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.547 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 21.2 m120 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.517 ' N ' HD22 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.732 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.541 ' HB2' ' NE2' ' A' ' 55' ' ' GLN . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.732 ' NE2' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.721 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 65' ' ' VAL . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.893 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' OG ' ' A' ' 82' ' ' SER . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.651 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.755 ' N ' HD23 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 13' ' ' LEU . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 71' ' ' VAL . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.775 HD21 ' HG3' ' A' ' 93' ' ' GLN . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 66' ' ' VAL . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.475 HG22 HD21 ' A' ' 24' ' ' LEU . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.447 ' HB3' HD22 ' A' ' 81' ' ' LEU . 5.2 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.775 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 94' ' ' LEU . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.96 -29.5 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 99' ' ' VAL . 17.9 t -102.06 30.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.008 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -62.92 53.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.871 179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.613 ' N ' ' O ' ' A' ' 99' ' ' VAL . 94.2 mt-30 -85.54 -0.44 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.472 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -101.39 140.14 36.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.062 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.06 -18.15 8.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.9 mt -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.664 0.269 . . . . 0.0 110.337 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.649 179.953 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 t -150.56 57.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.71 0.29 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -69.53 -4.4 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.051 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -102.06 131.24 48.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -123.03 80.81 51.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.221 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.92 -4.78 15.3 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.352 2.701 . . . . 0.0 113.3 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -67.71 124.77 24.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.659 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.81 130.44 34.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.28 158.63 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.94 136.34 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.365 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -91.38 145.75 32.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.076 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.906 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 72.7 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.445 ' HE1' HD13 ' A' ' 58' ' ' LEU . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.61 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.541 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.541 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 23.0 m120 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.609 ' N ' HD23 ' A' ' 47' ' ' LEU . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.842 HG23 ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 59' ' ' VAL . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.842 ' NE2' HG23 ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.782 ' N ' HD12 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.776 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.797 ' N ' HD23 ' A' ' 70' ' ' LEU . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.696 ' HE2' HD11 ' A' ' 13' ' ' LEU . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 71' ' ' VAL . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' HG23 ' A' ' 66' ' ' VAL . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.731 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 93' ' ' GLN . 23.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.82 -36.23 72.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 95' ' ' PRO . 74.1 t -77.88 -41.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.544 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 102' ' ' GLU . 67.5 mm-40 64.11 63.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.625 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -73.18 17.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.867 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 100' ' ' GLN . 95.5 mt-10 -53.18 144.81 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.988 0.423 . . . . 0.0 110.96 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.26 176.91 17.68 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' ILE . 17.5 tt -112.26 125.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.509 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.4 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 3' ' ' SER . 19.5 t -106.56 138.37 42.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.666 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 2' ' ' SER . 93.8 p 16.73 95.54 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.411 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 4' ' ' LEU . 4.5 tt -80.13 -6.89 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.424 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.32 80.8 71.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.274 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.24 149.75 64.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.877 2.385 . . . . 0.0 112.806 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 65.38 79.7 0.24 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.771 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.35 53.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.341 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.26 -169.97 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.359 -179.419 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.36 153.84 40.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.99 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -87.42 138.36 32.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.909 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.592 ' C ' HG23 ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.474 HH22 ' CB ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 29' ' ' VAL . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 68' ' ' PRO . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 25' ' ' SER . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' NZ ' ' CG1' ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.554 ' OD1' ' O ' ' A' ' 30' ' ' GLN . 22.8 m120 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.75 ' OE1' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.819 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.474 ' CB ' HH22 ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.774 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.603 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.603 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 71' ' ' VAL . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 83' ' ' GLY . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.808 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' GLN . 9.0 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' GLN . 25.8 mm100 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' GLN . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.02 -40.46 65.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 95' ' ' PRO . 65.4 t -70.7 -34.91 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.083 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 96' ' ' GLN . 95.2 mt-30 58.83 -163.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.94 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 54.87 81.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.353 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 -49.62 144.62 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 110.503 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -36.53 167.08 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.24 133.12 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.147 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.621 -179.484 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.891 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.7 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 69' ' ' ALA . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' C ' HG23 ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.597 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 32' ' ' VAL . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 28' ' ' ILE . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.8 m-20 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.584 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.737 HG23 ' NE2' ' A' ' 55' ' ' GLN . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.737 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.3 pt20 -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HD12 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.771 HG23 ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.706 HH12 HG23 ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG23 HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 93' ' ' GLN . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.771 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.599 ' HG3' HD21 ' A' ' 81' ' ' LEU . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 39' ' ' VAL . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.871 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.871 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.2 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 69' ' ' ALA . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.566 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.65 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 25' ' ' SER . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.692 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 39' ' ' VAL . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.757 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 HD22 ' A' ' 13' ' ' LEU . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.623 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.695 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.876 ' N ' HD23 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HE2' HD11 ' A' ' 13' ' ' LEU . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 17.5 mm100 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 71' ' ' VAL . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.492 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.642 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 HG21 ' A' ' 28' ' ' ILE . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.492 HE22 ' HA ' ' A' ' 81' ' ' LEU . 2.6 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CH2' HD12 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.713 0.292 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.894 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 70' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.858 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.6 ' CD2' HG22 ' A' ' 29' ' ' VAL . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.544 HG23 ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.835 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.835 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.791 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.658 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 28' ' ' ILE . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 82.5 m-20 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 36' ' ' LEU . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.679 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.793 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.798 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.787 HE21 HD23 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.943 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.865 ' N ' HD13 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.618 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.836 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.443 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.895 HE22 ' HE1' ' A' ' 97' ' ' TRP . 25.3 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 71' ' ' VAL . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.461 HD11 ' HZ2' ' A' ' 97' ' ' TRP . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.618 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 28' ' ' ILE . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.3 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.895 ' HE1' HE22 ' A' ' 79' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.763 0.316 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.745 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 68' ' ' PRO . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.45 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.0 m-20 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.741 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.678 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.759 HG23 ' NE2' ' A' ' 55' ' ' GLN . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 50' ' ' ILE . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.758 ' H ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.881 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.695 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.853 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.62 HG13 HG22 ' A' ' 71' ' ' VAL . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' LEU . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.695 ' OG ' HG23 ' A' ' 66' ' ' VAL . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 1.9 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.527 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.873 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 20.0 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.685 ' C ' HG23 ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.567 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.983 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.3 m-20 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.866 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.508 ' N ' HD23 ' A' ' 47' ' ' LEU . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.65 HD11 ' NE2' ' A' ' 16' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' A' ' 53' ' ' ALA . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 67' ' ' THR . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' OD1' ' A' ' 51' ' ' ASN . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.637 ' O ' HD11 ' A' ' 58' ' ' LEU . 2.6 pt20 -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.776 ' H ' HD12 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 65' ' ' VAL . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.772 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.645 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.537 HG21 HG11 ' A' ' 52' ' ' VAL . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.845 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.792 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.445 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.507 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HG13 ' A' ' 71' ' ' VAL . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 93' ' ' GLN . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.645 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.932 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.6 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.662 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 39' ' ' VAL . 50.9 mt . . . . . 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 11' ' ' GLN . 3.3 mt-30 . . . . . 0 CA--C 1.528 0.119 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.904 ' N ' HD13 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 25' ' ' SER . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 25' ' ' SER . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.764 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG12 HD13 ' A' ' 13' ' ' LEU . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.988 HG22 ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.757 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 67' ' ' THR . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.988 ' NE2' HG22 ' A' ' 50' ' ' ILE . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.678 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 64' ' ' LEU . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.717 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 52' ' ' VAL . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 80' ' ' VAL . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 93' ' ' GLN . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.717 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.479 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.467 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.675 ' HG3' HD21 ' A' ' 81' ' ' LEU . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.649 0.262 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.885 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.888 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.485 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.996 ' O ' HG23 ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 86' ' ' LEU . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 28' ' ' ILE . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.686 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.2 m-20 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.68 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.71 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.653 HG23 HD22 ' A' ' 13' ' ' LEU . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.686 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.777 HG23 ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.777 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.51 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.867 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.587 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 24.3 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.75 HG13 HG22 ' A' ' 71' ' ' VAL . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.51 ' OG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.904 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 28' ' ' ILE . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.549 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.587 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 98' ' ' LEU . 89.7 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.756 0.312 . . . . 0.0 110.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 23.6 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.622 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.649 ' C ' HG23 ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.649 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.921 ' O ' HG23 ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 68' ' ' PRO . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.6 m-20 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' HD23 ' A' ' 47' ' ' LEU . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.851 ' ND2' ' HB3' ' A' ' 53' ' ' ALA . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 18' ' ' PHE . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.851 ' HB3' ' ND2' ' A' ' 51' ' ' ASN . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 3.1 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.936 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' CG1' HD12 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.769 ' N ' HD23 ' A' ' 70' ' ' LEU . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' NH1' ' CE1' ' A' ' 62' ' ' TYR . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.817 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 17.0 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 71' ' ' VAL . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 66' ' ' VAL . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.72 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.688 ' HG3' HD21 ' A' ' 81' ' ' LEU . 98.2 mm-40 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.604 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.817 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.53 0.205 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 24.8 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 69' ' ' ALA . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.951 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.409 HD12 ' HG2' ' A' ' 68' ' ' PRO . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.678 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD2' HG21 ' A' ' 87' ' ' THR . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.5 m-20 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.719 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 HD22 ' A' ' 13' ' ' LEU . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.515 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.845 HD11 ' NE2' ' A' ' 16' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG11 HG21 ' A' ' 67' ' ' THR . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.8 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 64' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.654 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.768 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.736 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.734 HG21 HG11 ' A' ' 52' ' ' VAL . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.79 ' N ' HD23 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.563 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.1 mm100 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 71' ' ' VAL . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.736 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.694 HD23 ' HB2' ' A' ' 70' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 31' ' ' ARG . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.9 mm-40 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.412 0.148 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.881 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.915 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.594 ' CD2' HG22 ' A' ' 29' ' ' VAL . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.993 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 32' ' ' VAL . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG23 ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 87' ' ' THR . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 93.0 m-20 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.907 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 36' ' ' LEU . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 13' ' ' LEU . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.686 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 64' ' ' LEU . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.817 ' N ' HD13 ' A' ' 64' ' ' LEU . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.579 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.715 ' N ' HD23 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.727 ' CB ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.521 HH12 HG21 ' A' ' 80' ' ' VAL . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 31' ' ' ARG . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.874 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.545 ' NE2' HE22 ' A' ' 79' ' ' GLN . 25.5 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 39' ' ' VAL . 95.0 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.746 0.308 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.889 HD11 HD21 ' A' ' 70' ' ' LEU . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.874 ' N ' HD13 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 29' ' ' VAL . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HE2' HD12 ' A' ' 58' ' ' LEU . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.599 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.599 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.615 HD13 HD13 ' A' ' 86' ' ' LEU . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 25' ' ' SER . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.698 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 78.0 m-20 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.805 HG11 HD21 ' A' ' 94' ' ' LEU . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 58' ' ' LEU . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.51 HD21 ' HG3' ' A' ' 55' ' ' GLN . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.789 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.677 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.892 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.678 ' O ' HG13 ' A' ' 71' ' ' VAL . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.677 ' OG ' HG23 ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 4.1 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.805 HD21 HG11 ' A' ' 39' ' ' VAL . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.517 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.816 0.341 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.933 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.933 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.903 ' N ' HD13 ' A' ' 15' ' ' LEU . 22.0 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' A' ' 29' ' ' VAL . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.557 ' C ' HG23 ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.974 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.649 HD12 ' HG2' ' A' ' 68' ' ' PRO . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HB3' HG21 ' A' ' 87' ' ' THR . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 88.3 m-20 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.888 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.9 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.799 HD11 ' NE2' ' A' ' 16' ' ' GLN . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.897 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.803 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.649 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.508 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 31' ' ' ARG . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.428 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 1.2 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 36' ' ' LEU . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.507 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.907 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.907 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 15' ' ' LEU . 25.6 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' CD2' HG22 ' A' ' 29' ' ' VAL . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 25' ' ' SER . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.626 ' C ' HG23 ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 29' ' ' VAL . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 68' ' ' PRO . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.69 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.1 mm100 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.9 m-20 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LEU . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 13' ' ' LEU . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.654 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.632 HD11 ' NE2' ' A' ' 16' ' ' GLN . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.46 ' HA ' HE22 ' A' ' 55' ' ' GLN . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.711 ' H ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.773 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.815 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.631 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 71' ' ' VAL . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD22 ' CD ' ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.773 ' OG ' HG23 ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.526 ' CD ' HD22 ' A' ' 81' ' ' LEU . 1.7 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 98' ' ' LEU . 89.4 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.742 0.306 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.914 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 26.7 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.84 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.413 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.705 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.705 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 1.7 m120 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.549 ' O ' HG12 ' A' ' 39' ' ' VAL . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.473 ' ND2' HG22 ' A' ' 21' ' ' THR . 33.0 m120 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.899 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.576 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 15' ' ' LEU . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.871 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.546 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.546 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.726 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 22.9 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.668 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 82' ' ' SER . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.861 ' HB3' HD22 ' A' ' 81' ' ' LEU . 10.0 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.726 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.911 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.918 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.545 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.446 HH21 HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 HH21 ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' VAL . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.666 ' HD3' HG21 ' A' ' 87' ' ' THR . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 28' ' ' ILE . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.4 m-20 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.594 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 36' ' ' LEU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.632 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.858 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HD2' ' A' ' 18' ' ' PHE . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.91 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.778 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.694 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.685 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HE3' HD11 ' A' ' 13' ' ' LEU . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG13 HG22 ' A' ' 71' ' ' VAL . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 89' ' ' GLN . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.856 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 31' ' ' ARG . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 39' ' ' VAL . 79.6 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.664 0.268 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.908 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 69' ' ' ALA . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.6 ' C ' HG23 ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 68' ' ' PRO . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NE ' HG21 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' ILE . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.9 m-20 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.903 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 13' ' ' LEU . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 18' ' ' PHE . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.623 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.71 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.707 ' N ' HD23 ' A' ' 70' ' ' LEU . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 71' ' ' VAL . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.623 ' OG ' HG23 ' A' ' 66' ' ' VAL . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.886 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.44 HG21 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.407 ' CD ' HD22 ' A' ' 81' ' ' LEU . 4.0 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.559 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 . . . . . 0 C--O 1.231 0.105 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.955 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.942 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.597 ' HD2' HG12 ' A' ' 52' ' ' VAL . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 68' ' ' PRO . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.7 m-20 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 13' ' ' LEU . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.652 ' N ' HD23 ' A' ' 47' ' ' LEU . 17.1 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 18' ' ' PHE . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 65' ' ' VAL . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.715 HG23 ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 52' ' ' VAL . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.955 HD21 HD11 ' A' ' 15' ' ' LEU . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.832 ' N ' HD23 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.828 HE22 ' HE1' ' A' ' 97' ' ' TRP . 28.4 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 71' ' ' VAL . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 93' ' ' GLN . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 66' ' ' VAL . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.704 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.73 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.619 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.828 ' HE1' HE22 ' A' ' 79' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.911 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.866 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.3 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.569 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.639 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 17' ' ' LEU . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.662 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.0 m-20 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.82 HD11 ' NE2' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' ND2' HG22 ' A' ' 21' ' ' THR . 13.9 m120 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 50' ' ' ILE . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 55' ' ' GLN . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.793 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.689 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.639 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.911 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' CA ' ' HZ3' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' VAL . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.689 ' OG ' HG23 ' A' ' 66' ' ' VAL . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' GLN . 3.8 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 98' ' ' LEU . 79.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.88 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 70' ' ' LEU . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 29' ' ' VAL . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.596 ' C ' HG23 ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.999 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.2 mm100 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 68' ' ' PRO . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 28' ' ' ILE . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.702 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.7 m-20 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 HD22 ' A' ' 13' ' ' LEU . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' CE1' ' A' ' 18' ' ' PHE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 67' ' ' THR . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.1 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.795 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.691 HG23 ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 52' ' ' VAL . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 15' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.808 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.787 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.787 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.691 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 83' ' ' GLY . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 82' ' ' SER . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.421 ' CD ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.501 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.751 0.31 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.864 ' N ' HD13 ' A' ' 15' ' ' LEU . 24.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.649 ' CD2' HG22 ' A' ' 29' ' ' VAL . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 58' ' ' LEU . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.617 ' C ' HG23 ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.961 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.679 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' ILE . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.019 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.019 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.628 HG23 HD22 ' A' ' 13' ' ' LEU . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 58' ' ' LEU . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.526 ' ND2' HG22 ' A' ' 21' ' ' THR . 20.2 m120 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' HD21 ' A' ' 58' ' ' LEU . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.917 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.917 ' N ' HD12 ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.665 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.777 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.731 ' N ' HD13 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.489 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.863 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.777 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.745 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.683 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 82' ' ' SER . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.9 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.568 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.955 ' N ' HD23 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.69 ' CD2' HG22 ' A' ' 29' ' ' VAL . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.97 ' O ' HG23 ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.753 HD13 HD13 ' A' ' 86' ' ' LEU . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.8 m-20 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.695 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.577 HG23 HD22 ' A' ' 13' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.639 ' N ' HD23 ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.45 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.796 ' N ' ' NE2' ' A' ' 55' ' ' GLN . 13.3 m120 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.796 ' NE2' ' N ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.75 ' H ' HD12 ' A' ' 58' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.917 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.724 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.895 ' N ' HD23 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.667 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 54.2 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 71' ' ' VAL . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.681 ' OG ' HG23 ' A' ' 66' ' ' VAL . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.924 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 1.5 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 39' ' ' VAL . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.667 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 120.749 0.309 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.923 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.869 ' N ' HD13 ' A' ' 15' ' ' LEU . 22.3 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 86' ' ' LEU . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 28' ' ' ILE . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.6 m-20 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.89 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.89 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.711 HG23 HD22 ' A' ' 13' ' ' LEU . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.621 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.812 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 67' ' ' THR . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.849 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 52' ' ' VAL . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 15' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.812 HG22 HG13 ' A' ' 80' ' ' VAL . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.499 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 52.9 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.812 HG13 HG22 ' A' ' 71' ' ' VAL . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 39' ' ' VAL . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 94' ' ' LEU . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.652 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.912 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.884 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 69' ' ' ALA . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.604 ' C ' HG23 ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.511 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 84' ' ' ILE . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 1.003 ' O ' HG23 ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 32' ' ' VAL . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 2.8 mm100 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' ILE . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 80.6 m-20 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.517 ' N ' HD22 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.584 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.691 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.721 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 65' ' ' VAL . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.893 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' OG ' ' A' ' 82' ' ' SER . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.651 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.755 ' N ' HD23 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 13' ' ' LEU . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 71' ' ' VAL . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.775 HD21 ' HG3' ' A' ' 93' ' ' GLN . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 66' ' ' VAL . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.475 HG22 HD21 ' A' ' 24' ' ' LEU . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.447 ' HB3' HD22 ' A' ' 81' ' ' LEU . 1.1 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.775 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 94' ' ' LEU . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 . . . . . 0 N--CA 1.456 -0.158 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.906 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.906 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 20.5 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.445 ' HE1' HD13 ' A' ' 58' ' ' LEU . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.61 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.609 ' N ' HD23 ' A' ' 47' ' ' LEU . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.842 HG23 ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 59' ' ' VAL . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.842 ' NE2' HG23 ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.782 ' N ' HD12 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.776 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.797 ' N ' HD23 ' A' ' 70' ' ' LEU . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.696 ' HE2' HD11 ' A' ' 13' ' ' LEU . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 71' ' ' VAL . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' HG23 ' A' ' 66' ' ' VAL . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.731 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 93' ' ' GLN . 4.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.56 0.219 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.909 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.592 ' C ' HG23 ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.474 HH22 ' CB ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 29' ' ' VAL . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 68' ' ' PRO . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 25' ' ' SER . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.483 ' NZ ' ' CG1' ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.9 HG22 ' NE2' ' A' ' 55' ' ' GLN . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.706 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.9 ' NE2' HG22 ' A' ' 50' ' ' ILE . 2.7 pm0 -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.819 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.474 ' CB ' HH22 ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.774 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.603 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.603 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 71' ' ' VAL . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 83' ' ' GLY . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.808 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.9 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' GLN . 89.1 mm-40 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.3 p -96.91 153.65 17.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.3 p -106.64 139.12 41.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.459 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.1 tp -95.94 -47.67 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.292 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.33 66.82 75.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.374 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.75 141.9 15.21 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.434 2.089 . . . . 0.0 112.386 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -104.73 132.2 51.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.65 43.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 9' ' ' LEU . 1.5 pt? -84.6 148.74 26.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 133.26 49.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.923 0.392 . . . . 0.0 110.974 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -93.1 151.15 40.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.291 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -44.56 163.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.571 2.181 . . . . 0.0 111.767 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.0 tt -82.0 132.74 35.26 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.7 mt -95.12 115.41 27.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -127.08 131.73 50.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.955 -178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.891 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.7 mt-30 -128.19 145.24 51.09 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.208 0.528 . . . . 0.0 111.218 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 69' ' ' ALA . 15.8 tp -123.72 127.19 47.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.268 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 74.0 m-85 -97.24 119.42 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.037 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.4 m -136.69 158.68 37.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.325 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' C ' HG23 ' A' ' 21' ' ' THR . 53.5 p30 -99.0 17.05 20.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.794 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.597 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 78.04 10.35 2.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.609 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 10.9 ptm180 -73.72 141.79 79.61 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -51.95 -35.66 61.29 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.31 2.007 . . . . 0.0 111.793 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.1 tp -54.64 -43.96 72.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.005 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.1 p -66.87 -39.91 87.67 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -63.54 -33.82 76.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.9 t-80 -62.42 -52.66 62.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.994 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 32' ' ' VAL . 88.3 mt -65.13 -33.61 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.506 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 25' ' ' SER . 44.2 t -56.17 -47.01 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.127 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.682 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 19.4 mm100 -60.34 -42.98 96.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -63.64 -38.75 92.31 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 120.099 -0.641 . . . . 0.0 109.697 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 28' ' ' ILE . 76.4 t -63.97 -54.87 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.881 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 47' ' ' LEU . 67.6 mttm -62.46 -40.82 97.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.324 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.8 m-20 -61.17 -43.01 99.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 93.2 mt -68.09 -49.14 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.072 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 39' ' ' VAL . 87.4 mt -58.46 -40.71 83.4 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' O ' ' OE2' ' A' ' 40' ' ' GLU . . . -68.24 -9.81 50.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.333 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.39 13.64 6.41 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.271 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.4 p -151.86 -29.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 120.171 -0.612 . . . . 0.0 112.168 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.72 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 47.4 mp0 36.56 -96.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.25 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.45 -178.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 71.6 p -76.47 -9.23 58.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.386 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -118.0 71.45 8.27 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -52.34 152.76 14.73 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.531 2.154 . . . . 0.0 112.448 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -109.81 135.72 47.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.348 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 t -104.77 122.51 45.86 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -99.49 122.33 42.42 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.577 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.584 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.1 mm100 -122.5 127.78 49.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.535 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 t -99.64 134.12 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.457 . . . . 0.0 111.393 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.737 HG23 ' NE2' ' A' ' 55' ' ' GLN . 21.7 mt -115.76 127.77 73.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -81.94 102.62 11.03 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.042 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.9 m -58.69 -17.94 11.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.171 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.85 -30.17 63.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.604 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -94.52 -27.66 15.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.762 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.737 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.3 pt20 -142.81 85.53 10.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.958 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.87 -7.32 15.47 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 123.617 2.878 . . . . 0.0 112.626 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.18 -45.22 74.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.4 -23.27 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.254 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.789 ' N ' HD12 ' A' ' 58' ' ' LEU . 41.4 t -63.53 -43.95 98.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.85 -35.32 76.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.688 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -56.89 -42.26 79.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.301 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.577 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.1 m-85 -83.38 14.24 3.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 mtt85 57.82 5.68 0.38 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -62.31 133.91 55.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.323 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -141.4 -11.6 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.526 -0.469 . . . . 0.0 112.072 -178.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.771 HG23 ' OG ' ' A' ' 82' ' ' SER . 29.3 m -114.7 143.69 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.871 0.367 . . . . 0.0 110.845 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.432 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.2 p -137.34 149.05 64.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.826 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -71.84 157.24 97.16 Favored 'Cis proline' 0 C--N 1.311 -1.412 0 C-N-CA 123.446 -1.481 . . . . 0.0 112.135 0.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -147.28 153.35 39.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.487 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -125.88 131.58 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.666 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.2 t -128.71 128.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.051 -0.66 . . . . 0.0 112.455 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 3.7 tttt -92.93 127.86 38.59 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.303 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.87 -21.18 5.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.782 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 129.93 -158.98 22.51 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.01 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.1 Cg_exo -54.65 158.83 16.14 Favored 'Cis proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.685 -1.798 . . . . 0.0 112.028 0.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.65 -164.45 12.62 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.9 t -68.46 157.96 34.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.11 0.481 . . . . 0.0 110.98 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.706 HH12 HG23 ' A' ' 80' ' ' VAL . 64.5 ttp85 -98.46 142.84 29.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.269 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.2 mt-30 -140.77 157.6 45.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.897 0.38 . . . . 0.0 110.478 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG23 HH12 ' A' ' 78' ' ' ARG . 58.6 t -129.26 115.42 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.108 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 93' ' ' GLN . 14.7 mt -110.87 131.36 55.11 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.771 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.3 t -157.47 171.18 20.84 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.362 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.68 52.77 2.39 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.226 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 34.2 pt 42.19 5.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.8 p-10 -97.64 11.41 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.107 0.479 . . . . 0.0 110.232 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 90' ' ' LEU . 84.5 mt -48.19 -48.19 34.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.21 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.1 p -65.97 -38.09 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.687 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -71.47 -49.5 40.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.476 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.53 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.469 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.591 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 60.3 tp -57.06 -49.6 75.35 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.578 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.27 -30.49 68.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.372 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -80.32 -38.04 31.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.135 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.599 ' HG3' HD21 ' A' ' 81' ' ' LEU . 99.7 mm-40 -77.72 -37.82 48.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.992 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD21 HG11 ' A' ' 39' ' ' VAL . 17.0 tp -52.77 -60.07 7.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.828 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.578 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.99 -43.01 31.23 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.299 1.999 . . . . 0.0 111.314 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -64.01 -36.12 82.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.527 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.489 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 43.2 m0 -65.44 -39.98 92.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.905 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.4 mt -79.79 -42.49 24.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 101' ' ' GLN . 69.3 t -69.49 -51.24 43.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.598 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 97' ' ' TRP . 29.9 mm-40 48.51 35.85 6.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.727 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.555 ' H ' HG12 ' A' ' 99' ' ' VAL . 55.1 mt-30 -106.46 125.93 51.62 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.597 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -96.71 -3.28 42.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.41 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 168.33 -170.94 42.39 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.506 ' O ' ' C ' ' A' ' 105' ' ' PHE . 73.5 mt -104.68 129.19 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.866 0.365 . . . . 0.0 110.562 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.506 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.1 t80 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.703 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 m -133.5 -97.48 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.732 0.301 . . . . 0.0 110.66 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.8 p -64.85 155.39 34.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.387 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.615 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -117.18 -76.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.372 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.75 159.89 29.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.533 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' O ' ' C ' ' A' ' 7' ' ' GLN . 2.6 Cg_endo -48.12 144.78 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.796 2.331 . . . . 0.0 111.699 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.608 ' C ' ' O ' ' A' ' 6' ' ' PRO . 30.1 mt-30 -5.36 98.09 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.567 0.542 . . . . 0.0 111.365 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.62 122.22 19.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.588 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.838 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.07 145.01 26.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.836 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.725 ' O ' HD22 ' A' ' 9' ' ' LEU . . . -68.08 -163.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.328 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -88.28 118.08 69.12 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.49 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.67 158.2 33.78 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.072 1.848 . . . . 0.0 111.781 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.1 tt -80.76 128.77 34.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 40.3 mt -96.53 117.25 30.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.304 0.573 . . . . 0.0 110.019 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.871 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -122.28 131.97 54.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.836 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.871 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.2 mt-30 -129.3 155.83 44.98 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.588 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 69' ' ' ALA . 16.7 tp -137.76 125.51 22.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.805 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -95.51 119.65 34.39 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 16.3 m -132.12 155.4 41.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.901 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.566 ' C ' HG23 ' A' ' 21' ' ' THR . 52.5 p30 -97.68 14.75 25.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.498 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.566 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.59 6.23 3.98 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.872 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.542 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 2.1 ptm85 -72.95 145.47 86.48 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.411 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -50.21 -40.53 51.66 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.553 2.169 . . . . 0.0 112.181 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.542 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.4 tp -54.76 -44.71 73.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.491 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.645 ' O ' HG23 ' A' ' 29' ' ' VAL . 57.9 p -64.23 -43.02 96.24 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -64.69 -35.1 79.96 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.7 t-80 -60.3 -50.49 73.42 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.245 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.65 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.32 -34.17 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.61 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 25' ' ' SER . 50.0 t -56.26 -45.13 81.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.403 -0.519 . . . . 0.0 109.811 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.692 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.8 mm-40 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -62.5 -39.06 92.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.754 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.22 -52.68 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -61.77 -41.82 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.963 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.52 -44.38 97.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.469 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.65 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -69.31 -48.07 69.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.599 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' O ' HG12 ' A' ' 39' ' ' VAL . 81.0 mt -57.64 -41.42 81.4 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.553 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.18 -8.16 43.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.461 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.49 17.05 4.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.583 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.6 p -149.86 -27.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.989 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.757 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 94.9 mt-10 40.46 -110.79 0.12 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.436 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 88.58 176.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.622 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.5 p -74.95 -4.62 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.822 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 m -119.44 71.34 13.08 Favored Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.659 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.7 148.36 45.42 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.706 HG23 HD22 ' A' ' 13' ' ' LEU . 3.9 mp -104.14 140.79 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -102.76 121.33 42.24 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.02 126.85 46.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.01 0.433 . . . . 0.0 110.707 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.623 ' N ' HD23 ' A' ' 47' ' ' LEU . 20.3 mt-30 -127.97 123.65 35.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.068 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.7 t -98.64 135.06 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.949 0.404 . . . . 0.0 110.429 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' CG2' ' CD ' ' A' ' 55' ' ' GLN . 15.6 mt -117.8 125.84 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -81.59 102.28 10.53 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.0 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 m -58.59 -14.45 4.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.06 -33.93 70.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.227 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -99.02 -29.36 12.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.302 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.695 ' O ' HD11 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -135.3 77.09 55.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.304 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.37 -6.25 13.68 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.911 3.074 . . . . 0.0 112.446 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -65.77 -45.74 81.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.139 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.02 -21.96 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.12 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' LEU . 58.0 t -62.29 -47.08 94.75 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.63 -33.67 72.97 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -55.91 -41.52 74.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.643 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 64' ' ' LEU . 57.3 m-85 -87.12 14.9 6.79 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.904 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 57.86 5.11 0.32 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.875 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.98 137.01 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.596 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.875 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -146.19 -13.11 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.22 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.642 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.4 m -111.24 142.07 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.913 0.387 . . . . 0.0 111.082 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 16.6 p -135.16 147.83 64.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.345 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -73.32 158.45 98.43 Favored 'Cis proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.507 -1.455 . . . . 0.0 111.903 0.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.83 151.64 33.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.559 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.876 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.6 tt -127.1 131.85 50.75 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.876 ' N ' HD23 ' A' ' 70' ' ' LEU . 22.0 t -128.37 127.49 67.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.552 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.638 ' HE2' HD11 ' A' ' 13' ' ' LEU . 12.8 tttm -91.26 128.49 37.11 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.11 -15.86 7.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.945 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.496 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 145.98 -157.67 27.45 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.822 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' O ' ' O ' ' A' ' 76' ' ' GLY . 2.5 Cg_endo -53.66 -82.26 0.0 OUTLIER 'Cis proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.752 -1.77 . . . . 0.0 112.447 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 75' ' ' PRO . . . 1.22 -125.01 0.01 OUTLIER Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.52 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -109.88 154.81 22.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -81.22 139.48 35.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.567 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 17.5 mm100 -142.12 147.21 36.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 71' ' ' VAL . 61.3 t -118.72 123.56 71.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.971 0.415 . . . . 0.0 110.701 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.492 ' HA ' HE22 ' A' ' 89' ' ' GLN . 12.5 mt -116.68 128.89 55.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.642 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.6 t -157.06 170.36 22.69 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.601 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 92.98 48.75 2.81 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.091 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.2 pt 41.95 6.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 46.8 p30 -97.84 12.76 32.88 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.65 HD12 HG21 ' A' ' 28' ' ' ILE . 80.2 mt -47.45 -46.99 27.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.464 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 55.7 p -66.31 -36.93 84.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.866 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -72.3 -47.11 52.47 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.492 HE22 ' HA ' ' A' ' 81' ' ' LEU . 2.6 tt0 -68.25 -44.41 75.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.975 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 94' ' ' LEU . 47.5 tp -56.77 -47.9 79.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.03 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -39.01 79.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.677 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.48 -38.02 35.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.188 0.518 . . . . 0.0 110.67 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.7 mm-40 -77.85 -33.57 52.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.674 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.31 -57.98 13.32 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.526 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -47.13 -46.79 18.41 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.241 1.961 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -61.96 -34.43 76.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.944 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CH2' HD12 ' A' ' 90' ' ' LEU . 45.1 m0 -64.32 -42.12 96.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.1 -35.41 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.291 0.567 . . . . 0.0 109.821 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.61 -44.47 98.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.179 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 101' ' ' GLN . 82.0 mt-30 54.46 50.08 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.966 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.589 ' O ' ' O ' ' A' ' 100' ' ' GLN . 88.8 mt-30 -36.83 165.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.54 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.6 -36.02 75.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.977 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 158.22 177.04 30.94 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.452 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.31 134.45 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.612 0.244 . . . . 0.0 110.667 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.2 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.502 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 p -64.8 162.59 15.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.455 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t 67.59 4.24 3.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.506 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.4 tp -99.68 134.91 41.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.173 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.49 156.17 36.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.676 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -49.05 156.36 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 123.042 2.495 . . . . 0.0 111.802 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.34 138.92 49.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.77 152.01 19.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.031 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -82.93 160.48 22.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.722 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.8 134.78 53.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.933 0.397 . . . . 0.0 110.436 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.67 149.15 38.72 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.755 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -47.95 159.59 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.387 2.058 . . . . 0.0 111.44 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.894 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.09 131.26 36.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.153 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.894 ' N ' HD23 ' A' ' 13' ' ' LEU . 23.0 mt -95.77 113.74 25.41 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.285 0.564 . . . . 0.0 109.63 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.908 HD11 HD21 ' A' ' 70' ' ' LEU . 2.5 tm? -129.84 132.3 46.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.217 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.858 ' N ' HD13 ' A' ' 15' ' ' LEU . 77.4 mt-30 -126.68 151.25 48.35 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.289 0.566 . . . . 0.0 111.935 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.6 ' CD2' HG22 ' A' ' 29' ' ' VAL . 32.3 tp -128.45 124.66 36.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.095 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.2 m-85 -97.2 120.83 38.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.173 0.511 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.544 HG23 ' NH1' ' A' ' 22' ' ' ARG . 5.0 m -134.13 169.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.096 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.835 ' N ' HH11 ' A' ' 22' ' ' ARG . 2.6 p-10 -139.76 70.03 1.36 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.998 0.428 . . . . 0.0 111.638 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.808 ' N ' ' NH1' ' A' ' 22' ' ' ARG . 63.3 p 54.81 -3.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.835 HH11 ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.77 126.17 88.75 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.216 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.56 -28.29 85.34 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.39 2.06 . . . . 0.0 112.408 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.8 tp -53.86 -44.48 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.217 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.791 ' O ' HG23 ' A' ' 29' ' ' VAL . 5.6 p -67.58 -40.32 84.84 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -61.41 -33.36 73.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.62 -54.74 27.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.717 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.658 HG21 HD12 ' A' ' 86' ' ' LEU . 94.5 mt -64.8 -31.5 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.345 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 25' ' ' SER . 38.6 t -55.97 -45.08 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 7.1 mm100 -60.05 -43.86 95.09 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -63.33 -39.16 93.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.875 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 28' ' ' ILE . 75.3 t -65.48 -51.25 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -62.75 -43.04 99.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 82.5 m-20 -61.45 -44.1 97.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.054 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 88.3 mt -66.66 -50.99 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.679 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 36' ' ' LEU . 89.9 mt -58.76 -41.39 86.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.825 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 -8.2 38.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.361 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.51 8.53 13.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.583 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -150.75 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.97 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.679 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 90.3 mt-10 35.55 -87.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.658 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.6 -169.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.0 p -76.74 -6.99 54.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.573 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -120.61 71.17 18.56 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.582 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.93 153.56 15.01 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.214 1.943 . . . . 0.0 111.904 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.793 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.3 mp -104.53 141.34 20.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.677 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.5 t -99.24 110.24 22.81 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.679 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.4 121.34 41.37 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.585 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.679 ' N ' HD23 ' A' ' 47' ' ' LEU . 54.2 mt-30 -123.15 138.11 54.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.933 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.56 134.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.201 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.798 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 8.1 mt -117.44 124.27 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.3 105.73 13.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 18' ' ' PHE . 35.3 m -54.15 -24.71 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.77 -13.08 61.6 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -92.91 -30.72 15.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.091 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.787 HE21 HD23 ' A' ' 58' ' ' LEU . 0.9 OUTLIER -152.83 77.7 6.28 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.529 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.74 -9.61 26.68 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.572 2.181 . . . . 0.0 111.843 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -71.17 -44.36 65.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.54 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.943 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.34 -25.88 61.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.373 -179.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 64' ' ' LEU . 24.2 t -62.67 -45.33 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.67 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.7 -32.31 72.02 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.718 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -54.18 -41.05 68.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 55.3 m-85 -85.66 14.47 5.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.868 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.7 mtm180 60.2 2.77 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.865 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.59 130.83 45.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.229 -1.35 . . . . 0.0 109.584 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.865 ' N ' HD13 ' A' ' 64' ' ' LEU . 39.2 t -145.19 -5.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.398 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.618 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.9 m -107.77 140.86 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 120.938 0.399 . . . . 0.0 110.775 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 3.3 p -138.28 148.63 60.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.459 ' C ' ' HA ' ' A' ' 67' ' ' THR . 2.8 Cg_endo -71.28 152.26 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.512 0 C-N-CA 123.353 -1.52 . . . . 0.0 112.217 0.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.09 143.77 30.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.703 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.908 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -120.51 137.22 54.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.298 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.836 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.3 t -133.02 129.69 57.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HE3' ' CE2' ' A' ' 97' ' ' TRP . 10.6 ttmt -91.81 126.65 36.98 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.661 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -103.79 -14.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.404 -178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 14' ' ' LEU . . . 148.9 -178.72 26.27 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 119.324 -1.417 . . . . 0.0 112.4 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -68.39 166.4 69.2 Favored 'Cis proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.76 -1.767 . . . . 0.0 112.251 0.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.14 -163.19 23.08 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.4 t -66.73 164.77 16.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.281 0.562 . . . . 0.0 111.394 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.443 HH12 ' CG2' ' A' ' 80' ' ' VAL . 71.4 ttp85 -96.8 145.09 26.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.408 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.895 HE22 ' HE1' ' A' ' 97' ' ' TRP . 25.3 mt-30 -143.01 154.92 44.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.516 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 71' ' ' VAL . 59.4 t -128.78 124.79 62.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.38 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.461 HD11 ' HZ2' ' A' ' 97' ' ' TRP . 11.7 mt -118.77 123.76 45.61 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.618 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.3 t -155.03 167.44 30.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.303 0.573 . . . . 0.0 111.286 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.25 52.22 2.08 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.927 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 13.1 pt 42.44 6.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.692 0.282 . . . . 0.0 111.53 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 83' ' ' GLY . 30.5 p-10 -95.92 9.14 41.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.923 0.392 . . . . 0.0 110.273 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 28' ' ' ILE . 75.2 mt -46.45 -48.9 18.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.454 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -65.92 -38.77 89.54 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.637 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -70.9 -48.73 52.11 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.824 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.3 tt0 -68.61 -44.65 73.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.357 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.2 tp -56.82 -47.77 79.53 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.649 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.516 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.77 -39.55 77.72 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.449 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -79.8 -37.96 34.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.758 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.677 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 92.3 mm-40 -77.39 -34.5 54.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.873 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.27 -57.93 13.48 Favored Pre-proline 0 C--N 1.323 -0.547 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.093 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.5 Cg_endo -47.77 -47.11 19.42 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.937 1.758 . . . . 0.0 111.746 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -60.9 -33.75 73.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.735 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.895 ' HE1' HE22 ' A' ' 79' ' ' GLN . 36.3 m0 -62.35 -44.57 96.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.56 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.4 mt -75.54 -40.68 56.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.714 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 95' ' ' PRO . 76.4 t -63.69 -43.0 97.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.813 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 89.3 mt-30 52.54 29.62 7.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -152.49 163.84 38.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 57.32 -144.81 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.18 54.94 5.41 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 tp -96.13 135.21 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.822 0.344 . . . . 0.0 110.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.457 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.2 m -57.33 -38.34 73.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.708 0.289 . . . . 0.0 110.9 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -72.11 148.96 45.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.85 0.357 . . . . 0.0 110.585 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 tp -89.67 -74.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.518 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.85 58.28 0.4 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -45.34 146.05 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.767 2.312 . . . . 0.0 111.87 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' O ' ' C ' ' A' ' 8' ' ' ALA . 58.0 tp60 -65.17 143.64 57.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 27.69 76.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.673 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -85.87 138.25 32.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.668 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.28 153.02 43.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.335 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -81.8 147.07 57.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.396 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.06 159.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.499 2.133 . . . . 0.0 111.789 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -79.96 133.47 36.19 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 31.1 mt -94.71 111.05 22.83 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.305 0.574 . . . . 0.0 109.966 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.29 134.26 48.9 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.85 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.8 mt-30 -131.34 154.81 48.18 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.566 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.745 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.1 tp -133.22 132.18 41.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.573 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 86.3 m-85 -98.41 123.03 42.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.082 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.42 152.96 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.568 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.562 ' O ' ' OG1' ' A' ' 21' ' ' THR . 9.6 p-10 -100.71 21.63 13.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.166 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.6 p 72.71 3.97 4.84 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.004 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 25' ' ' SER . 16.2 ptm180 -73.1 143.81 84.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -52.32 -39.76 71.95 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.374 2.049 . . . . 0.0 112.358 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 16.8 tp -54.31 -43.18 70.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.43 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 1.004 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.2 p -65.09 -42.34 94.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -64.49 -33.83 76.8 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.5 t-80 -65.49 -54.18 31.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.15 -1.386 . . . . 0.0 108.868 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 68' ' ' PRO . 85.8 mt -63.47 -33.79 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.004 HG23 ' O ' ' A' ' 25' ' ' SER . 55.6 t -56.22 -43.82 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.626 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.6 mt-30 -59.78 -41.96 92.27 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.45 HH21 ' HB ' ' A' ' 87' ' ' THR . 0.2 OUTLIER -60.9 -40.9 94.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.51 -50.03 74.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.362 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttt -62.27 -42.56 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.886 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.0 m-20 -63.36 -43.77 96.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.935 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -67.21 -51.9 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.648 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 44.0 mt -60.26 -41.0 92.3 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.039 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.76 -12.02 61.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.69 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -87.97 10.47 18.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.919 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.9 p -149.72 -31.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.228 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.741 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.2 mt-10 35.88 -85.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 85.76 -175.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.551 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.1 p -73.64 -5.04 37.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.53 73.07 41.12 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.823 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.52 145.79 11.65 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.948 1.765 . . . . 0.0 111.05 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.764 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.5 mp -103.16 141.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.267 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.3 t -101.38 108.88 20.61 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.35 123.29 42.38 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.698 -178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.678 ' N ' HD23 ' A' ' 47' ' ' LEU . 30.9 mm-40 -125.94 130.79 51.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.828 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.5 t -98.5 137.87 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.998 0.428 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.759 HG23 ' NE2' ' A' ' 55' ' ' GLN . 12.9 mt -114.95 125.97 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.3 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLN . 31.4 m120 -83.35 102.22 11.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.034 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 m -59.09 -19.85 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.01 63.01 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.439 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -100.61 -29.14 12.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.583 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 50' ' ' ILE . 19.9 pt20 -138.49 77.02 35.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.911 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -79.91 -7.6 14.38 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 123.642 2.894 . . . . 0.0 112.617 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -66.83 -46.14 76.04 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.68 -22.12 60.96 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.186 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.758 ' H ' HD12 ' A' ' 58' ' ' LEU . 46.7 t -63.01 -46.95 94.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.59 -34.43 74.12 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -55.73 -41.85 74.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.657 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.6 m-85 -84.96 15.73 3.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.497 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.3 mmm-85 57.23 5.01 0.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -62.44 133.88 55.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.245 179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.881 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -141.93 -12.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.179 -178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.695 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.8 m -114.07 142.46 26.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.647 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.411 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 15.8 p -134.26 148.32 67.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.064 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -73.91 157.35 99.37 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 123.425 -1.49 . . . . 0.0 111.841 0.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.552 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -149.47 145.7 27.03 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.018 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -119.63 133.45 55.64 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.271 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.853 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.0 t -131.12 126.51 59.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 120.507 -0.477 . . . . 0.0 112.281 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -92.33 131.26 37.66 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.454 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.33 -20.78 5.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.613 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.38 -174.66 27.99 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.942 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.46 162.41 55.54 Favored 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.641 -1.816 . . . . 0.0 112.154 0.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.23 -166.35 22.07 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -69.53 159.99 32.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.318 0.58 . . . . 0.0 111.54 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -90.43 140.87 29.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.116 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 97.6 mt-30 -139.29 146.13 39.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.652 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.62 HG13 HG22 ' A' ' 71' ' ' VAL . 40.2 t -120.02 124.41 72.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' LEU . 12.3 mt -117.83 128.66 55.06 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.695 ' OG ' HG23 ' A' ' 66' ' ' VAL . 37.0 t -157.61 168.47 27.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.919 -0.713 . . . . 0.0 112.076 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.94 54.72 2.12 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.638 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.5 pt 41.7 5.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 3.6 p30 -99.84 9.84 42.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.276 0.56 . . . . 0.0 109.49 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -49.14 -44.64 42.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' HH21 ' A' ' 31' ' ' ARG . 21.5 p -66.65 -38.69 87.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -70.41 -46.58 63.68 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 1.9 tt0 -69.62 -48.05 61.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.848 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 40.1 tp -55.86 -46.77 78.14 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.585 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.527 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.42 -35.31 71.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.051 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.5 -38.25 30.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.1 mm-40 -77.27 -35.49 55.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.868 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 20.0 tp -52.71 -59.66 8.29 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.999 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.904 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.39 -44.04 30.73 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.212 1.941 . . . . 0.0 111.313 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -62.09 -33.71 74.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.672 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.3 m0 -64.18 -32.18 73.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.789 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 70.5 mt -90.18 -25.15 20.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 95' ' ' PRO . 25.5 t -86.74 32.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 74.1 mt-30 -57.87 142.78 44.84 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.849 -0.341 . . . . 0.0 110.518 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.494 ' O ' ' C ' ' A' ' 102' ' ' GLU . 75.1 mt-30 -158.19 -93.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.313 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' ' 101' ' ' GLN . 66.4 mm-40 30.38 40.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.962 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -86.33 151.84 24.87 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.13 125.76 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 110.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.0 t80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.617 -179.94 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.675 ' C ' ' H ' ' A' ' 4' ' ' LEU . 6.2 p -80.06 -0.39 35.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.773 0.32 . . . . 0.0 110.383 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.28 -14.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.675 ' H ' ' C ' ' A' ' 2' ' ' SER . 12.0 tp -60.6 -39.8 89.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.6 OUTLIER -122.47 80.49 46.55 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.822 -179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.34 151.79 76.0 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.648 2.232 . . . . 0.0 112.015 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.643 ' O ' ' N ' ' A' ' 9' ' ' LEU . 37.1 tt0 -101.77 131.41 48.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.225 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.581 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . -16.77 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.017 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.056 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -85.06 138.75 32.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.23 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.64 146.31 54.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -89.66 146.25 35.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.334 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -53.82 156.79 11.45 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.579 2.186 . . . . 0.0 111.16 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.873 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -79.23 125.31 29.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.873 ' N ' HD23 ' A' ' 13' ' ' LEU . 24.5 mt -90.69 116.15 28.33 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.674 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.7 tm? -128.12 131.56 49.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.158 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 20.0 mt-30 -126.89 149.47 49.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.366 0.603 . . . . 0.0 112.039 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.0 tp -131.39 130.76 43.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.297 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 68.4 m-85 -98.58 124.27 43.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.445 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.28 152.27 29.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.38 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.685 ' C ' HG23 ' A' ' 21' ' ' THR . 38.9 p30 -102.63 17.31 24.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.828 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.685 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.6 p 81.22 10.05 0.93 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.466 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.567 HH21 ' CB ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -74.45 142.94 78.63 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.18 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.86 -36.48 83.17 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.324 2.016 . . . . 0.0 111.25 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.567 ' CB ' HH21 ' A' ' 22' ' ' ARG . 16.1 tp -54.48 -42.67 70.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.983 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -64.55 -42.24 95.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -63.55 -35.12 79.43 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -64.15 -54.03 40.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.741 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.5 mt -64.71 -34.17 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.861 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.983 HG23 ' O ' ' A' ' 25' ' ' SER . 59.8 t -55.81 -47.1 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 C-N-CA 120.519 -0.473 . . . . 0.0 110.052 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.3 mm-40 -60.35 -42.87 96.64 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -62.26 -37.96 87.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.63 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.5 t -65.81 -51.48 61.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -62.97 -41.94 99.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.463 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.3 m-20 -61.85 -45.02 95.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.058 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 86.8 mt -69.54 -50.46 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.496 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.866 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.5 mt -59.35 -39.41 83.14 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.491 -0.484 . . . . 0.0 109.8 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -10.63 60.04 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.855 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -80.81 -21.81 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.992 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.866 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.4 p -87.95 -9.24 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.934 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 41' ' ' ALA . 87.2 mt-10 45.19 -82.02 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 48.38 163.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.248 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 19.4 p -82.93 -4.3 58.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.41 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -114.18 78.5 4.5 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.19 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 146.73 85.89 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.07 1.846 . . . . 0.0 111.599 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.562 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.9 mp -98.54 143.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.8 t -100.75 117.18 34.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -100.45 121.37 41.44 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.384 -178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.508 ' N ' HD23 ' A' ' 47' ' ' LEU . 19.6 mt-30 -123.05 128.82 50.68 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.644 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.2 t -99.05 138.74 22.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.119 0.485 . . . . 0.0 110.448 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.65 HD11 ' NE2' ' A' ' 16' ' ' GLN . 13.6 mt -119.67 125.69 74.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.561 ' OD1' ' HB3' ' A' ' 53' ' ' ALA . 14.9 t-20 -79.54 110.63 15.04 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.69 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 67' ' ' THR . 18.8 m -54.93 -31.29 24.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.114 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' HB3' ' OD1' ' A' ' 51' ' ' ASN . . . -73.14 -24.27 60.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.043 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 60.4 m-20 -89.48 -18.93 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.238 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.637 ' O ' HD11 ' A' ' 58' ' ' LEU . 2.6 pt20 -165.64 74.59 1.32 Allowed Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.399 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.13 -3.83 14.35 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 123.269 2.646 . . . . 0.0 112.558 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.68 -44.44 86.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -73.26 -22.81 60.31 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.909 179.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.776 ' H ' HD12 ' A' ' 58' ' ' LEU . 59.2 t -65.13 -47.04 89.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.81 -34.29 73.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.543 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.25 -42.07 80.83 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.635 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.45 18.53 2.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.299 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 65' ' ' VAL . 91.6 mtt180 53.29 6.3 0.06 Allowed 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.772 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -61.99 132.07 51.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.621 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.772 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -139.05 -7.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.596 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.645 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -117.25 146.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 121.057 0.456 . . . . 0.0 111.272 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.537 HG21 HG11 ' A' ' 52' ' ' VAL . 11.6 p -139.64 148.72 57.04 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.288 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.577 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.9 157.71 98.68 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.703 -1.374 . . . . 0.0 111.802 0.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.52 154.82 41.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.86 0.362 . . . . 0.0 110.79 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.845 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.62 130.99 52.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.172 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.792 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.7 t -130.97 126.24 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.859 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 5.9 tttt -90.34 129.22 36.58 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.445 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -101.69 -23.57 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.229 -178.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 150.24 -165.4 29.88 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.611 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -67.87 2.34 3.2 Favored 'Cis proline' 0 N--CA 1.496 1.635 0 C-N-CA 123.738 -1.359 . . . . 0.0 113.181 0.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.507 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -83.91 -168.23 43.43 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -60.19 153.61 21.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.246 0.545 . . . . 0.0 111.173 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -87.24 129.75 34.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.338 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.631 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 53.1 mt-30 -143.79 154.19 43.16 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.252 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HG13 ' A' ' 71' ' ' VAL . 61.5 t -123.07 121.04 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.63 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 93' ' ' GLN . 19.0 mt -118.69 129.31 55.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.645 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.8 t -156.74 170.35 22.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.282 0.563 . . . . 0.0 111.327 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.698 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.22 56.81 2.1 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.915 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 83' ' ' GLY . 18.4 pt 42.3 3.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.698 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.2 p30 -98.95 6.54 46.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.932 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.8 mp -50.28 -49.74 52.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.46 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -65.31 -37.75 88.07 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.908 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -71.33 -49.63 40.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' CG ' HD22 ' A' ' 81' ' ' LEU . 1.6 tt0 -68.03 -42.93 79.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.858 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 50.8 tp -56.62 -49.52 74.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.706 0.288 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.525 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.27 -33.47 69.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.936 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -78.95 -38.45 37.1 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.209 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.662 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.4 mm-40 -77.13 -34.0 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.76 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -51.94 -58.06 12.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.964 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.0 Cg_endo -50.36 -43.24 44.96 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.943 1.762 . . . . 0.0 110.931 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.461 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 94.8 mt-30 -60.4 -37.13 79.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.359 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.631 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 31.2 m0 -65.2 -41.98 94.0 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 39' ' ' VAL . 50.9 mt -75.38 -45.1 41.27 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 95' ' ' PRO . 92.7 t -64.0 -39.07 84.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 101' ' ' GLN . 95.1 mt-30 58.6 30.73 20.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.301 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.612 ' O ' ' O ' ' A' ' 100' ' ' GLN . 92.7 mt-30 37.77 -171.3 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.764 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.557 ' O ' ' C ' ' A' ' 103' ' ' GLY . 62.5 mm-40 -92.19 139.16 30.9 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.557 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 27.76 -127.22 0.07 OUTLIER Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.03 134.21 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.842 0.353 . . . . 0.0 110.311 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.515 ' OXT' ' CD2' ' A' ' 105' ' ' PHE . 84.5 t80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.441 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -83.44 -1.4 53.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.832 0.349 . . . . 0.0 110.651 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.7 m -85.0 168.09 15.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.676 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -86.6 115.9 24.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.938 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.731 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -163.6 101.7 0.95 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.421 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -67.18 57.58 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.995 1.797 . . . . 0.0 111.877 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 5' ' ' SER . 98.3 mt-30 -87.71 131.93 34.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -164.54 34.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.794 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.1 pp -84.77 137.99 32.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.027 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.43 156.85 33.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.252 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 11' ' ' GLN . 3.3 mt-30 -82.38 161.87 58.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.312 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -72.32 158.82 50.88 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 121.922 1.748 . . . . 0.0 111.245 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.7 tt -80.45 130.4 35.13 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.895 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.4 mt -96.77 115.34 27.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.173 0.511 . . . . 0.0 110.062 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.934 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.04 134.41 52.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.21 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.904 ' N ' HD13 ' A' ' 15' ' ' LEU . 35.9 mt-30 -128.87 157.91 40.23 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.101 0.477 . . . . 0.0 111.944 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 69' ' ' ALA . 11.5 tp -136.89 130.84 32.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.065 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.442 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 81.9 m-85 -95.14 122.5 37.88 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.577 ' CG1' ' OG ' ' A' ' 25' ' ' SER . 2.4 m -138.0 152.56 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.712 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 21' ' ' THR . 54.2 p30 -100.84 16.13 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.608 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.6 p 77.83 11.44 2.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.703 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG3' ' H ' ' A' ' 25' ' ' SER . 9.2 ptm180 -74.14 144.5 81.99 Favored Pre-proline 0 N--CA 1.463 0.223 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.345 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -51.9 -42.39 58.18 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.747 2.298 . . . . 0.0 112.553 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.95 -42.32 72.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.352 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.8 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.2 t -63.65 -44.81 92.72 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.8 -32.87 74.52 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.14 -53.07 55.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.554 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.8 mt -64.54 -33.46 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.23 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 25' ' ' SER . 40.9 t -56.33 -45.29 81.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.945 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.556 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 19.4 mm100 -59.88 -43.38 94.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.479 ' NE ' HG21 ' A' ' 87' ' ' THR . 41.2 mtm180 -63.07 -41.32 99.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.72 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -65.27 -51.42 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 51.1 mttm -62.87 -42.2 99.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.57 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.556 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -62.84 -44.62 95.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.389 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.45 -52.09 35.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.474 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.764 ' O ' HG12 ' A' ' 39' ' ' VAL . 84.8 mt -61.9 -42.63 99.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.11 -14.86 62.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.751 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -84.36 -11.87 55.54 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.814 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.8 p -87.94 -14.97 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' O ' ' O ' ' A' ' 41' ' ' ALA . 78.3 mm-40 33.36 -80.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.121 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 46.64 175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 52.0 p -79.91 -8.16 59.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.737 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.0 82.9 22.16 Favored Pre-proline 0 N--CA 1.45 -0.468 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.292 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.42 146.39 85.29 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.546 2.164 . . . . 0.0 111.891 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG12 HD13 ' A' ' 13' ' ' LEU . 2.9 mt -104.83 136.9 36.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.387 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -99.37 127.9 45.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.873 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.25 128.06 50.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 -179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -124.48 132.52 53.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.7 t -98.78 136.8 28.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.259 0.552 . . . . 0.0 110.865 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.988 HG22 ' NE2' ' A' ' 55' ' ' GLN . 9.6 mt -118.06 126.47 74.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.448 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.757 ' C ' HE21 ' A' ' 55' ' ' GLN . 2.1 t-20 -83.68 100.43 10.86 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG11 HG21 ' A' ' 67' ' ' THR . 22.6 m -57.39 -27.02 27.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.725 0.298 . . . . 0.0 111.429 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.11 -17.24 60.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.096 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -101.81 -29.67 11.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.949 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.988 ' NE2' HG22 ' A' ' 50' ' ' ILE . 3.0 pp0? -142.16 74.21 21.28 Favored Pre-proline 0 N--CA 1.451 -0.389 0 CA-C-O 121.263 0.554 . . . . 0.0 112.212 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.99 -3.59 13.53 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 122.855 2.37 . . . . 0.0 111.413 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -68.22 -58.76 3.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.823 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.678 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -69.62 -22.02 63.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.194 -179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' CG1' HD12 ' A' ' 64' ' ' LEU . 29.9 t -60.19 -44.72 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -68.69 -32.76 72.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.02 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -54.57 -41.24 69.59 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.544 ' C ' ' H ' ' A' ' 64' ' ' LEU . 72.5 m-85 -86.03 13.61 7.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.676 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 4.53 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.56 130.62 45.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.61 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.3 t -140.46 -8.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.656 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.717 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -114.85 146.92 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.911 0.386 . . . . 0.0 110.952 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.549 HG21 HG11 ' A' ' 52' ' ' VAL . 9.7 p -138.2 150.04 65.56 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.385 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.2 Cg_exo -73.15 160.49 95.64 Favored 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.535 -1.444 . . . . 0.0 111.803 0.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.75 153.13 37.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.02 0.438 . . . . 0.0 111.021 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.934 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -126.75 129.43 48.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.893 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 80' ' ' VAL . 21.9 t -129.81 126.72 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -95.02 134.04 38.14 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.333 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.32 -24.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.089 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.17 -172.67 31.42 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.002 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.05 159.41 55.37 Favored 'Cis proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.793 -1.753 . . . . 0.0 112.222 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.36 -176.43 27.79 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -57.38 161.72 3.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 111.172 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -95.68 142.74 27.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.302 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -142.36 146.86 35.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.515 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -120.36 123.02 69.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.675 HD21 ' HG3' ' A' ' 93' ' ' GLN . 13.4 mt -114.96 131.87 56.76 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.717 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.5 t -156.52 169.14 25.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.33 0.586 . . . . 0.0 111.464 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 94.9 48.83 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.064 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 45.3 pt 42.63 5.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.699 ' N ' ' O ' ' A' ' 83' ' ' GLY . 39.9 p30 -98.45 12.73 34.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.204 0.525 . . . . 0.0 109.725 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.9 mt -49.93 -43.83 50.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.874 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.479 HG21 ' NE ' ' A' ' 31' ' ' ARG . 68.8 p -65.51 -39.33 91.72 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.894 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -72.35 -46.9 53.45 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.467 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.47 -47.72 66.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.423 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 31.9 tp -57.14 -47.24 81.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.05 0.453 . . . . 0.0 110.232 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.24 -30.22 66.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.416 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -80.68 -37.17 31.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.658 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.675 ' HG3' HD21 ' A' ' 81' ' ' LEU . 97.7 mm-40 -78.08 -41.19 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.033 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.7 tp -51.7 -57.89 12.98 Favored Pre-proline 0 C--N 1.326 -0.414 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.926 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.634 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.24 -44.0 35.3 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.061 1.841 . . . . 0.0 111.295 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -62.16 -36.18 81.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.931 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 36.6 m0 -63.4 -40.43 97.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.057 0.455 . . . . 0.0 109.785 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.6 mt -68.3 -40.02 81.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.983 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 101' ' ' GLN . 89.3 t -74.1 -41.01 52.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.267 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 60.99 34.5 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.37 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.439 ' HB2' HG12 ' A' ' 99' ' ' VAL . 95.5 mt-30 -138.31 143.33 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.2 0.524 . . . . 0.0 111.23 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' O ' ' O ' ' A' ' 103' ' ' GLY . 91.4 mt-10 -96.13 143.98 26.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.305 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . 53.89 151.1 0.01 OUTLIER Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -110.66 136.81 45.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.983 0.42 . . . . 0.0 111.305 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--O 1.221 -0.423 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.525 179.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.469 ' O ' ' O ' ' A' ' 1' ' ' GLY . 33.2 m -58.38 -125.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.34 . . . . 0.0 110.455 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 4' ' ' LEU . 73.5 m -79.55 7.02 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.954 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.5 tp 46.5 102.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.78 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.78 152.89 95.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.191 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.16 140.65 19.29 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.45 2.1 . . . . 0.0 111.536 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -88.27 135.84 33.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.702 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 142.59 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -86.79 115.48 24.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.645 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 148.31 50.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -85.69 141.1 35.88 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.383 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.12 158.92 16.41 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.159 1.906 . . . . 0.0 111.84 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -82.29 132.02 35.23 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.885 ' N ' HD23 ' A' ' 13' ' ' LEU . 18.2 mt -97.08 112.44 24.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.471 0.653 . . . . 0.0 110.62 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.888 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -126.77 132.65 51.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.304 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 58.9 mt-30 -131.9 154.59 49.08 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.534 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 ' CD2' HG22 ' A' ' 29' ' ' VAL . 21.7 tp -127.09 130.46 49.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.493 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 77.0 m-85 -96.82 120.51 37.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.1 m -137.3 155.09 31.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.104 -0.639 . . . . 0.0 111.914 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.595 ' O ' ' OG1' ' A' ' 21' ' ' THR . 50.3 p30 -101.23 16.16 26.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.598 178.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.4 p 78.01 9.54 2.24 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.547 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.485 HH11 ' HD3' ' A' ' 68' ' ' PRO . 4.2 ptm180 -73.49 144.94 84.39 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.695 -0.402 . . . . 0.0 109.916 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -50.91 -38.8 58.87 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.613 2.208 . . . . 0.0 112.401 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.08 -43.26 70.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.321 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.996 ' O ' HG23 ' A' ' 29' ' ' VAL . 20.4 m -63.34 -45.07 92.92 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -64.36 -34.27 77.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.431 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -63.94 -56.49 14.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.967 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HD13 HD13 ' A' ' 86' ' ' LEU . 97.8 mt -64.44 -31.9 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.276 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.996 HG23 ' O ' ' A' ' 25' ' ' SER . 42.3 t -55.66 -44.8 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.686 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 98.5 mm-40 -60.48 -43.87 96.53 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -62.14 -40.6 96.48 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.611 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 28' ' ' ILE . 71.7 t -64.38 -51.98 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 74.9 mttt -61.86 -42.11 98.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.686 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.2 m-20 -62.13 -45.44 93.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.332 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.9 mt -68.93 -46.81 78.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.303 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.68 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.1 mt -58.37 -42.26 86.59 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.809 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.1 -10.45 57.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.321 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.99 18.23 3.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.381 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.5 p -149.88 -31.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.604 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.71 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 77.2 mm-40 35.88 -97.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.23 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.8 -176.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.672 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.5 p -75.94 -1.87 27.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.412 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.01 71.65 53.14 Favored Pre-proline 0 N--CA 1.452 -0.365 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.079 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.71 144.98 32.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.024 1.816 . . . . 0.0 111.293 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.653 HG23 HD22 ' A' ' 13' ' ' LEU . 3.8 mp -106.1 140.82 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.265 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -103.96 120.75 41.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.686 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.93 124.89 48.32 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.796 -179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.686 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -127.61 133.03 49.71 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.76 135.96 30.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.706 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.777 HG23 ' NE2' ' A' ' 55' ' ' GLN . 16.4 mt -113.81 127.42 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -82.49 103.78 12.29 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.025 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.5 m -59.08 -32.43 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.902 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.04 -25.79 61.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.244 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -91.84 -20.35 21.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.777 ' NE2' HG23 ' A' ' 50' ' ' ILE . 1.0 OUTLIER -155.3 79.7 4.42 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.971 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.78 -6.0 15.74 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.771 2.98 . . . . 0.0 112.517 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.67 -45.83 77.62 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.09 -22.27 59.57 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.398 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.755 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.6 t -63.3 -47.16 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -69.45 -34.73 74.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.078 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -55.93 -41.9 75.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.95 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 64' ' ' LEU . 49.0 m-85 -84.2 10.44 10.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.702 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 60.84 6.67 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.82 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.6 135.63 57.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.295 -1.321 . . . . 0.0 109.689 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.33 -7.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.99 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.51 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.5 m -114.36 142.06 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.955 0.407 . . . . 0.0 110.987 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 40.9 p -137.77 147.02 55.31 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.891 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.8 Cg_endo -72.13 155.44 98.37 Favored 'Cis proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.543 -1.44 . . . . 0.0 112.121 0.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 145.77 29.41 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.073 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.888 HD21 HD11 ' A' ' 15' ' ' LEU . 5.8 tt -121.84 133.7 54.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.914 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.867 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.0 t -130.72 128.64 63.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.074 -0.65 . . . . 0.0 112.342 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.21 129.45 38.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.129 178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.63 -24.18 4.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.362 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.94 -170.44 31.96 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.07 -1.062 . . . . 0.0 111.874 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.39 164.44 30.97 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.763 -1.766 . . . . 0.0 112.1 -0.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.26 -168.19 25.48 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -68.12 158.59 32.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.24 0.543 . . . . 0.0 111.257 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.9 ttp180 -91.53 140.08 30.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.383 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.587 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 24.3 mt-30 -141.25 156.61 45.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.75 HG13 HG22 ' A' ' 71' ' ' VAL . 43.4 t -123.06 128.13 74.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.971 0.415 . . . . 0.0 111.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 22.9 mt -118.04 125.82 51.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.51 ' OG ' HG23 ' A' ' 66' ' ' VAL . 42.0 t -158.06 178.54 10.09 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.485 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.707 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.27 51.74 3.44 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.115 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.3 pt 42.58 4.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.5 p30 -101.18 11.28 39.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.904 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.9 mp -47.43 -47.0 27.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.764 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 28' ' ' ILE . 81.5 p -66.14 -37.94 86.91 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.031 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -71.17 -45.03 64.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.3 tt0 -69.15 -47.2 65.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.943 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.3 tp -54.97 -50.05 69.92 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.098 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.583 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.65 -36.45 76.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.756 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -80.59 -38.35 29.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.242 0.544 . . . . 0.0 110.694 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.549 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 68.5 mm-40 -77.22 -36.03 55.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.55 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.505 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 12.5 tp -52.06 -57.77 13.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.807 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.583 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -48.74 -44.67 30.6 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.009 1.806 . . . . 0.0 111.595 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.659 ' O ' ' N ' ' A' ' 100' ' ' GLN . 94.9 mt-30 -61.72 -33.42 73.99 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.54 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.587 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 44.3 m0 -63.01 -42.99 99.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.91 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 98' ' ' LEU . 89.7 mt -73.37 -41.7 63.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.123 0.487 . . . . 0.0 110.007 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.6 t -76.0 -41.14 38.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.381 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' GLN . 99.2 mm-40 62.6 49.0 4.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.714 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.485 HE21 ' HA ' ' A' ' 101' ' ' GLN . 0.8 OUTLIER -58.26 -34.45 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 50.18 18.37 0.4 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.843 0.354 . . . . 0.0 110.383 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.72 158.24 28.5 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.579 ' C ' ' CG ' ' A' ' 105' ' ' PHE . 26.9 pt -116.36 153.45 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 110.722 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.558 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.466 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -64.67 160.58 19.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.832 0.349 . . . . 0.0 110.646 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -143.83 -96.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 4' ' ' LEU . 29.1 tp -81.28 52.4 1.81 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.125 0.488 . . . . 0.0 110.126 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.92 158.31 84.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.016 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -47.92 176.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 123.31 2.673 . . . . 0.0 112.103 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.27 151.19 47.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.271 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.77 142.37 2.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.848 0.356 . . . . 0.0 110.601 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.2 -170.79 3.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.273 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.56 157.98 30.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -85.64 147.5 46.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.449 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' O ' ' CD2' ' A' ' 14' ' ' LEU . 2.7 Cg_endo -51.51 157.08 5.33 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.444 2.096 . . . . 0.0 111.21 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.877 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -71.98 131.46 42.95 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.877 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.91 109.05 20.49 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.37 0.605 . . . . 0.0 109.873 -179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.4 tm? -119.73 133.49 55.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.674 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 23.6 mt-30 -131.77 155.75 47.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.55 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.622 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.0 tp -139.01 125.3 20.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.77 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 10.0 m-85 -96.41 123.17 39.96 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.9 m -131.36 154.32 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.876 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.649 ' C ' HG23 ' A' ' 21' ' ' THR . 44.9 p30 -100.62 14.67 30.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.525 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.649 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 79.36 10.04 1.56 Allowed 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.293 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 25' ' ' SER . 15.4 ptm180 -73.96 140.89 77.7 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 120.379 -0.529 . . . . 0.0 109.947 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.43 -36.22 47.72 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.423 2.082 . . . . 0.0 111.595 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.5 tp -56.23 -40.57 74.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.185 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.921 ' O ' HG23 ' A' ' 29' ' ' VAL . 24.6 m -65.2 -45.38 85.02 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -63.54 -33.77 76.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.01 -55.4 19.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.528 HD12 ' HG2' ' A' ' 68' ' ' PRO . 91.6 mt -64.03 -32.74 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.357 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.921 HG23 ' O ' ' A' ' 25' ' ' SER . 51.2 t -56.15 -44.39 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.7 mm100 -60.12 -43.69 95.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -61.95 -39.59 92.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.81 -53.47 44.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.587 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 32.2 mttm -61.72 -41.35 97.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.859 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.6 m-20 -61.94 -46.45 89.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.553 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.3 -51.6 46.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.43 . . . . 0.0 110.266 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.916 ' O ' HG12 ' A' ' 39' ' ' VAL . 97.7 mt -59.68 -35.5 74.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.36 -23.95 64.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.002 179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 -12.95 53.3 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.395 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.916 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.6 p -85.68 -16.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.294 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 73.3 mm-40 39.45 -115.69 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.571 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.05 160.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.718 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.2 p -72.1 -4.1 27.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.617 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -122.66 87.95 49.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.87 150.93 74.86 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.051 1.834 . . . . 0.0 111.448 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.1 mp -100.43 142.73 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-O 120.7 0.286 . . . . 0.0 110.991 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 t -101.02 119.27 38.49 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -103.56 117.46 34.49 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.171 -179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' N ' HD23 ' A' ' 47' ' ' LEU . 45.2 mt-30 -123.87 118.09 26.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.565 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -92.54 139.73 17.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.682 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 17.2 mt -116.99 128.85 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.851 ' ND2' ' HB3' ' A' ' 53' ' ' ALA . 6.7 t30 -83.47 109.27 17.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.146 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 18' ' ' PHE . 27.2 m -58.07 -25.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.851 ' HB3' ' ND2' ' A' ' 51' ' ' ASN . . . -70.94 -12.5 61.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -101.34 -37.82 8.32 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.211 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.63 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 3.1 pt20 -138.57 72.12 43.63 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.498 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.8 -9.97 22.88 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.841 2.361 . . . . 0.0 111.671 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -70.06 -46.53 64.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.734 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.936 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.41 -26.62 62.84 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.733 -179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' CG1' HD12 ' A' ' 64' ' ' LEU . 18.9 t -61.62 -41.52 90.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.26 -34.74 76.75 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.411 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -54.41 -42.01 69.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.132 0.492 . . . . 0.0 110.042 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' C ' ' H ' ' A' ' 64' ' ' LEU . 51.2 m-85 -84.33 13.08 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.872 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 63' ' ' ARG . 20.4 mtm105 58.31 4.83 0.36 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.5 tm? -62.84 131.89 50.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.632 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.768 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.97 -9.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.737 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.0 m -104.82 136.04 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.661 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.443 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 17.0 p -133.41 148.21 67.95 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.047 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.5 Cg_endo -72.99 161.01 94.74 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.44 -1.484 . . . . 0.0 111.989 1.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.75 137.96 22.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.96 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.785 HD21 HD11 ' A' ' 15' ' ' LEU . 5.6 tt -113.66 130.08 56.46 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.769 ' N ' HD23 ' A' ' 70' ' ' LEU . 50.1 t -126.79 126.31 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.464 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.01 129.45 38.93 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.299 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.28 -18.9 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.98 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.47 -174.88 25.31 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 119.935 -1.126 . . . . 0.0 111.568 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -65.37 170.06 38.32 Favored 'Cis proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.878 -1.717 . . . . 0.0 111.918 0.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.99 -160.82 23.28 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 t -71.71 155.28 40.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' NH1' ' CE1' ' A' ' 62' ' ' TYR . 21.6 ttp180 -87.74 141.49 28.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.859 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.817 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 17.0 mt-30 -143.27 156.98 44.86 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.973 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.703 HG13 HG22 ' A' ' 71' ' ' VAL . 44.4 t -130.93 122.43 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.529 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.72 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.4 mt -118.25 129.77 55.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.421 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 66' ' ' VAL . 39.8 t -159.26 171.02 20.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.221 0.534 . . . . 0.0 111.286 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.9 54.21 2.23 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.898 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 16.0 pt 42.57 1.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.719 ' N ' ' O ' ' A' ' 83' ' ' GLY . 50.9 p30 -99.67 9.24 43.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.846 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.2 mp -48.86 -42.15 35.54 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.307 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 82.4 p -66.64 -43.07 85.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.613 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -72.48 -45.03 61.37 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.174 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.72 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -67.35 -41.53 84.98 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.932 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 43.1 tp -58.96 -46.08 88.95 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.127 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.604 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -59.3 -31.62 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.499 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -81.35 -38.83 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.688 ' HG3' HD21 ' A' ' 81' ' ' LEU . 98.2 mm-40 -78.44 -36.2 45.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.649 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.59 -60.36 6.65 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.919 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.743 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.13 -48.36 16.81 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.254 1.969 . . . . 0.0 111.453 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -60.13 -34.23 73.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.654 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.817 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 45.2 m0 -64.19 -39.7 94.54 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 75.5 mt -75.74 -37.31 59.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 95' ' ' PRO . 58.4 t -66.6 -46.88 85.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.03 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 97' ' ' TRP . 86.6 mt-30 48.99 60.78 3.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.558 -0.457 . . . . 0.0 109.87 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.72 124.42 20.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.146 0.498 . . . . 0.0 111.182 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 103' ' ' GLY . 43.1 mt-10 -99.1 131.28 45.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.957 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' A' ' 102' ' ' GLU . . . 30.62 -125.2 0.16 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' PHE . 15.7 tt -117.84 137.12 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.75 0.309 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.619 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 p -77.62 7.68 5.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 0.0 110.774 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 t -130.89 51.18 2.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.774 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 4' ' ' LEU . 9.1 tt -60.25 -37.04 79.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.013 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.64 166.04 12.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.35 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -76.98 -71.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.442 2.095 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -97.57 153.26 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.402 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.45 138.89 58.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.684 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.802 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -85.41 152.97 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.063 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.93 144.37 55.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.397 . . . . 0.0 110.268 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -86.02 140.9 35.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.29 171.28 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.336 2.024 . . . . 0.0 111.959 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -82.81 132.79 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.691 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.4 mt -96.2 113.12 24.68 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.356 0.598 . . . . 0.0 109.903 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -125.42 131.7 52.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.855 -178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 24.8 mt-30 -124.85 158.22 33.98 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.25 0.548 . . . . 0.0 111.609 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 69' ' ' ALA . 18.8 tp -137.61 130.55 30.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.607 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.3 m-85 -96.28 122.22 38.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.923 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 3.2 m -134.98 154.37 36.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.605 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.585 ' O ' ' OG1' ' A' ' 21' ' ' THR . 48.2 p30 -105.35 19.03 21.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.632 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 7.9 p 78.34 6.07 2.55 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.861 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 3.9 ptt180 -75.36 144.65 78.47 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.689 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.97 -36.81 54.91 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.766 2.31 . . . . 0.0 112.307 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.2 tp -54.74 -43.78 72.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.818 0.342 . . . . 0.0 110.252 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.951 ' O ' HG23 ' A' ' 29' ' ' VAL . 96.0 p -64.72 -41.39 96.01 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.6 mm-40 -64.45 -33.42 75.83 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -63.73 -52.71 59.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.815 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.409 HD12 ' HG2' ' A' ' 68' ' ' PRO . 96.3 mt -64.74 -35.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.672 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 25' ' ' SER . 73.2 t -56.04 -45.94 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.678 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 97.7 mm-40 -61.18 -42.94 99.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.525 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' HD2' HG21 ' A' ' 87' ' ' THR . 90.6 mtt180 -62.25 -42.21 99.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.824 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 36' ' ' LEU . 55.1 t -63.6 -51.44 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -62.59 -42.13 99.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.448 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.678 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 86.5 m-20 -63.14 -45.27 92.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.285 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.5 mt -68.06 -47.67 77.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.701 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.719 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.3 mt -60.47 -40.34 90.88 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.53 -14.55 63.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -85.24 -22.91 28.45 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.96 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 36' ' ' LEU . 2.4 p -86.07 -10.52 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.818 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.614 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 76.6 tt0 31.3 -107.41 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 76.54 172.32 0.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.077 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.7 p -79.86 -12.16 59.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -115.95 88.94 22.95 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.693 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.07 152.85 79.27 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.384 2.056 . . . . 0.0 111.777 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 HD22 ' A' ' 13' ' ' LEU . 4.5 mp -106.65 140.74 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.633 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.0 t -104.47 130.5 52.38 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.515 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -104.03 126.18 50.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.26 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.515 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.6 mm-40 -123.84 123.99 41.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.781 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.19 134.51 33.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.845 HD11 ' NE2' ' A' ' 16' ' ' GLN . 30.0 mt -113.22 120.79 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.589 ' ND2' ' OD1' ' A' ' 54' ' ' ASP . 54.6 t-20 -82.56 104.65 12.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.087 0.47 . . . . 0.0 109.834 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG11 HG21 ' A' ' 67' ' ' THR . 5.9 m -57.38 -31.94 39.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.32 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.79 -21.56 62.47 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.589 ' OD1' ' ND2' ' A' ' 51' ' ' ASN . 8.1 m-20 -95.33 -26.42 15.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.144 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.632 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 1.8 pt20 -155.97 79.12 4.21 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 120.891 0.377 . . . . 0.0 111.745 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.56 -3.78 13.6 Favored 'Trans proline' 0 N--CA 1.498 1.735 0 C-N-CA 124.018 3.146 . . . . 0.0 112.874 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -64.65 -46.47 82.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.037 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -75.45 -22.52 57.23 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.725 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 64' ' ' LEU . 95.1 t -60.2 -47.87 90.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.73 -32.44 67.76 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -56.12 -42.76 77.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.668 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.654 ' C ' ' H ' ' A' ' 64' ' ' LEU . 45.8 m-85 -84.98 13.99 5.41 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.8 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.2 OUTLIER 60.76 -0.79 0.27 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.768 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -64.32 122.66 17.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.522 178.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.689 ' N ' HD13 ' A' ' 64' ' ' LEU . 8.4 t -133.04 -8.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.688 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.736 HG23 ' OG ' ' A' ' 82' ' ' SER . 17.0 m -112.67 140.01 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.073 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.734 HG21 HG11 ' A' ' 52' ' ' VAL . 7.8 p -133.3 150.05 74.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.794 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.1 Cg_exo -74.59 160.31 96.56 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.543 -1.441 . . . . 0.0 111.779 0.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.52 150.15 32.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.338 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -123.27 128.73 50.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.79 ' N ' HD23 ' A' ' 70' ' ' LEU . 46.4 t -129.16 130.66 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -93.8 132.98 37.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.339 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -20.02 6.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.579 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.73 -174.12 25.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 119.926 -1.13 . . . . 0.0 111.951 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.14 156.26 76.68 Favored 'Cis proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.873 -1.72 . . . . 0.0 112.037 0.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.11 -164.75 15.03 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.4 t -67.0 158.4 31.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.307 0.575 . . . . 0.0 111.615 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -91.67 144.38 25.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.294 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.563 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.1 mm100 -137.58 151.13 48.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.947 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.432 HG13 HG22 ' A' ' 71' ' ' VAL . 39.3 t -127.06 118.46 50.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.002 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.7 mt -117.46 130.13 56.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.736 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -158.02 166.78 31.67 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.973 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 55.8 2.09 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.606 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.3 pt 42.41 4.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 56.1 p30 -97.12 10.78 38.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.694 HD23 ' HB2' ' A' ' 70' ' ' LEU . 8.5 mp -49.41 -45.3 46.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.276 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 HG21 ' HD2' ' A' ' 31' ' ' ARG . 56.3 p -67.82 -41.95 82.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.712 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -70.21 -44.43 68.67 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.931 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.7 tt0 -69.52 -47.18 64.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.057 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' LEU . 50.9 tp -58.64 -45.43 89.28 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.726 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.26 -41.87 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.512 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -82.43 -36.96 26.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.574 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.9 mm-40 -75.54 -35.31 60.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.348 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 90' ' ' LEU . 15.9 tp -52.49 -60.15 7.05 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.582 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.36 -42.52 34.14 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.359 2.04 . . . . 0.0 111.842 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -60.36 -33.95 73.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.588 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.574 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.0 m0 -64.02 -43.02 96.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.455 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.4 mt -66.15 -37.2 85.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.205 0.526 . . . . 0.0 109.755 178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.07 -48.62 78.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.251 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 62.64 39.36 11.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.332 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.583 ' O ' ' O ' ' A' ' 102' ' ' GLU . 83.5 mt-30 -148.12 -94.81 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.27 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 101' ' ' GLN . 80.4 mm-40 25.57 -148.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 125.76 0.02 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 105' ' ' PHE . 61.1 mt -103.34 136.13 37.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.344 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ILE . 37.9 t80 . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.5 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.69 ' O ' ' N ' ' A' ' 3' ' ' SER . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.673 ' O ' ' N ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER 40.1 14.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.803 0.335 . . . . 0.0 110.665 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 1' ' ' GLY . 57.4 p 31.51 29.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.666 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.673 ' N ' ' O ' ' A' ' 2' ' ' SER . 29.4 tp -90.86 115.33 27.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.746 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t -168.66 67.09 0.69 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.232 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.08 137.82 70.13 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.198 1.932 . . . . 0.0 111.892 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.663 ' O ' ' CB ' ' A' ' 8' ' ' ALA . 39.1 tt0 -94.33 -74.71 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.83 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' CB ' ' O ' ' A' ' 7' ' ' GLN . . . 128.27 100.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.888 0.742 . . . . 0.0 109.899 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 120.83 27.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.142 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.29 157.82 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.178 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -86.12 135.78 36.75 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.739 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -54.98 158.74 10.73 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.079 1.853 . . . . 0.0 111.361 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -83.52 128.18 34.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.881 ' N ' HD23 ' A' ' 13' ' ' LEU . 27.5 mt -95.39 113.33 24.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.429 0.633 . . . . 0.0 109.936 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.6 tm? -122.23 133.16 54.71 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.955 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.915 ' N ' HD13 ' A' ' 15' ' ' LEU . 81.7 mt-30 -127.56 151.65 48.63 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.444 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.594 ' CD2' HG22 ' A' ' 29' ' ' VAL . 17.8 tp -132.36 127.46 35.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.686 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 25.2 m-85 -95.06 119.58 33.81 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.5 m -134.34 155.71 39.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.771 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.59 ' C ' HG23 ' A' ' 21' ' ' THR . 47.2 p30 -99.03 16.18 23.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.65 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.3 p 76.92 8.34 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.44 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -74.27 144.11 81.02 Favored Pre-proline 0 CA--C 1.529 0.144 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.249 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -50.51 -37.98 53.17 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.709 2.273 . . . . 0.0 112.324 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 19.6 tp -54.68 -43.33 72.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.025 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.993 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.4 m -62.95 -45.41 92.59 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -63.38 -34.25 77.32 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.35 -57.5 10.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.248 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 32' ' ' VAL . 69.9 mt -63.58 -31.67 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.159 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG23 ' O ' ' A' ' 25' ' ' SER . 44.4 t -56.57 -44.26 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 79.9 mm-40 -60.24 -42.06 94.46 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG21 ' A' ' 87' ' ' THR . 92.8 mtt-85 -62.85 -41.07 99.21 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 28' ' ' ILE . 79.0 t -63.96 -53.4 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -62.93 -41.72 99.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.388 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.546 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 93.0 m-20 -60.68 -43.86 97.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.4 mt -69.13 -48.79 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.757 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.907 ' O ' HG12 ' A' ' 39' ' ' VAL . 23.2 mt -60.03 -39.81 87.15 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.78 62.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.703 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.43 -20.62 36.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 36' ' ' LEU . 13.6 p -88.89 -8.15 10.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.935 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' O ' ' A' ' 41' ' ' ALA . 97.2 mt-10 34.79 -83.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.895 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 49.49 163.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.3 p -77.87 -4.96 49.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.813 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -117.87 82.45 16.94 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 110.498 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -64.71 153.97 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.801 2.334 . . . . 0.0 112.25 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.632 HG23 HD22 ' A' ' 13' ' ' LEU . 4.3 mp -104.57 142.93 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.3 t -101.61 114.76 29.09 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.69 118.12 36.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.873 -179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 90.1 mt-30 -117.93 136.94 53.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.1 t -99.71 136.28 31.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.07 0.462 . . . . 0.0 111.561 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 7.7 mt -116.68 125.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -82.26 110.45 17.45 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.348 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HA ' HE22 ' A' ' 55' ' ' GLN . 17.7 m -53.96 -25.06 11.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.732 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.21 -11.04 60.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.592 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -94.68 -49.18 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.501 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.69 ' OE1' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -133.55 78.46 62.26 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-O 121.388 0.613 . . . . 0.0 111.617 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.72 -7.78 21.35 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 123.018 2.479 . . . . 0.0 111.814 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -70.98 -47.26 59.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.129 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.686 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -72.41 -27.52 62.41 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.086 -0.646 . . . . 0.0 109.618 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 64' ' ' LEU . 46.3 t -63.01 -46.03 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.818 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.38 -30.63 69.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.371 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -54.15 -42.48 69.6 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' LEU . 53.7 m-85 -83.77 14.71 3.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.452 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.456 HH11 ' HB3' ' A' ' 63' ' ' ARG . 44.8 mtm105 59.55 4.35 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.817 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -63.97 130.04 42.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.523 -1.217 . . . . 0.0 109.228 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.817 ' N ' HD13 ' A' ' 64' ' ' LEU . 59.4 t -147.03 -2.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.89 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -111.15 143.22 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 120.746 0.308 . . . . 0.0 110.688 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.0 p -138.02 149.51 64.2 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.135 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' HD3' HH11 ' A' ' 22' ' ' ARG . 3.3 Cg_exo -73.56 157.9 98.89 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.517 -1.451 . . . . 0.0 112.365 0.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.579 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.2 157.88 43.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.667 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -127.46 138.83 53.06 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.736 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.715 ' N ' HD23 ' A' ' 70' ' ' LEU . 51.3 t -131.04 122.76 52.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.572 -0.451 . . . . 0.0 112.035 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.727 ' CB ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -94.69 129.19 41.68 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -21.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.109 -179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.91 -170.07 27.9 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 119.723 -1.227 . . . . 0.0 112.356 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.49 158.17 61.37 Favored 'Cis proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.637 -1.818 . . . . 0.0 111.771 0.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.12 -164.73 15.83 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.1 t -70.99 161.42 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 111.574 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.521 HH12 HG21 ' A' ' 80' ' ' VAL . 72.1 ttp85 -87.86 141.74 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.411 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.668 ' NE2' ' OE1' ' A' ' 93' ' ' GLN . 76.4 mt-30 -139.66 148.53 42.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 78' ' ' ARG . 60.1 t -131.46 127.98 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.972 0.415 . . . . 0.0 111.622 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.874 HD22 ' HB3' ' A' ' 89' ' ' GLN . 31.0 mt -117.13 130.73 56.82 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 31.2 t -154.6 167.16 31.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 52.29 2.5 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 114.576 -1.193 . . . . 0.0 111.616 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 28.4 pt 42.68 4.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.9 p30 -98.36 9.34 43.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.205 0.526 . . . . 0.0 109.71 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.738 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.1 mp -50.62 -38.75 47.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.373 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.446 HG21 ' HD2' ' A' ' 31' ' ' ARG . 43.9 p -62.18 -44.5 96.47 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.803 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -72.09 -43.09 65.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.331 0.586 . . . . 0.0 109.496 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.874 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -67.63 -41.81 83.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.593 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 90' ' ' LEU . 2.7 tm? -53.84 -55.71 24.18 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' HD2' ' A' ' 95' ' ' PRO . . . -59.56 -30.75 68.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.194 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -75.65 -36.4 60.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.069 0.461 . . . . 0.0 110.543 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 99.1 mm-40 -76.7 -29.76 56.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 15.6 tp -52.14 -58.04 12.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.531 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -48.03 -43.98 29.05 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.176 1.917 . . . . 0.0 111.79 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.545 ' NE2' HE22 ' A' ' 79' ' ' GLN . 25.5 mt-30 -62.19 -34.73 77.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.015 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 93' ' ' GLN . 32.8 m0 -65.7 -44.72 85.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.014 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 39' ' ' VAL . 95.0 mt -77.27 -36.83 54.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.696 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 95' ' ' PRO . 55.1 t -64.01 -44.97 97.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.878 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' C ' ' O ' ' A' ' 99' ' ' VAL . 75.9 mm-40 21.23 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.947 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.412 ' HG3' HG12 ' A' ' 99' ' ' VAL . 95.1 mt-30 -114.43 -70.42 0.8 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.791 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -70.54 150.5 46.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.191 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.02 48.64 0.65 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 105' ' ' PHE . 11.0 pt -102.97 141.74 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.399 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.575 ' O ' ' O ' ' A' ' 104' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.336 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' GLY . 7.3 t 46.45 -173.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.89 0.376 . . . . 0.0 110.788 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.58 142.03 3.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.464 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.782 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.3 tm? -57.36 -34.0 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.337 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.45 83.55 16.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.66 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.47 150.32 63.71 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.6 2.2 . . . . 0.0 112.05 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 60.36 39.69 18.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.62 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.07 -158.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.905 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.89 144.21 29.37 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.181 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.64 147.14 52.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.451 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.77 147.9 47.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.596 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.87 164.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.794 2.329 . . . . 0.0 111.774 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -85.64 132.24 34.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.9 mt -96.41 112.06 23.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.41 0.624 . . . . 0.0 110.784 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.889 HD11 HD21 ' A' ' 70' ' ' LEU . 1.8 tm? -124.95 132.01 53.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.708 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.874 ' N ' HD13 ' A' ' 15' ' ' LEU . 90.7 mt-30 -129.8 156.2 44.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.386 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 29' ' ' VAL . 18.7 tp -129.48 130.95 46.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.044 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HE2' HD12 ' A' ' 58' ' ' LEU . 10.0 m-85 -97.23 119.4 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 3.5 m -134.78 153.49 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.974 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.599 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.1 p-10 -98.74 19.71 14.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.006 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.599 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 4.8 p 76.8 4.69 3.42 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.352 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 1.8 ptm180 -74.95 141.96 75.69 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.414 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.06 -35.26 61.03 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.525 2.15 . . . . 0.0 112.248 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 tp -54.16 -43.17 70.38 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.76 ' O ' HG23 ' A' ' 29' ' ' VAL . 22.9 m -64.69 -44.3 90.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -62.67 -34.13 76.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -62.88 -54.06 44.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.713 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.615 HD13 HD13 ' A' ' 86' ' ' LEU . 79.6 mt -64.26 -32.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.293 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 25' ' ' SER . 36.2 t -56.01 -46.67 80.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.698 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 96.8 mm-40 -60.11 -42.25 94.33 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -61.11 -42.09 97.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.318 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.8 t -64.8 -50.29 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.33 -43.43 98.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.201 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 78.0 m-20 -63.41 -42.77 98.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.557 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.6 mt -69.37 -47.28 73.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.644 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.3 mt -57.69 -44.25 85.69 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.001 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.65 -8.54 48.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.3 5.2 27.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.41 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.805 HG11 HD21 ' A' ' 94' ' ' LEU . 5.1 p -141.1 -8.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.516 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.6 tt0 29.24 -86.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.893 0.378 . . . . 0.0 110.726 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.01 171.28 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.114 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.6 p -74.44 -6.59 49.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.874 0.368 . . . . 0.0 110.134 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.9 m -129.53 82.26 67.89 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.01 152.24 30.56 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.927 1.751 . . . . 0.0 112.142 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.9 mp -104.28 146.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.551 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.3 t -104.46 124.2 48.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.549 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.692 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -105.28 123.67 48.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.945 -179.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.692 ' N ' HD23 ' A' ' 47' ' ' LEU . 9.1 mt-30 -125.42 135.36 52.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.153 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 t -101.06 134.31 41.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.076 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 58' ' ' LEU . 17.3 mt -117.12 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -83.1 106.84 15.23 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.101 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.06 -33.37 50.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.05 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.06 62.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.385 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -94.0 -23.11 18.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.028 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.4 pt20 -151.09 78.82 7.1 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.407 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.48 -6.05 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 123.288 2.659 . . . . 0.0 112.275 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -69.78 -49.77 49.68 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.51 HD21 ' HG3' ' A' ' 55' ' ' GLN . 1.2 pp -75.23 -23.11 57.51 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.279 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.423 ' CG1' HD12 ' A' ' 64' ' ' LEU . 13.7 t -62.77 -47.43 92.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.18 -32.48 71.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.164 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -55.14 -41.45 71.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.7 m-85 -84.74 13.0 6.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.371 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 47.4 mtt85 61.39 5.12 1.08 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -63.81 129.92 42.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.789 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.3 t -141.71 -6.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.698 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.677 HG23 ' OG ' ' A' ' 82' ' ' SER . 22.4 m -113.22 143.21 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.972 0.415 . . . . 0.0 110.889 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.409 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 43.5 p -136.99 147.38 58.71 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.032 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.24 158.22 98.89 Favored 'Cis proline' 0 C--N 1.309 -1.53 0 C-N-CA 123.394 -1.503 . . . . 0.0 111.942 0.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -148.4 148.56 30.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.892 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.4 tt -125.12 133.25 52.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.892 ' N ' HD23 ' A' ' 70' ' ' LEU . 19.5 t -134.99 128.57 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 120.081 -0.647 . . . . 0.0 112.653 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 129.82 37.8 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.11 -22.7 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.886 -178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 155.06 -178.01 31.97 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.164 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.99 169.83 47.44 Favored 'Cis proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.8 -1.75 . . . . 0.0 112.295 0.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.04 -166.39 28.58 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -69.21 157.66 36.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.187 0.518 . . . . 0.0 111.063 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' OE1' ' A' ' 79' ' ' GLN . 49.9 ttp180 -81.26 149.32 29.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.238 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.678 ' O ' HG13 ' A' ' 71' ' ' VAL . 21.3 mm100 -140.07 145.51 37.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -127.26 118.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.6 mt -118.3 127.19 53.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.677 ' OG ' HG23 ' A' ' 66' ' ' VAL . 33.5 t -157.51 168.82 26.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.322 0.582 . . . . 0.0 111.622 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.702 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.25 54.74 2.07 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.446 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 29.3 pt 42.5 4.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.702 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.4 p30 -99.34 9.22 43.76 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.8 mp -48.06 -49.2 32.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.44 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.9 p -67.04 -38.87 86.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.372 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.27 -47.0 63.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 4.1 tt0 -68.69 -47.05 67.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.7 tp -56.86 -45.9 82.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.617 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.517 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.14 -37.55 74.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.099 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -81.34 -37.47 28.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.81 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 98.9 mm-40 -77.88 -35.67 50.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.778 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.805 HD21 HG11 ' A' ' 39' ' ' VAL . 16.5 tp -53.1 -60.09 7.59 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.977 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.79 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.3 Cg_endo -49.48 -43.02 40.37 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.076 1.851 . . . . 0.0 111.319 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -61.05 -37.64 83.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.42 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.463 ' NE1' ' HG3' ' A' ' 79' ' ' GLN . 47.9 m0 -65.88 -46.72 77.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.957 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.23 -40.63 82.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.476 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 95' ' ' PRO . 78.3 t -67.53 -38.98 81.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.303 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 61.07 67.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.668 ' O ' ' N ' ' A' ' 103' ' ' GLY . 94.5 mt-30 -77.3 2.71 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.25 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 59.45 -60.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.698 0.285 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . 100.98 1.18 54.97 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.96 138.21 33.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 110.745 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.573 179.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.3 t -110.24 138.81 46.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.964 0.412 . . . . 0.0 111.107 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -85.57 169.79 13.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.755 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.7 tp -88.83 131.55 35.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.482 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.2 89.46 52.24 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.401 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 3.0 Cg_exo -73.03 -167.81 0.38 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.765 2.31 . . . . 0.0 111.168 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -95.1 -6.76 41.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.144 0.497 . . . . 0.0 109.924 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.39 44.7 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.019 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -83.9 91.07 7.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.178 0.514 . . . . 0.0 110.04 179.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.67 167.57 12.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.234 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -146.53 147.45 30.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.371 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.07 151.43 8.92 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.153 1.902 . . . . 0.0 110.983 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.933 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.3 tt -77.82 134.95 37.89 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.933 ' N ' HD23 ' A' ' 13' ' ' LEU . 17.7 mt -98.43 114.05 26.27 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.789 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -132.3 132.96 43.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.058 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.903 ' N ' HD13 ' A' ' 15' ' ' LEU . 22.0 mt-30 -131.35 132.98 44.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.109 0.481 . . . . 0.0 111.091 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CD2' HG22 ' A' ' 29' ' ' VAL . 12.1 tp -107.34 129.94 54.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.82 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.698 ' CE1' HD12 ' A' ' 50' ' ' ILE . 15.0 m-85 -98.41 122.31 41.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 6.9 m -130.62 158.11 42.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.046 0.451 . . . . 0.0 111.689 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.557 ' C ' HG23 ' A' ' 21' ' ' THR . 43.0 p-10 -99.96 17.75 20.16 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.984 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.5 p 75.55 3.73 3.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.892 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.7 142.46 80.51 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 120.529 -0.468 . . . . 0.0 109.908 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.66 -36.24 50.01 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.614 2.209 . . . . 0.0 112.547 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.34 -42.5 73.92 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.032 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.974 ' O ' HG23 ' A' ' 29' ' ' VAL . 85.1 p -64.27 -42.04 96.63 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -63.75 -34.25 77.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -65.79 -55.41 17.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.2 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.649 HD12 ' HG2' ' A' ' 68' ' ' PRO . 68.5 mt -63.76 -31.9 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.063 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 25' ' ' SER . 40.6 t -55.85 -45.58 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' O ' ' CG ' ' A' ' 34' ' ' ASN . 14.2 mm100 -59.92 -41.79 92.53 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HB3' HG21 ' A' ' 87' ' ' THR . 47.7 mtt180 -61.87 -42.78 99.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.842 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.91 -51.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.889 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 43.6 mttt -62.49 -42.33 99.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.995 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' CG ' ' O ' ' A' ' 30' ' ' GLN . 88.3 m-20 -62.6 -43.83 97.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.096 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.518 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 97.2 mt -68.21 -51.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.436 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.888 ' O ' HG12 ' A' ' 39' ' ' VAL . 64.3 mt -59.08 -41.79 88.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.955 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.25 -12.98 62.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.31 -17.3 46.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.435 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 36' ' ' LEU . 8.8 p -89.54 -5.07 10.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.371 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 75.3 mm-40 41.13 -114.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.167 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.54 163.41 0.17 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.89 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 73.5 p -82.48 -7.91 59.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.433 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.28 83.92 56.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -65.12 161.8 35.65 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.856 2.371 . . . . 0.0 112.848 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.6 mp -103.67 143.76 15.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.396 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.6 t -103.18 111.91 24.52 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -97.36 123.63 41.25 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.419 -0.513 . . . . 0.0 110.676 -179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.618 ' N ' HD23 ' A' ' 47' ' ' LEU . 4.9 mt-30 -123.67 132.41 53.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.183 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.5 t -96.68 132.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.897 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.799 HD11 ' NE2' ' A' ' 16' ' ' GLN . 24.2 mt -116.23 123.74 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' C ' ' N ' ' A' ' 53' ' ' ALA . 68.1 m-20 -82.96 112.58 19.87 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 120.194 -0.602 . . . . 0.0 109.439 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.1 m -51.54 -16.45 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.989 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.405 ' N ' ' C ' ' A' ' 51' ' ' ASN . . . -74.81 -15.41 60.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.451 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.12 -38.18 11.23 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -146.34 71.28 13.09 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-O 121.257 0.551 . . . . 0.0 111.53 -179.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -67.83 -10.82 30.06 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.516 2.144 . . . . 0.0 111.586 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -71.53 -44.2 65.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.895 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.897 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.28 -26.56 62.93 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 64' ' ' LEU . 26.3 t -62.3 -44.51 99.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.24 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.84 -31.27 70.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.387 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -53.58 -42.58 67.74 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 64' ' ' LEU . 63.5 m-85 -84.67 14.39 4.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.755 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.417 ' O ' HG23 ' A' ' 65' ' ' VAL . 0.7 OUTLIER 58.91 9.2 1.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.803 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.6 tm? -67.23 130.25 42.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.008 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.803 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.3 t -145.37 -5.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.343 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.606 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -105.34 141.41 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 120.9 0.381 . . . . 0.0 110.375 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 18.6 p -138.03 149.14 62.93 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.645 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.649 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -72.88 159.62 96.71 Favored 'Cis proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.385 -1.506 . . . . 0.0 111.964 0.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -143.08 152.02 41.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.753 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 15' ' ' LEU . 5.5 tt -125.36 130.22 51.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.956 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.54 127.36 68.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 121.062 0.458 . . . . 0.0 112.148 -178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 13.2 tttt -93.73 128.51 39.99 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.774 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -12.96 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.647 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 140.51 -172.56 23.5 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.706 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.1 Cg_exo -62.61 166.12 37.78 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.695 -1.794 . . . . 0.0 111.92 0.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 93.21 -157.83 23.48 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 156.46 33.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.438 0.637 . . . . 0.0 111.591 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 8.0 ttp-105 -84.19 147.3 27.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.775 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.691 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 95.2 mt-30 -136.55 156.57 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.097 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.9 114.29 29.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.408 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . 10.7 mt -118.94 123.84 45.59 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 66' ' ' VAL . 35.3 t -156.63 169.98 23.45 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.52 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.1 63.35 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.795 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 19.0 pt 40.94 5.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.716 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.0 p30 -105.23 9.12 34.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.889 0.376 . . . . 0.0 110.557 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 86' ' ' LEU . 2.4 mp -49.2 -47.73 45.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.55 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 31' ' ' ARG . 81.4 p -67.67 -37.15 81.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.465 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -70.4 -46.28 64.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.227 0.537 . . . . 0.0 109.565 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.428 ' NE2' ' HA ' ' A' ' 81' ' ' LEU . 1.2 tt0 -68.47 -49.55 59.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.433 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.499 HD21 HD21 ' A' ' 36' ' ' LEU . 41.2 tp -55.29 -47.1 76.03 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.772 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.05 -35.92 69.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -81.01 -34.54 32.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.799 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.546 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 96.8 mm-40 -76.84 -35.99 57.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.504 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 10.8 tp -51.79 -59.18 8.67 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.396 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.862 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.99 -39.62 50.01 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.195 1.93 . . . . 0.0 111.49 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -61.23 -38.83 88.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.135 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.691 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 34.0 m0 -65.69 -46.55 78.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.363 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 21.0 mt -66.46 -33.06 74.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.16 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 95' ' ' PRO . 77.3 t -65.87 -39.34 84.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.558 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.1 mm-40 -12.51 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.463 0.477 . . . . 0.0 111.21 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.483 ' O ' ' C ' ' A' ' 102' ' ' GLU . 85.3 mt-30 -73.59 7.56 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.025 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 101' ' ' GLN . 95.9 mt-10 31.42 47.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.845 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.89 -127.95 4.62 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.57 ' O ' ' C ' ' A' ' 105' ' ' PHE . 13.4 tt -113.43 133.27 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 110.453 -0.203 . . . . 0.0 110.453 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.57 ' C ' ' O ' ' A' ' 104' ' ' ILE . 66.3 m-85 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.2 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.63 ' OG ' ' N ' ' A' ' 3' ' ' SER . 59.6 p -95.24 -90.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 110.644 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.63 ' N ' ' OG ' ' A' ' 2' ' ' SER . 55.2 p -73.02 161.24 30.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.357 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 37.1 tp -125.11 -95.72 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.573 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.82 146.25 99.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.577 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 8' ' ' ALA . 2.5 Cg_endo -51.78 143.85 36.95 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.474 2.116 . . . . 0.0 112.23 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' LEU . 24.1 mt-30 23.02 -80.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.109 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.701 ' N ' ' O ' ' A' ' 6' ' ' PRO . . . 47.27 5.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.985 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' GLN . 1.5 pp -85.07 143.71 28.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.927 0.394 . . . . 0.0 110.791 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.14 162.93 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.155 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -85.16 114.21 54.74 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.516 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.31 163.65 14.39 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.951 1.767 . . . . 0.0 111.691 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.907 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -77.94 128.1 33.38 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.907 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.2 mt -95.92 117.37 30.48 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.321 0.581 . . . . 0.0 109.435 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.2 tm? -125.68 136.63 53.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.328 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 15' ' ' LEU . 25.6 mt-30 -132.72 155.13 49.4 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' CD2' HG22 ' A' ' 29' ' ' VAL . 9.8 tp -138.29 136.0 36.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.897 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 88.4 m-85 -99.33 124.31 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.821 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 25' ' ' SER . 7.7 m -135.26 151.34 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.173 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.626 ' C ' HG23 ' A' ' 21' ' ' THR . 49.7 p30 -106.43 21.12 17.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.292 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 78.15 5.06 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.428 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' H ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -73.39 140.54 79.38 Favored Pre-proline 0 N--CA 1.464 0.239 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -52.45 -36.48 69.92 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.231 1.954 . . . . 0.0 112.145 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 tp -55.92 -44.23 78.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.673 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.968 ' O ' HG23 ' A' ' 29' ' ' VAL . 60.5 p -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.51 -34.26 77.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.423 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.8 t-80 -62.57 -54.97 31.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.285 -1.325 . . . . 0.0 108.8 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 68' ' ' PRO . 73.4 mt -63.91 -34.89 71.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.365 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG23 ' O ' ' A' ' 25' ' ' SER . 56.1 t -56.38 -43.95 78.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.69 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 4.1 mm100 -60.0 -44.9 94.24 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -62.98 -38.79 92.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.875 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 28' ' ' ILE . 63.1 t -63.46 -52.35 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.607 -0.437 . . . . 0.0 109.999 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -62.84 -41.42 99.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.68 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.9 m-20 -60.8 -45.22 95.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.381 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.8 mt -67.97 -50.78 56.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.199 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LEU . 95.9 mt -58.63 -42.92 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.59 -8.92 55.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.655 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.15 3.8 25.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.278 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 41' ' ' ALA . 7.6 p -148.96 -28.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.389 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 18.6 tp10 32.89 -83.42 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.668 0.27 . . . . 0.0 110.865 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 83.67 -174.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -74.86 -6.93 51.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.588 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.2 m -123.76 73.22 53.54 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.394 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -50.69 150.04 12.93 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.138 1.892 . . . . 0.0 112.101 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.6 HG23 HD22 ' A' ' 13' ' ' LEU . 3.7 mp -99.38 141.97 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.391 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.1 t -99.88 110.98 23.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.05 124.47 44.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.168 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.654 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -124.91 132.06 53.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.783 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.58 134.5 37.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.401 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.632 HD11 ' NE2' ' A' ' 16' ' ' GLN . 21.6 mt -114.68 122.03 67.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 6.1 t-20 -81.58 103.54 11.37 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.46 ' HA ' HE22 ' A' ' 55' ' ' GLN . 15.9 m -57.35 -21.45 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.1 -178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.14 -13.91 60.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.578 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.19 -47.99 4.55 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.175 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.708 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -138.35 81.31 25.58 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 111.791 -178.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.68 -2.25 12.36 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 123.436 2.758 . . . . 0.0 112.821 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -45.15 89.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.964 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.711 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -74.03 -22.4 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.641 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.711 ' H ' HD12 ' A' ' 58' ' ' LEU . 42.3 t -62.32 -47.31 93.68 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.69 -33.9 73.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -55.56 -41.71 73.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.78 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.615 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.4 m-85 -84.12 14.46 4.21 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.049 178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 60.28 2.09 0.42 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -62.4 132.59 53.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.567 179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.876 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.4 t -143.89 -8.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.635 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.773 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.2 m -113.04 142.48 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 120.866 0.365 . . . . 0.0 110.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 24.9 p -136.36 148.13 62.92 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.723 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.688 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.33 158.46 98.42 Favored 'Cis proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.51 -1.454 . . . . 0.0 111.961 0.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -149.22 154.84 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.398 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.928 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.75 132.66 51.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.287 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.815 ' N ' HD23 ' A' ' 70' ' ' LEU . 61.7 t -129.18 128.51 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.522 -0.471 . . . . 0.0 112.134 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.631 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.6 tttm -93.14 133.6 36.16 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.547 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -106.09 -17.92 7.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.949 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.61 -172.49 24.35 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.146 -1.025 . . . . 0.0 112.078 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.84 149.63 69.21 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 111.887 0.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.59 -163.57 12.14 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 t -74.06 160.84 30.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.1 ttm105 -84.16 145.86 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.734 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.04 146.67 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.126 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.454 HG13 HG22 ' A' ' 71' ' ' VAL . 49.0 t -128.71 119.95 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.834 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD22 ' CD ' ' A' ' 89' ' ' GLN . 12.4 mt -118.61 128.02 54.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.694 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.773 ' OG ' HG23 ' A' ' 66' ' ' VAL . 38.8 t -157.71 168.35 27.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.517 0.675 . . . . 0.0 111.764 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.53 58.76 1.9 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.741 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.9 pt 41.24 5.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -99.85 8.66 43.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.463 0.649 . . . . 0.0 109.29 178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.4 mp -52.49 -45.39 66.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.212 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.0 p -66.62 -41.74 87.88 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.764 -0.375 . . . . 0.0 111.978 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -70.2 -45.2 67.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.383 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.526 ' CD ' HD22 ' A' ' 81' ' ' LEU . 1.7 tt0 -68.06 -48.21 66.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.796 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.9 tp -55.44 -47.38 76.1 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.49 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.1 -36.28 72.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.802 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.56 -36.77 32.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.186 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 87.4 mm-40 -77.04 -34.37 57.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.704 -178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.488 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.9 tp -52.79 -59.68 8.31 Favored Pre-proline 0 C--N 1.327 -0.403 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.102 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.49 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.59 -45.17 24.15 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.213 1.942 . . . . 0.0 111.524 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.92 -34.5 76.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.522 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.565 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 41.1 m0 -65.52 -44.96 85.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 98' ' ' LEU . 89.4 mt -67.49 -41.15 84.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.104 0.478 . . . . 0.0 110.056 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.85 -36.85 71.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.075 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 101' ' ' GLN . 95.9 mt-30 60.71 111.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.173 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 103' ' ' GLY . 94.9 mm-40 38.78 -134.38 0.13 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.364 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 59.78 -33.96 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -56.72 -27.99 56.22 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.4 mt -95.74 135.91 28.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.643 0.259 . . . . 0.0 110.385 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 85.7 t80 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.606 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.557 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.557 ' C ' ' O ' ' A' ' 1' ' ' GLY . 22.6 t 23.32 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.694 0.283 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.575 ' O ' ' C ' ' A' ' 4' ' ' LEU . 8.5 p -69.22 162.15 27.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.262 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' C ' ' O ' ' A' ' 3' ' ' SER . 11.6 tp 18.12 -131.05 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.066 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.489 ' H ' ' CG ' ' A' ' 4' ' ' LEU . 11.7 m -138.51 88.41 14.5 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.893 0.378 . . . . 0.0 110.912 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.77 143.48 74.06 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.684 2.256 . . . . 0.0 112.328 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 81.4 mm-40 -86.54 7.51 25.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.037 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 7' ' ' GLN . . . 68.21 99.46 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.526 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -85.52 147.24 26.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.124 179.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.85 146.02 54.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.196 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -86.35 145.17 39.39 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.808 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -51.13 166.79 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.716 2.277 . . . . 0.0 112.024 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.949 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.6 tt -83.13 135.27 34.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.833 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.949 ' N ' HD23 ' A' ' 13' ' ' LEU . 14.6 mt -96.55 110.94 23.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.249 0.547 . . . . 0.0 110.569 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.914 HD11 HD21 ' A' ' 70' ' ' LEU . 1.6 tm? -126.94 131.02 51.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.22 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.876 ' N ' HD13 ' A' ' 15' ' ' LEU . 26.7 mt-30 -127.35 159.08 35.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.096 0.474 . . . . 0.0 111.34 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.618 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -136.55 125.98 25.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.653 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.84 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 6.9 m-85 -94.86 121.75 36.78 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.96 160.12 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' C ' HG23 ' A' ' 21' ' ' THR . 54.9 p-10 -99.14 14.02 30.84 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.549 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.7 p 76.71 6.16 3.38 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.912 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.413 HH11 HD23 ' A' ' 24' ' ' LEU . 8.5 ptm180 -74.46 147.88 85.32 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.1 Cg_endo -53.1 -38.52 80.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.48 2.12 . . . . 0.0 112.295 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD23 HH11 ' A' ' 22' ' ' ARG . 22.9 tp -54.11 -44.36 71.22 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.2 m -62.9 -44.09 97.04 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.91 -33.31 75.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.705 ' CE1' HH22 ' A' ' 31' ' ' ARG . 1.3 t-80 -65.72 -56.34 12.56 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.26 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.0 mt -63.62 -31.22 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.96 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 25' ' ' SER . 38.7 t -56.48 -46.08 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 6.7 mt-30 -59.37 -40.93 88.09 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.705 HH22 ' CE1' ' A' ' 27' ' ' HIS . 81.2 mtt85 -61.2 -39.05 88.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.31 -51.05 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.9 mttm -61.84 -41.77 98.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.24 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 1.7 m120 -60.98 -46.1 92.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.228 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.613 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 90.5 mt -69.95 -51.42 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.718 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.549 ' O ' HG12 ' A' ' 39' ' ' VAL . 68.9 mt -59.03 -41.58 88.17 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.564 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.57 -9.36 53.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.438 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -86.12 13.73 7.37 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.48 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 41' ' ' ALA . 14.0 p -149.87 -26.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.822 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 85.6 tt0 36.67 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.842 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 82.31 172.19 0.1 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.347 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.0 p -69.61 -10.66 59.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.028 0.442 . . . . 0.0 109.938 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.2 76.45 42.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.985 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.15 153.66 51.02 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.427 2.084 . . . . 0.0 111.903 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.4 mp -101.75 142.7 15.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.8 t -100.26 117.9 35.44 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -99.1 114.67 27.51 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.847 -179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.455 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -118.73 129.24 55.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.926 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.8 t -99.81 136.59 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.171 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 12.6 mt -116.89 127.12 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.473 ' ND2' HG22 ' A' ' 21' ' ' THR . 33.0 m120 -80.82 106.74 13.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.09 -23.8 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.505 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.43 61.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.125 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -93.05 -32.84 14.33 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.593 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 1.7 pt20 -144.23 77.22 14.42 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.997 0.427 . . . . 0.0 111.313 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.78 -9.11 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.324 2.682 . . . . 0.0 111.786 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -69.57 -46.71 65.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.544 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.899 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -73.11 -23.89 60.56 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 95.2 t -61.35 -44.43 98.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.114 178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -67.3 -35.58 79.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.77 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -54.63 -43.7 72.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.655 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.62 ' C ' ' H ' ' A' ' 64' ' ' LEU . 30.7 m-85 -91.04 21.18 4.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.162 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.595 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.3 mmt85 46.68 11.66 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -64.13 62.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.9 t -84.65 2.37 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.22 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.1 m -116.57 143.24 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 120.998 0.428 . . . . 0.0 111.086 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 p -139.09 147.29 52.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.786 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.75 168.07 78.22 Favored 'Cis proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.494 -1.461 . . . . 0.0 111.642 0.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.576 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.44 148.09 27.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.204 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.914 HD21 HD11 ' A' ' 15' ' ' LEU . 5.0 tt -121.0 129.46 53.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.871 ' N ' HD23 ' A' ' 70' ' ' LEU . 11.4 t -132.01 128.6 59.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.285 -179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HA3' ' A' ' 76' ' ' GLY . 14.4 tttt -92.15 127.89 37.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -102.2 -20.57 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.242 -178.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.546 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 155.96 -162.49 31.33 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.033 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.99 -0.28 2.05 Favored 'Cis proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.511 -1.454 . . . . 0.0 113.07 0.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.546 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -85.04 -170.37 47.11 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 72' ' ' LYS . 6.0 t -60.14 166.54 2.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.368 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 62' ' ' TYR . 40.9 ttt-85 -94.39 141.56 28.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.726 ' NE2' ' HE1' ' A' ' 97' ' ' TRP . 22.9 mt-30 -141.01 143.84 34.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.984 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -117.39 120.49 65.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.469 . . . . 0.0 111.673 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 89' ' ' GLN . 44.9 mt -118.7 130.31 55.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.368 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.668 ' HA ' HD21 ' A' ' 86' ' ' LEU . 29.9 t -157.26 166.71 32.41 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.416 0.626 . . . . 0.0 111.525 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.689 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 95.16 45.78 2.97 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.603 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.5 pt 42.58 4.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 83' ' ' GLY . 37.2 p-10 -94.75 10.29 35.67 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.668 HD21 ' HA ' ' A' ' 82' ' ' SER . 44.5 mt -50.78 -38.58 49.01 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 70.8 p -65.88 -40.54 91.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.594 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.36 -44.02 59.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.861 ' HB3' HD22 ' A' ' 81' ' ' LEU . 10.0 mt-30 -69.88 -49.78 48.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.339 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 86' ' ' LEU . 56.0 tp -58.01 -46.53 85.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.111 0.481 . . . . 0.0 109.942 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.96 -34.48 68.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -79.12 -35.39 42.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.145 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.668 ' OE1' ' NE2' ' A' ' 79' ' ' GLN . 97.1 mm-40 -78.16 -33.64 50.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 22.6 tp -51.97 -59.27 8.62 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.422 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.884 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.3 Cg_endo -47.35 -44.82 23.92 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.267 1.978 . . . . 0.0 112.124 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.61 -37.52 84.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.726 ' HE1' ' NE2' ' A' ' 79' ' ' GLN . 39.2 m0 -65.3 -46.17 81.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.753 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.5 mt -66.06 -31.02 71.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.054 0.455 . . . . 0.0 110.122 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.884 HG23 ' O ' ' A' ' 95' ' ' PRO . 71.9 t -63.28 -16.12 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.764 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -60.46 43.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.737 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 99' ' ' VAL . 90.7 mt-30 -91.04 137.74 32.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.372 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -89.91 156.62 18.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.296 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.81 102.54 0.01 OUTLIER Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.484 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 105' ' ' PHE . 30.7 mm -101.3 127.94 54.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.517 ' C ' ' O ' ' A' ' 104' ' ' ILE . 81.5 m-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.457 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -67.57 168.48 10.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.539 0.209 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p 176.33 -0.51 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.478 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 5' ' ' SER . 6.8 tt -93.49 134.78 35.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 111.366 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.678 ' N ' HD23 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -115.77 98.69 51.47 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.278 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.03 16.42 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.674 2.25 . . . . 0.0 113.675 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.05 150.58 28.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.01 146.05 44.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.967 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.028 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -86.95 162.18 17.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.275 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.87 170.21 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.343 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -150.85 149.22 24.91 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.927 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -48.21 152.34 3.67 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.218 1.945 . . . . 0.0 110.918 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.6 tt -76.81 130.39 37.58 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.911 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.3 mt -94.94 113.46 25.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -126.75 135.02 50.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.558 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.918 ' N ' HD13 ' A' ' 15' ' ' LEU . 83.0 mt-30 -130.24 153.46 48.58 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.241 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.4 tp -135.37 128.52 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.09 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.858 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 9.1 m-85 -98.29 124.76 43.08 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.73 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 21' ' ' THR . 3.4 m -133.94 157.85 42.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.911 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.545 ' O ' ' OG1' ' A' ' 21' ' ' THR . 53.8 p30 -99.51 18.12 18.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.458 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.6 p 75.56 7.76 3.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.716 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.446 HH21 HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -75.02 142.85 76.63 Favored Pre-proline 0 CA--C 1.531 0.218 0 C-N-CA 120.701 -0.4 . . . . 0.0 109.923 178.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.13 -36.51 77.2 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.317 2.012 . . . . 0.0 112.674 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD23 HH21 ' A' ' 22' ' ' ARG . 13.4 tp -54.52 -44.18 72.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.883 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 29' ' ' VAL . 15.8 m -62.89 -42.73 99.88 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -64.23 -33.72 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -66.03 -53.77 34.43 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.688 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' VAL . 91.6 mt -63.2 -34.04 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.625 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 25' ' ' SER . 41.6 t -56.39 -43.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.947 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -59.32 -43.81 92.66 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.666 ' HD3' HG21 ' A' ' 87' ' ' THR . 3.2 mtp-105 -61.37 -41.95 97.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.833 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 28' ' ' ILE . 98.5 t -63.03 -50.75 78.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 25.0 mttt -62.35 -43.29 99.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.4 m-20 -61.99 -44.95 95.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.359 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.91 -51.77 46.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.96 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.594 ' O ' HG12 ' A' ' 39' ' ' VAL . 70.7 mt -61.73 -39.57 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.158 0.504 . . . . 0.0 109.743 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -70.04 -16.61 63.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.04 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.66 -23.94 36.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.244 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 36' ' ' LEU . 10.6 p -93.46 -16.0 7.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.853 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.761 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 95.8 mt-10 39.68 -106.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.72 -179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 90.23 167.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 111.377 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.1 p -73.93 -8.67 56.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.359 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.32 88.06 53.34 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.29 152.37 60.93 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.161 1.907 . . . . 0.0 111.749 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.722 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -102.61 143.93 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.058 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -104.0 110.93 23.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.473 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -98.39 123.29 42.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.632 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.8 mm-40 -126.41 131.87 51.64 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.087 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 17' ' ' LEU . 12.3 t -99.59 134.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.486 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.858 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 16.0 mt -117.9 130.98 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 110.17 14.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.696 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.486 HG12 ' HD2' ' A' ' 18' ' ' PHE . 32.3 m -57.58 -29.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.66 -11.69 60.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.974 0.416 . . . . 0.0 110.308 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -94.46 -37.28 11.49 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.067 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CD ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -143.36 71.72 17.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.265 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -70.79 -7.64 21.81 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.754 2.302 . . . . 0.0 111.371 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.911 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.91 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -71.45 -27.14 63.06 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.288 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.9 t -62.85 -46.34 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.91 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.77 -31.82 71.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.291 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -55.16 -41.29 71.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.963 0.411 . . . . 0.0 109.932 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.4 m-85 -84.33 15.36 3.66 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.593 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.9 mtm180 60.04 5.24 0.73 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -67.17 128.58 36.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.572 -1.195 . . . . 0.0 109.349 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.778 ' N ' HD13 ' A' ' 64' ' ' LEU . 4.0 t -145.45 -3.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.726 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.694 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.0 m -108.24 142.45 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.159 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.406 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 36.4 p -137.61 148.13 60.08 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.223 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.488 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -74.3 161.0 95.4 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.501 -1.458 . . . . 0.0 112.147 0.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.47 145.59 29.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.229 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -120.09 131.23 55.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.112 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.685 ' N ' HD23 ' A' ' 70' ' ' LEU . 21.4 t -127.33 126.66 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.271 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HE3' HD11 ' A' ' 13' ' ' LEU . 46.0 tttt -92.63 135.89 33.69 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.539 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.47 -18.51 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.689 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.5 -173.49 25.87 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.171 -1.014 . . . . 0.0 111.761 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -63.01 164.19 46.35 Favored 'Cis proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.743 -1.774 . . . . 0.0 112.342 0.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.06 -155.01 20.29 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.0 t -77.46 162.35 27.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.354 0.597 . . . . 0.0 111.632 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 49.4 ttp85 -87.73 138.49 31.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.882 179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -134.49 148.98 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.508 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG13 HG22 ' A' ' 71' ' ' VAL . 42.3 t -129.7 121.05 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.722 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 89' ' ' GLN . 10.9 mt -118.53 132.46 56.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.99 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.8 t -158.62 168.51 26.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.529 0.68 . . . . 0.0 112.09 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.65 53.36 2.28 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.55 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.1 pt 41.97 4.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 83' ' ' GLY . 45.7 p30 -101.27 5.86 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.083 0.468 . . . . 0.0 110.403 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.856 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.0 OUTLIER -49.39 -37.53 25.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.647 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 31' ' ' ARG . 75.6 p -65.6 -42.67 91.4 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.621 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -72.66 -42.52 64.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.675 ' NE2' ' OD2' ' A' ' 85' ' ' ASP . 78.7 mt-30 -66.16 -49.86 65.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.801 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.405 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.5 tp -56.07 -47.51 77.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.993 0.425 . . . . 0.0 110.395 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.608 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.63 -30.34 67.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -78.83 -42.48 27.49 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.625 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 4.7 mm100 -78.5 -32.61 48.26 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.632 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.508 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.8 tp -52.52 -56.13 25.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.959 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.608 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.4 Cg_endo -48.87 -47.94 19.61 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 121.764 1.643 . . . . 0.0 111.193 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 93' ' ' GLN . 95.6 mt-30 -60.81 -34.67 74.89 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 38.1 m0 -64.52 -36.09 83.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.123 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 39' ' ' VAL . 79.6 mt -82.91 -40.47 20.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.697 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 95' ' ' PRO . 77.9 t -66.85 -49.58 72.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.874 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 99' ' ' VAL . 92.5 mt-30 37.84 49.09 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.558 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 103' ' ' GLY . 26.0 mt-30 59.79 -102.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.083 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 52.5 -71.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.259 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' GLN . . . -45.81 175.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.946 -0.861 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.53 ' O ' ' C ' ' A' ' 105' ' ' PHE . 74.1 mt -99.22 134.74 37.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' C ' ' O ' ' A' ' 104' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.877 -1.058 . . . . 0.0 110.824 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.62 ' OG ' ' N ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -153.67 -162.61 1.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.787 0.327 . . . . 0.0 110.371 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.62 ' N ' ' OG ' ' A' ' 2' ' ' SER . 25.6 p -56.46 -19.65 16.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.267 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 tp 39.39 -91.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.04 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -96.48 162.17 24.33 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 120.901 0.382 . . . . 0.0 110.688 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -45.37 150.81 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.025 2.483 . . . . 0.0 112.035 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -82.2 156.56 24.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.615 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.5 132.39 48.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.044 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.4 pt? -85.96 156.2 20.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.582 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.45 149.77 47.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -82.72 148.93 59.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.414 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -47.65 160.4 0.41 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.431 2.088 . . . . 0.0 111.653 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.937 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.5 tt -86.98 134.2 33.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.549 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.937 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 mt -95.96 112.82 24.45 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.152 0.501 . . . . 0.0 110.027 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.94 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -128.93 132.95 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.432 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.908 ' N ' HD13 ' A' ' 15' ' ' LEU . 96.1 mt-30 -134.37 157.81 45.44 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.109 -0.636 . . . . 0.0 112.075 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.71 HD12 ' O ' ' A' ' 69' ' ' ALA . 14.4 tp -132.39 130.27 40.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.806 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 7.9 m-85 -95.86 122.08 38.28 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.0 m -132.18 155.26 41.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.121 -0.631 . . . . 0.0 111.666 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.6 ' C ' HG23 ' A' ' 21' ' ' THR . 27.7 p-10 -99.49 20.66 13.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.573 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.7 p 76.07 4.05 3.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.286 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 5.3 ptm180 -73.86 141.11 78.28 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -53.28 -35.54 74.74 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.516 2.144 . . . . 0.0 112.345 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.58 -42.99 71.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.275 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.895 ' O ' HG23 ' A' ' 29' ' ' VAL . 21.1 m -63.68 -43.4 96.76 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.581 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.9 OUTLIER -63.45 -32.38 73.81 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -65.56 -54.99 20.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.633 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 68' ' ' PRO . 70.1 mt -64.07 -32.91 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.15 178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 25' ' ' SER . 49.8 t -56.2 -44.36 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.689 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.3 mm100 -59.53 -43.17 93.53 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NE ' HG21 ' A' ' 87' ' ' THR . 46.3 mtm180 -62.63 -39.75 94.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.668 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 28' ' ' ILE . 95.4 t -65.17 -51.87 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.613 178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.93 -42.24 99.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.727 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.689 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.9 m-20 -61.73 -46.03 91.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.566 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 85.6 mt -70.15 -49.25 56.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.684 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.903 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.4 mt -58.64 -40.31 83.02 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.311 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.0 -18.0 64.59 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.93 -11.8 56.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.903 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.29 -9.16 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.21 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.672 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.3 mt-10 36.9 -121.88 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.317 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.34 168.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.972 0.415 . . . . 0.0 111.033 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.2 p -86.82 -6.96 58.65 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 m -115.38 72.23 3.45 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.294 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.96 153.06 21.56 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.23 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.714 HG23 ' HB3' ' A' ' 13' ' ' LEU . 1.9 mp -105.33 141.64 20.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.829 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.6 t -101.91 119.59 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.87 129.85 48.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.312 -178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -134.51 130.87 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.519 178.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -95.24 139.06 19.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.388 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.641 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 7.7 mt -118.41 130.87 72.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -81.89 110.1 16.86 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.936 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.586 HG12 ' HD2' ' A' ' 18' ' ' PHE . 23.4 m -57.69 -28.71 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.024 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.24 -17.56 62.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.481 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.22 -25.02 18.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.067 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.641 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 4.1 pt20 -145.25 70.47 14.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.519 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.69 -9.76 25.46 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.91 2.407 . . . . 0.0 111.578 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -71.33 -48.07 52.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.401 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -72.73 -24.91 61.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.599 -179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 89.6 t -63.26 -41.97 94.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -67.37 -35.09 78.64 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.148 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -55.04 -43.91 74.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.748 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.773 ' CD1' ' NH2' ' A' ' 78' ' ' ARG . 37.5 m-85 -90.87 16.02 10.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.386 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 8.5 mmm180 51.37 9.28 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.644 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.54 65.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.064 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.5 t -84.66 1.46 4.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.979 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG23 ' OG ' ' A' ' 82' ' ' SER . 19.5 m -113.58 142.07 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.029 0.442 . . . . 0.0 111.563 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.0 p -139.15 148.23 56.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.629 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.564 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.0 Cg_endo -76.04 166.5 82.75 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.638 -1.401 . . . . 0.0 111.942 0.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.71 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -150.24 153.02 35.48 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.567 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.94 HD21 HD11 ' A' ' 15' ' ' LEU . 5.7 tt -126.87 131.38 51.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.042 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.707 ' N ' HD23 ' A' ' 70' ' ' LEU . 59.9 t -128.75 125.65 63.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.54 125.25 38.05 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -19.14 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.146 -0.621 . . . . 0.0 112.468 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.95 -173.38 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.581 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.03 163.3 56.4 Favored 'Cis proline' 0 N--CA 1.489 1.259 0 C-N-CA 122.734 -1.778 . . . . 0.0 111.953 0.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.09 -165.41 19.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.0 t -70.1 158.97 34.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 0.0 111.238 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.773 ' NH2' ' CD1' ' A' ' 62' ' ' TYR . 68.5 ttt-85 -94.74 145.27 24.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.9 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 96.5 mt-30 -143.18 155.55 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.581 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 71' ' ' VAL . 71.9 t -128.4 126.26 65.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.971 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.407 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.9 mt -117.6 130.3 56.3 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.623 ' OG ' HG23 ' A' ' 66' ' ' VAL . 41.0 t -158.14 167.3 30.22 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.749 -0.78 . . . . 0.0 112.118 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.55 57.96 1.69 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.711 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 83' ' ' GLY . 21.9 pt 41.33 5.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.718 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.1 p30 -100.9 9.41 42.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.305 0.574 . . . . 0.0 109.615 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.886 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.7 mp -49.22 -49.27 43.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.107 -0.951 . . . . 0.0 112.078 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.44 HG21 ' NE ' ' A' ' 31' ' ' ARG . 75.3 p -66.23 -38.42 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.79 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -70.52 -47.52 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.692 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.407 ' CD ' HD22 ' A' ' 81' ' ' LEU . 4.0 tt0 -66.53 -44.86 81.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.957 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -55.49 -48.65 74.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.966 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.559 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.15 -35.09 71.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.322 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -81.23 -37.7 28.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.013 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.7 mm-40 -77.86 -35.3 51.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.573 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.472 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.4 tp -52.91 -60.59 6.31 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.541 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.568 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.3 -42.15 41.1 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.037 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -61.67 -34.9 76.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.004 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 35.0 m0 -64.27 -33.55 76.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.076 0.465 . . . . 0.0 110.105 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.4 mt -87.1 -12.75 46.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.56 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 99' ' ' VAL . 61.2 t -108.87 15.89 7.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.215 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' C ' ' O ' ' A' ' 99' ' ' VAL . 91.6 mt-30 -32.19 90.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.768 0.318 . . . . 0.0 111.135 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 102' ' ' GLU . 94.2 mt-30 -153.18 -14.7 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.655 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 101' ' ' GLN . 52.2 mp0 35.01 -160.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.083 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.74 72.81 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.5 tt -109.82 128.76 65.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.408 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 105' ' ' PHE . 44.6 p90 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.526 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 p -61.36 -81.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.707 0.289 . . . . 0.0 110.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -90.97 125.67 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.121 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.825 ' C ' HD13 ' A' ' 4' ' ' LEU . 3.2 tm? -65.87 -42.34 90.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.009 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.31 159.13 30.27 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 110.951 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -53.45 138.49 65.71 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.636 2.224 . . . . 0.0 111.559 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.584 ' O ' ' O ' ' A' ' 8' ' ' ALA . 61.2 tp60 -139.73 42.97 1.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.159 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' O ' ' O ' ' A' ' 7' ' ' GLN . . . 41.25 -175.41 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.602 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.18 143.87 28.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 145.8 55.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -85.65 145.28 41.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.267 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.39 156.35 8.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.481 2.121 . . . . 0.0 111.764 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD23 ' N ' ' A' ' 14' ' ' LEU . 4.9 tt -80.34 130.14 34.98 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.897 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.6 mt -94.81 114.28 26.15 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.858 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.955 HD11 HD21 ' A' ' 70' ' ' LEU . 1.7 tm? -128.06 135.69 50.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.123 -178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.942 ' N ' HD13 ' A' ' 15' ' ' LEU . 86.7 mt-30 -132.3 155.65 47.96 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.466 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.7 tp -133.39 129.06 36.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.531 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.597 ' HD2' HG12 ' A' ' 52' ' ' VAL . 12.8 m-85 -96.62 122.65 39.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 25' ' ' SER . 4.0 m -132.62 156.13 42.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.792 -178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.573 ' O ' ' OG1' ' A' ' 21' ' ' THR . 36.6 p-10 -99.46 18.97 16.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.628 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.7 p 73.56 8.03 5.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.871 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.48 142.32 77.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -51.37 -36.8 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.502 2.135 . . . . 0.0 112.252 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.2 tp -54.91 -42.91 72.77 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.252 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.918 ' O ' HG23 ' A' ' 29' ' ' VAL . 59.9 p -64.78 -42.77 94.82 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -63.98 -33.42 75.7 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.88 -54.04 37.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.019 -1.446 . . . . 0.0 108.916 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 68' ' ' PRO . 77.2 mt -63.97 -33.57 63.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.548 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 25' ' ' SER . 55.7 t -56.02 -46.33 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.798 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.695 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 11.8 mm100 -59.93 -42.77 94.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -62.02 -41.55 98.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.687 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.54 -50.0 78.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -62.42 -42.86 99.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.207 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.695 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.7 m-20 -61.51 -45.72 93.02 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.528 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 87.9 mt -68.84 -49.54 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG12 ' A' ' 39' ' ' VAL . 95.1 mt -59.97 -40.31 88.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.183 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.25 -16.74 64.46 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.26 -12.3 56.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.109 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 36' ' ' LEU . 4.4 p -85.51 -12.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.966 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 39' ' ' VAL . 97.1 mt-10 38.64 -105.54 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.644 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 60.51 152.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.8 p -68.3 -1.24 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.7 82.57 41.58 Favored Pre-proline 0 N--CA 1.451 -0.387 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.461 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -69.69 155.55 65.89 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.901 2.401 . . . . 0.0 111.998 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.639 HG12 HD13 ' A' ' 13' ' ' LEU . 3.8 mp -105.26 142.92 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.38 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.0 t -100.95 117.9 35.92 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.652 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -101.79 122.6 44.27 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.041 -178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.652 ' N ' HD23 ' A' ' 47' ' ' LEU . 17.1 mt-30 -126.03 138.29 53.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.061 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.9 t -100.84 136.32 32.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.633 ' CG2' ' NE2' ' A' ' 55' ' ' GLN . 10.4 mt -115.99 131.32 68.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -80.56 108.98 14.65 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.283 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 18' ' ' PHE . 21.7 m -56.47 -23.0 15.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.892 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 -12.98 60.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.649 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -94.75 -40.53 9.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.495 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.633 ' NE2' ' CG2' ' A' ' 50' ' ' ILE . 3.4 pt20 -139.53 80.11 22.96 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.121 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.96 -9.13 23.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.987 2.458 . . . . 0.0 111.219 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -70.57 -46.68 63.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.849 -178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.872 ' C ' HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.19 -28.12 62.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.628 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 19.7 t -61.66 -45.06 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.27 -32.22 71.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.387 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -54.72 -42.24 71.31 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.574 ' C ' ' H ' ' A' ' 64' ' ' LEU . 40.4 m-85 -84.07 14.39 4.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.456 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.612 ' O ' HG23 ' A' ' 65' ' ' VAL . 54.2 mtm180 60.52 3.67 0.62 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -64.0 128.48 36.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.071 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 64' ' ' LEU . 2.8 t -141.22 -9.49 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.715 HG23 ' OG ' ' A' ' 82' ' ' SER . 12.4 m -109.09 142.51 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 120.878 0.37 . . . . 0.0 110.547 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.568 HG21 HG11 ' A' ' 52' ' ' VAL . 9.4 p -136.44 150.49 70.69 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.799 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -72.89 159.8 96.47 Favored 'Cis proline' 0 C--N 1.309 -1.51 0 C-N-CA 123.571 -1.429 . . . . 0.0 112.465 0.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.11 146.36 27.66 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.723 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.955 HD21 HD11 ' A' ' 15' ' ' LEU . 6.1 tt -120.31 134.72 55.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.533 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.832 ' N ' HD23 ' A' ' 70' ' ' LEU . 8.8 t -134.05 126.96 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.221 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 133.19 35.74 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -21.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.514 -0.474 . . . . 0.0 112.191 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 76' ' ' GLY . . . 152.85 -172.73 31.88 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 119.583 -1.294 . . . . 0.0 111.941 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -68.7 1.52 4.12 Favored 'Cis proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.543 0.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 74' ' ' GLY . . . -77.06 -177.34 45.47 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -64.13 156.58 27.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.642 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 -80.11 131.69 35.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.955 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.828 HE22 ' HE1' ' A' ' 97' ' ' TRP . 28.4 mt-30 -144.41 153.48 41.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.81 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 71' ' ' VAL . 59.8 t -126.21 120.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.732 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.73 HD21 ' HG3' ' A' ' 93' ' ' GLN . 21.2 mt -113.42 131.15 56.12 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.715 ' OG ' HG23 ' A' ' 66' ' ' VAL . 36.1 t -156.01 166.53 33.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.654 0.74 . . . . 0.0 112.053 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.21 54.18 2.34 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.772 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 31.5 pt 42.63 5.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.7 p30 -96.11 10.64 36.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.472 0.653 . . . . 0.0 109.316 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.655 ' H ' HD12 ' A' ' 86' ' ' LEU . 7.8 mp -50.87 -47.57 60.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.77 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 62.5 p -66.14 -42.47 89.05 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.734 -0.386 . . . . 0.0 112.02 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -71.1 -47.11 60.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.982 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.704 ' HB3' HD22 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -66.76 -41.62 87.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.074 179.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 39.2 tp -57.59 -46.48 83.99 Favored 'General case' 0 CA--C 1.523 -0.062 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.293 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.619 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.11 -32.33 68.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.239 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -80.41 -36.72 33.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.771 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.73 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.7 mm-40 -77.14 -38.89 51.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.727 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.511 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 16.7 tp -52.45 -57.72 14.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.331 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.688 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -47.21 -44.28 24.25 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.126 1.884 . . . . 0.0 110.929 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.22 -36.27 83.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.828 ' HE1' HE22 ' A' ' 79' ' ' GLN . 37.5 m0 -64.49 -35.5 81.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.2 mt -75.2 -32.38 61.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.371 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 95' ' ' PRO . 97.2 t -66.37 -48.28 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.274 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 99' ' ' VAL . 77.4 mt-30 29.92 38.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.312 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.599 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.3 mm-40 -122.06 0.66 9.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.938 0.399 . . . . 0.0 110.322 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.547 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 54.6 mp0 -55.53 143.98 27.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.426 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.63 11.84 4.89 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.588 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.55 ' O ' ' O ' ' A' ' 105' ' ' PHE . 10.2 tt -114.16 131.06 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.47 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.55 ' O ' ' O ' ' A' ' 104' ' ' ILE . 59.2 m-85 . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m -85.51 2.89 42.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.651 0.262 . . . . 0.0 111.019 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 m -66.85 165.32 15.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 111.237 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.8 tp -53.62 -39.48 64.96 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.735 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.72 172.53 4.6 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.178 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -74.49 -79.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.188 1.925 . . . . 0.0 112.31 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.71 151.1 25.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.052 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.16 175.41 0.72 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.271 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.051 HD13 ' H ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -81.61 150.51 28.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.206 0.527 . . . . 0.0 111.166 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.06 142.96 55.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.775 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.93 149.83 46.48 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.128 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -46.68 157.44 0.5 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.283 1.988 . . . . 0.0 111.289 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.91 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -82.87 131.8 35.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.91 ' N ' HD23 ' A' ' 13' ' ' LEU . 32.0 mt -96.45 115.27 27.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.533 0.683 . . . . 0.0 109.71 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.911 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -123.36 132.04 53.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.307 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.866 ' N ' HD13 ' A' ' 15' ' ' LEU . 21.3 mt-30 -125.8 154.61 42.35 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 121.06 0.457 . . . . 0.0 111.485 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.629 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.3 tp -134.98 133.21 39.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.301 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.416 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 57.1 m-85 -99.12 121.66 41.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 25' ' ' SER . 12.9 m -133.2 154.88 40.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.289 -0.565 . . . . 0.0 111.603 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.569 ' O ' ' OG1' ' A' ' 21' ' ' THR . 46.2 p-10 -99.14 18.02 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.47 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 12.2 p 73.55 1.18 3.88 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.598 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' NH2' ' O ' ' A' ' 67' ' ' THR . 5.8 ptt180 -73.96 147.7 86.36 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.39 -39.62 81.02 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.483 2.122 . . . . 0.0 112.667 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.6 tp -53.96 -44.63 70.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.387 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 29' ' ' VAL . 19.0 m -63.39 -44.71 93.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' N ' ' CD ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -64.44 -33.52 76.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.47 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.4 t-80 -62.17 -51.57 67.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.153 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.639 HD12 ' HG2' ' A' ' 68' ' ' PRO . 89.1 mt -63.62 -31.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.287 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 ' CD2' ' A' ' 17' ' ' LEU . 39.0 t -56.45 -43.41 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.662 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 15.3 mm100 -58.78 -42.13 88.29 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -62.08 -39.13 91.39 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -65.21 -53.44 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -61.97 -40.91 97.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.998 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.662 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 88.0 m-20 -61.23 -44.56 97.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.699 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.3 mt -68.17 -49.6 65.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.082 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.07 -43.9 95.13 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.71 -11.44 60.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.109 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.99 11.89 8.64 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.683 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' O ' ' N ' ' A' ' 41' ' ' ALA . 3.4 p -151.15 -33.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.309 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.727 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt-10 37.39 -92.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.816 0.341 . . . . 0.0 110.417 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 86.33 -175.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.657 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 75.9 p -73.46 -6.95 49.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.334 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -124.0 89.03 52.07 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.106 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -66.03 146.12 81.37 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.547 2.165 . . . . 0.0 112.039 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.667 HG23 ' HB3' ' A' ' 13' ' ' LEU . 3.7 mp -101.18 139.97 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.157 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.3 t -99.8 114.29 27.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -99.62 117.9 34.99 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.536 -179.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.617 ' N ' HD23 ' A' ' 47' ' ' LEU . 40.8 mt-30 -117.7 141.3 48.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 t -101.22 137.25 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.82 HD11 ' NE2' ' A' ' 16' ' ' GLN . 16.8 mt -118.09 120.07 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' ND2' HG22 ' A' ' 21' ' ' THR . 13.9 m120 -83.78 110.57 18.44 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.797 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 m -56.51 -31.92 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.215 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.95 -21.12 61.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.653 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -94.92 -21.34 18.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.603 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.1 pt20 -155.68 78.65 4.45 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.934 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.44 -7.47 18.79 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 123.306 2.671 . . . . 0.0 112.02 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -69.69 -50.63 41.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.444 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD11 HG21 ' A' ' 50' ' ' ILE . 1.9 pp -75.12 -23.28 57.88 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.486 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 55' ' ' GLN . 22.0 t -62.04 -47.53 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.67 -34.03 73.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.783 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -55.67 -41.48 73.72 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.5 m-85 -84.88 15.75 3.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.391 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 15.0 mmt180 57.56 5.18 0.29 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.793 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.1 tm? -62.26 129.02 38.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.4 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -141.89 -12.92 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.52 -178.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.689 HG23 ' OG ' ' A' ' 82' ' ' SER . 9.3 m -108.35 141.43 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 120.869 0.366 . . . . 0.0 110.515 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.455 ' O ' ' NH2' ' A' ' 22' ' ' ARG . 37.5 p -134.55 146.48 59.35 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.833 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.639 ' HG2' HD12 ' A' ' 28' ' ' ILE . 3.1 Cg_exo -76.39 159.88 96.0 Favored 'Cis proline' 0 C--N 1.306 -1.678 0 C-N-CA 123.499 -1.459 . . . . 0.0 111.434 0.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.47 145.16 26.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.113 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.911 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -118.25 131.67 56.35 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.801 ' N ' HD23 ' A' ' 70' ' ' LEU . 47.9 t -124.49 128.33 73.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 14.1 tttm -93.82 131.16 39.47 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.088 177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -104.73 -21.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.509 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' CA ' ' HZ3' ' A' ' 72' ' ' LYS . . . 146.8 -173.11 27.12 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.756 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.442 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.3 Cg_exo -62.77 156.09 66.8 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.149 0.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.19 -175.39 21.99 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.0 t -60.16 157.35 13.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.147 0.498 . . . . 0.0 111.181 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -90.29 138.51 31.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.427 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -140.95 156.21 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.502 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 71' ' ' VAL . 58.9 t -130.04 128.57 64.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 70' ' ' LEU . 10.3 mt -112.83 129.38 56.46 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.689 ' OG ' HG23 ' A' ' 66' ' ' VAL . 47.0 t -158.0 167.72 29.14 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.533 -0.867 . . . . 0.0 112.327 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 86.95 54.05 2.7 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.402 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 83' ' ' GLY . 20.0 pt 41.91 5.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.703 ' N ' ' O ' ' A' ' 83' ' ' GLY . 49.3 p30 -98.66 9.07 44.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.14 0.495 . . . . 0.0 109.921 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.833 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.6 mp -49.35 -44.97 45.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.273 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 p -65.86 -38.09 87.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.182 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.2 -48.09 53.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 93' ' ' GLN . 3.8 tt0 -68.3 -44.82 74.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.501 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 48.7 tp -56.25 -48.25 76.91 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.707 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.522 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.68 -36.11 73.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.95 0.405 . . . . 0.0 110.068 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -79.7 -38.33 33.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.886 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.665 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.0 mm-40 -78.33 -34.41 48.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.076 -178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.497 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.5 tp -52.21 -58.89 9.79 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.985 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.3 Cg_endo -47.54 -46.06 21.57 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.342 2.028 . . . . 0.0 111.64 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -61.01 -32.99 72.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.584 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.665 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 34.8 m0 -65.28 -20.48 66.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.418 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 100' ' ' GLN . 79.7 mt -93.03 -32.8 14.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.277 0.56 . . . . 0.0 110.177 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.741 ' O ' HG12 ' A' ' 99' ' ' VAL . 84.0 t -65.02 8.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.837 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 98' ' ' LEU . 89.3 mt-30 -38.96 154.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.272 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 62.76 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.41 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.608 ' O ' ' O ' ' A' ' 99' ' ' VAL . 96.2 mt-10 -57.97 146.6 31.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.771 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 150.9 18.41 0.07 OUTLIER Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 98.5 mt -105.21 137.21 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.959 0.409 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 105' ' ' PHE . 1.2 m-85 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.651 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -110.18 145.65 36.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.738 0.304 . . . . 0.0 110.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 p -68.06 160.39 28.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.592 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.8 tp -178.23 -37.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.228 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 p -130.36 77.13 76.65 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.393 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.82 39.19 0.49 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.651 2.234 . . . . 0.0 111.483 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.57 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 84.0 mt-30 -77.23 -2.15 33.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.4 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.56 -86.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.238 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -83.89 173.73 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.579 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -65.45 -167.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.583 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.57 ' OE1' ' OE1' ' A' ' 7' ' ' GLN . 4.1 mm100 -86.4 119.09 71.27 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.8 154.59 48.61 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.725 1.617 . . . . 0.0 111.366 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.3 tt -72.4 129.35 38.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.88 ' N ' HD23 ' A' ' 13' ' ' LEU . 34.1 mt -96.3 114.6 26.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.552 0.691 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD11 HD21 ' A' ' 70' ' ' LEU . 1.3 tm? -124.07 131.4 53.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.977 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.88 ' N ' HD13 ' A' ' 15' ' ' LEU . 85.2 mt-30 -127.56 150.69 49.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.13 0.491 . . . . 0.0 111.337 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 29' ' ' VAL . 14.5 tp -131.76 131.44 42.98 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.462 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 50' ' ' ILE . 58.5 m-85 -95.6 121.86 37.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.05 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.6 m -134.05 149.07 30.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.063 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.596 ' C ' HG23 ' A' ' 21' ' ' THR . 49.1 p30 -101.61 20.09 16.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.514 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.0 p 76.89 9.75 2.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.205 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HE ' ' HB3' ' A' ' 24' ' ' LEU . 13.2 ptm180 -74.51 139.59 74.81 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.05 -36.25 64.67 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.273 1.982 . . . . 0.0 111.91 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.506 ' HB3' ' HE ' ' A' ' 22' ' ' ARG . 14.5 tp -55.03 -41.88 71.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.18 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.999 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.7 p -64.98 -42.19 94.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 26' ' ' GLN . 1.2 mm100 -63.98 -33.76 76.45 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -64.63 -55.1 22.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.042 -1.435 . . . . 0.0 108.709 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 68' ' ' PRO . 79.4 mt -64.71 -33.46 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.145 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.999 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.32 -43.7 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.702 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 14.5 mm100 -59.94 -44.13 94.55 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -62.54 -39.86 94.93 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.737 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 28' ' ' ILE . 72.6 t -64.32 -51.54 67.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 78.2 mttt -61.85 -42.13 98.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.031 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.702 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.7 m-20 -62.34 -46.44 88.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.773 -178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 98.7 mt -69.96 -48.48 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.696 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 39' ' ' VAL . 96.2 mt -58.49 -42.03 86.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.315 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.89 -14.78 62.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.8 22.9 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.691 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -149.6 -35.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.28 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 96.8 mt-10 32.69 -88.41 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.784 0.326 . . . . 0.0 110.385 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.08 46.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.781 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 18.5 p 64.73 -31.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 41' ' ' ALA . 2.5 m -111.07 96.21 28.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.102 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -66.38 156.66 64.15 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.555 2.17 . . . . 0.0 112.693 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 HD22 ' A' ' 13' ' ' LEU . 4.7 mp -103.17 143.33 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.312 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -98.36 115.69 29.0 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -100.0 122.46 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.01 -178.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.482 ' N ' HD23 ' A' ' 47' ' ' LEU . 61.8 mt-30 -123.07 134.59 54.25 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.516 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.0 t -97.47 136.61 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.998 0.428 . . . . 0.0 110.657 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' CE1' ' A' ' 18' ' ' PHE . 20.2 mt -114.81 122.06 68.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.401 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -84.87 106.17 16.19 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.076 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 67' ' ' THR . 28.1 m -58.27 -32.77 45.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.436 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.45 -25.57 62.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.334 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -91.64 -19.13 23.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.208 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 2.1 pt20 -155.51 71.49 5.49 Favored Pre-proline 0 C--N 1.331 -0.2 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.417 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.26 -7.13 19.38 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.196 2.598 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -68.85 -49.75 55.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.318 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -74.54 -22.8 58.83 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.177 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 64' ' ' LEU . 25.5 t -60.87 -47.47 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.65 -31.89 70.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.774 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -55.4 -41.72 73.08 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 64' ' ' LEU . 50.7 m-85 -84.26 14.7 4.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.249 178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 15.2 mmt85 59.75 3.33 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.795 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -64.47 129.36 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.159 179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.795 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.8 t -142.16 -6.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.371 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.691 HG23 ' OG ' ' A' ' 82' ' ' SER . 14.0 m -113.4 143.48 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-O 120.708 0.29 . . . . 0.0 110.236 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 52' ' ' VAL . 17.3 p -136.62 148.61 64.33 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.8 Cg_endo -73.95 160.7 95.69 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.458 -1.476 . . . . 0.0 111.899 0.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.19 141.19 24.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.272 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.901 HD21 HD11 ' A' ' 15' ' ' LEU . 5.3 tt -112.72 130.14 56.17 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.808 ' N ' HD23 ' A' ' 70' ' ' LEU . 31.8 t -126.08 123.99 65.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.171 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -93.9 130.47 39.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.205 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.5 -21.09 5.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.577 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.42 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 147.24 -164.03 28.67 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.157 -1.021 . . . . 0.0 111.622 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.42 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 2.7 Cg_endo -58.09 162.3 24.87 Favored 'Cis proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.757 -1.768 . . . . 0.0 111.956 0.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.15 -161.68 22.57 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -65.56 161.03 21.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.183 0.516 . . . . 0.0 111.556 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.787 HH12 ' CG2' ' A' ' 80' ' ' VAL . 66.7 ttp85 -95.94 145.63 25.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.323 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.648 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 57.6 mt-30 -140.83 152.0 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.444 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.787 ' CG2' HH12 ' A' ' 78' ' ' ARG . 46.9 t -127.12 122.17 59.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.813 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 70' ' ' LEU . 13.4 mt -117.74 129.92 56.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.691 ' OG ' HG23 ' A' ' 66' ' ' VAL . 28.9 t -156.75 168.51 27.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.442 0.639 . . . . 0.0 111.808 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.697 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 93.12 50.16 2.49 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.157 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 83' ' ' GLY . 28.2 pt 42.05 6.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 83' ' ' GLY . 9.6 p-10 -95.8 11.4 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 82' ' ' SER . 69.1 mt -49.11 -44.76 42.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.636 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.5 p -66.57 -39.86 88.7 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.303 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -45.16 62.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.421 ' CD ' HD22 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -70.36 -49.06 53.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.051 178.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 34.9 tp -56.85 -47.32 80.65 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.838 0.351 . . . . 0.0 110.718 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.85 -37.55 74.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -81.21 -37.65 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.802 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 99.4 mm-40 -77.82 -34.71 51.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.805 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.467 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.2 tp -52.17 -60.51 6.09 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.68 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.637 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -50.49 -40.51 54.16 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.262 1.974 . . . . 0.0 111.634 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -61.69 -36.76 81.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.221 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.648 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 39.9 m0 -63.3 -41.99 99.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.869 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.95 -37.24 78.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.691 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 95' ' ' PRO . 90.4 t -68.97 -36.98 76.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.297 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 57.27 106.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.807 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.25 156.88 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -58.88 -30.75 67.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.458 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.65 36.99 41.34 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.9 tt -111.69 135.83 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.78 0.324 . . . . 0.0 110.962 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.51 179.553 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 p -89.95 6.17 43.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.289 . . . . 0.0 110.835 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.59 ' O ' ' O ' ' A' ' 4' ' ' LEU . 39.1 p -79.77 -1.27 37.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.297 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 3' ' ' SER . 24.1 tp 54.19 144.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.728 0.299 . . . . 0.0 110.43 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.6 m -91.24 137.45 26.24 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.622 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.69 140.29 84.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.01 1.807 . . . . 0.0 111.68 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 46.46 82.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.584 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.26 132.01 47.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.782 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.86 144.64 26.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.15 -169.07 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -85.09 143.44 39.71 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.937 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -54.35 155.36 16.43 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.534 2.156 . . . . 0.0 111.404 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.866 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.4 tt -88.98 127.24 35.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 13' ' ' LEU . 41.6 mt -97.43 113.3 24.95 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.385 0.612 . . . . 0.0 110.267 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.915 HD11 HD21 ' A' ' 70' ' ' LEU . 1.9 tm? -127.08 132.14 50.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.621 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.864 ' N ' HD13 ' A' ' 15' ' ' LEU . 24.0 mt-30 -129.72 143.72 50.95 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.676 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.649 ' CD2' HG22 ' A' ' 29' ' ' VAL . 23.2 tp -119.89 130.9 55.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.806 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.538 ' CE2' HD13 ' A' ' 58' ' ' LEU . 85.5 m-85 -101.48 120.43 40.28 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 4.8 m -134.42 159.17 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.906 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.617 ' C ' HG23 ' A' ' 21' ' ' THR . 50.5 p30 -99.55 16.59 22.84 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.5 p 77.08 5.79 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 18.0 ptt-85 -73.79 145.62 84.44 Favored Pre-proline 0 N--CA 1.463 0.202 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.156 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.6 -38.16 64.73 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.802 2.334 . . . . 0.0 112.69 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.3 tp -54.77 -43.33 72.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 0.0 110.216 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.961 ' O ' HG23 ' A' ' 29' ' ' VAL . 16.4 m -63.95 -43.65 95.19 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -63.6 -33.44 75.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -63.95 -55.45 22.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.229 -1.351 . . . . 0.0 108.848 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 32' ' ' VAL . 92.7 mt -64.42 -33.9 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 25' ' ' SER . 65.1 t -56.23 -44.89 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.679 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 12.7 mm100 -59.71 -43.1 94.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -62.45 -41.17 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.521 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 28' ' ' ILE . 85.0 t -64.63 -52.22 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.44 -42.58 99.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.036 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.679 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -61.61 -44.99 95.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 84.6 mt -68.28 -47.35 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.754 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.019 ' O ' HG12 ' A' ' 39' ' ' VAL . 91.2 mt -59.04 -38.66 79.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.13 -17.16 64.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.288 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -82.52 -15.07 53.74 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.99 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.019 HG12 ' O ' ' A' ' 36' ' ' LEU . 7.3 p -85.64 -11.62 11.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.985 0.421 . . . . 0.0 110.286 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' O ' ' A' ' 41' ' ' ALA . 76.0 mm-40 33.99 -84.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.694 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 45.92 172.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.688 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 43.7 p -87.8 -2.87 58.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.3 86.01 9.25 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.631 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.58 152.19 75.21 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.492 2.128 . . . . 0.0 112.128 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.628 HG23 HD22 ' A' ' 13' ' ' LEU . 4.1 mp -106.53 140.91 23.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.0 t -100.25 112.7 25.03 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -100.56 127.05 47.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.004 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.627 ' N ' HD23 ' A' ' 47' ' ' LEU . 11.4 mt-30 -130.05 126.04 36.69 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.947 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -99.55 136.72 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.052 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.626 HG21 HD21 ' A' ' 58' ' ' LEU . 14.5 mt -118.64 129.88 74.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.526 ' ND2' HG22 ' A' ' 21' ' ' THR . 20.2 m120 -82.5 104.04 12.49 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.226 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 59' ' ' VAL . 34.7 m -60.15 -19.0 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.24 -29.41 66.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.009 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -94.71 -27.12 16.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.401 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.668 ' HG3' HD21 ' A' ' 58' ' ' LEU . 1.2 pt20 -141.84 79.03 17.04 Favored Pre-proline 0 C--N 1.33 -0.252 0 C-N-CA 120.626 -0.429 . . . . 0.0 112.035 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 59' ' ' VAL . 3.3 Cg_exo -75.69 -8.02 18.96 Favored 'Trans proline' 0 C--N 1.302 -1.898 0 C-N-CA 123.147 2.564 . . . . 0.0 112.094 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -68.21 -39.37 82.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.868 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.917 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -74.01 -23.52 59.44 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.74 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.917 ' N ' HD12 ' A' ' 58' ' ' LEU . 17.0 t -62.06 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.55 -36.45 76.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.829 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -56.79 -42.25 79.15 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.217 0.532 . . . . 0.0 109.938 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.665 ' C ' ' H ' ' A' ' 64' ' ' LEU . 44.9 m-85 -85.01 14.1 5.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.021 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.777 HH12 ' NH2' ' A' ' 78' ' ' ARG . 0.6 OUTLIER 57.12 2.26 0.11 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.731 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.3 OUTLIER -62.57 128.7 37.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.628 178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.731 ' N ' HD13 ' A' ' 64' ' ' LEU . 5.6 t -137.14 -8.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.947 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.683 HG23 ' OG ' ' A' ' 82' ' ' SER . 15.3 m -119.33 140.37 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.574 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.489 ' HB ' HH22 ' A' ' 22' ' ' ARG . 39.0 p -129.53 147.37 64.95 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.154 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 2.9 Cg_endo -74.28 156.33 99.78 Favored 'Cis proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.388 -1.505 . . . . 0.0 111.819 0.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.64 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -147.32 144.49 28.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.834 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.915 HD21 HD11 ' A' ' 15' ' ' LEU . 6.2 tt -120.84 136.49 54.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.411 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.863 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.1 t -132.2 127.31 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 97' ' ' TRP . 0.6 OUTLIER -93.87 130.5 39.89 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.42 -20.35 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.19 168.08 32.36 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 119.84 -1.171 . . . . 0.0 112.094 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -72.7 177.9 34.02 Favored 'Cis proline' 0 N--CA 1.491 1.325 0 C-N-CA 123.228 -1.571 . . . . 0.0 112.285 -0.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.81 -168.19 47.09 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.4 t -73.26 158.47 35.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.099 0.475 . . . . 0.0 110.506 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.777 ' NH2' HH12 ' A' ' 63' ' ' ARG . 51.2 ttp180 -82.28 139.0 34.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.195 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -137.41 147.19 45.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.745 HG13 HG22 ' A' ' 71' ' ' VAL . 42.1 t -115.09 122.3 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.983 0.42 . . . . 0.0 110.783 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 70' ' ' LEU . 17.9 mt -109.89 130.85 55.47 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.683 ' OG ' HG23 ' A' ' 66' ' ' VAL . 29.2 t -156.69 172.25 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.035 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 88.78 50.3 3.36 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.083 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.9 pt 42.2 5.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 53.3 p30 -96.25 11.4 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.238 0.542 . . . . 0.0 109.725 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 82' ' ' SER . 63.1 mt -47.78 -47.65 30.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.286 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.7 p -66.94 -37.43 84.3 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.911 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.79 -47.73 51.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 93' ' ' GLN . 2.9 tt0 -70.22 -46.55 64.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.235 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 41.5 tp -57.44 -47.13 82.63 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.777 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.568 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.76 -37.79 77.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.269 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -80.86 -37.48 29.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.754 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 95.3 mm-40 -77.72 -36.81 50.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.752 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 13.3 tp -52.05 -57.92 13.28 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.678 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.4 Cg_endo -48.19 -44.47 28.62 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.141 1.894 . . . . 0.0 111.582 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.678 ' O ' ' N ' ' A' ' 100' ' ' GLN . 26.2 mt-30 -62.05 -35.27 78.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.957 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.503 ' CD2' ' HE3' ' A' ' 72' ' ' LYS . 42.3 m0 -62.94 -44.17 96.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.222 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.35 -33.87 76.7 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.38 0.61 . . . . 0.0 109.387 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 95' ' ' PRO . 21.3 t -87.03 -22.73 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.582 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 96' ' ' GLN . 25.2 mt-30 63.13 47.89 3.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.201 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.58 ' HG2' HG12 ' A' ' 99' ' ' VAL . 96.1 mm-40 -101.53 147.56 26.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.841 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.4 mm-40 56.3 114.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.464 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.2 122.54 0.88 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.63 157.32 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.892 0.377 . . . . 0.0 110.796 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.913 -1.042 . . . . 0.0 110.694 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.476 ' O ' ' O ' ' A' ' 1' ' ' GLY . 21.6 m -57.69 -146.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.809 0.338 . . . . 0.0 110.463 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.2 p -64.42 164.17 11.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.27 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.4 tp 52.56 78.72 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.027 -179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 m -121.87 81.0 41.81 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.003 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.51 -166.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.923 1.748 . . . . 0.0 111.274 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -67.13 138.47 57.1 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.493 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.75 41.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.193 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.053 HD23 ' H ' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -84.17 155.6 22.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.482 -179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.16 175.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.804 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -83.23 137.23 42.73 Favored Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.982 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -51.36 157.46 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.187 1.925 . . . . 0.0 112.211 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.955 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.0 tt -77.15 138.23 39.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.936 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.955 ' N ' HD23 ' A' ' 13' ' ' LEU . 16.6 mt -98.32 113.62 25.64 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.457 0.646 . . . . 0.0 109.947 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.912 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.3 tm? -122.04 134.48 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.189 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.912 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.1 mt-30 -133.43 156.15 48.23 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.167 0.508 . . . . 0.0 111.934 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.69 ' CD2' HG22 ' A' ' 29' ' ' VAL . 8.7 tp -137.76 131.93 31.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.761 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 73.5 m-85 -98.47 119.53 37.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.98 179.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.2 m -133.66 152.88 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.607 -179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' O ' ' OG1' ' A' ' 21' ' ' THR . 42.6 p30 -99.96 16.26 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.864 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.601 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 6.7 p 76.77 7.75 3.16 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.356 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.575 ' CG ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -74.02 147.37 85.93 Favored Pre-proline 0 CA--C 1.532 0.262 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.069 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -51.02 -47.48 25.48 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.975 2.45 . . . . 0.0 113.385 -178.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HB3' ' CD ' ' A' ' 22' ' ' ARG . 5.1 tp -54.09 -39.41 66.34 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.257 -178.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.97 ' O ' HG23 ' A' ' 29' ' ' VAL . 86.1 p -65.39 -44.89 86.08 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.49 -33.96 77.11 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -63.99 -55.16 24.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.929 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.753 HD13 HD13 ' A' ' 86' ' ' LEU . 72.6 mt -64.82 -31.87 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.411 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 25' ' ' SER . 47.8 t -56.19 -46.08 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.644 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 99.2 mm-40 -60.13 -40.52 90.06 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -62.65 -40.0 95.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.418 178.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.9 -50.49 77.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.811 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -63.06 -45.02 94.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.265 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 84.8 m-20 -63.48 -44.59 93.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.892 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 96.3 mt -67.51 -50.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.357 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 98.6 mt -58.72 -41.98 87.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.035 0.445 . . . . 0.0 110.094 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.34 -14.68 63.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.586 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.85 -19.41 34.94 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.972 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.7 p -86.5 -13.16 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.931 0.396 . . . . 0.0 110.444 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.695 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.8 mt-10 38.82 -114.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.657 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 81.4 162.59 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.198 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 68.8 p -75.06 -2.7 28.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.693 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -120.33 85.78 37.41 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.4 149.4 91.27 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.367 2.044 . . . . 0.0 111.629 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.577 HG23 HD22 ' A' ' 13' ' ' LEU . 3.1 mp -104.85 144.26 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.4 t -102.62 126.35 49.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.639 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -106.37 126.73 52.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.181 -178.826 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.639 ' N ' HD23 ' A' ' 47' ' ' LEU . 55.0 mm-40 -127.16 131.27 50.78 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.639 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.14 137.38 27.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.097 -179.346 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.45 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 15.2 mt -117.28 127.08 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.507 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.796 ' N ' ' NE2' ' A' ' 55' ' ' GLN . 13.3 m120 -82.9 105.72 14.14 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.778 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.1 m -58.37 -22.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.19 -30.28 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.908 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.1 -29.0 15.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.236 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.796 ' NE2' ' N ' ' A' ' 51' ' ' ASN . 0.2 OUTLIER -135.6 75.81 56.2 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.972 0.415 . . . . 0.0 110.89 -179.559 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.56 -8.96 12.46 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 C-N-CA 123.851 3.034 . . . . 0.0 112.731 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -68.81 -46.64 68.11 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.75 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -72.92 -21.38 60.9 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.75 ' H ' HD12 ' A' ' 58' ' ' LEU . 92.5 t -61.82 -46.72 95.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.59 -35.8 79.67 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -57.46 -42.93 83.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.599 ' C ' ' H ' ' A' ' 64' ' ' LEU . 54.2 m-85 -89.22 13.92 12.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.674 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.917 ' O ' HG23 ' A' ' 65' ' ' VAL . 63.6 mtt85 54.8 6.32 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -59.77 61.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.917 179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.2 t -84.06 1.54 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.681 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.5 m -126.21 144.16 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.233 -179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 p -139.46 149.79 61.46 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.846 179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.724 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.6 Cg_endo -75.78 160.35 95.99 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.506 -1.456 . . . . 0.0 111.598 0.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.64 147.58 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.784 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.895 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.5 tt -117.65 133.26 56.14 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.895 ' N ' HD23 ' A' ' 70' ' ' LEU . 45.3 t -127.54 127.67 68.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.387 -178.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 13' ' ' LEU . 18.5 tttm -94.48 132.58 38.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.434 178.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -106.55 -20.63 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.517 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.38 -171.87 26.31 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.87 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -62.0 165.84 35.28 Favored 'Cis proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.663 -1.807 . . . . 0.0 111.94 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.13 -167.37 23.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.3 t -66.44 158.97 28.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.105 0.479 . . . . 0.0 111.356 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -89.12 142.04 27.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.107 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.667 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 54.2 mt-30 -142.76 152.22 42.07 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.698 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 71' ' ' VAL . 61.0 t -131.18 126.3 58.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 70' ' ' LEU . 21.7 mt -115.74 130.55 56.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.681 ' OG ' HG23 ' A' ' 66' ' ' VAL . 48.1 t -157.45 166.03 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.18 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.42 58.54 1.53 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.631 178.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 83' ' ' GLY . 15.4 pt 41.06 4.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.2 p30 -98.7 10.48 41.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.208 0.527 . . . . 0.0 109.702 179.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.924 ' H ' HD12 ' A' ' 86' ' ' LEU . 4.0 mp -47.66 -49.33 27.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.118 -179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.4 p -68.26 -40.58 81.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.627 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.04 -45.77 66.43 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.744 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 93' ' ' GLN . 1.5 tt0 -68.06 -45.95 72.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.824 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 33.0 tp -55.95 -45.86 78.73 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.751 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.06 -39.74 75.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -81.66 -35.37 30.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 89' ' ' GLN . 29.2 mm-40 -77.06 -36.53 55.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.674 -178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 39' ' ' VAL . 11.7 tp -52.63 -59.28 9.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.511 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -48.9 -40.7 40.08 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.117 1.878 . . . . 0.0 111.376 178.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.26 -36.17 79.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.694 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.667 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 40.7 m0 -65.11 -42.04 94.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.175 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.9 mt -68.79 -37.77 79.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.191 179.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 100' ' ' GLN . 55.6 t -64.26 -43.26 97.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.583 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.488 ' O ' ' O ' ' A' ' 99' ' ' VAL . 53.7 mt-30 57.59 131.27 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.937 179.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.414 ' O ' ' O ' ' A' ' 102' ' ' GLU . 88.8 mt-30 57.27 -154.2 0.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.91 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 101' ' ' GLN . 75.1 mm-40 57.05 158.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.756 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.16 -109.57 2.96 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.6 mt -95.46 123.01 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.747 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 3' ' ' SER . 27.1 t -132.09 -117.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.801 0.334 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.505 ' N ' ' OG ' ' A' ' 2' ' ' SER . 91.4 p -80.31 -1.01 39.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.021 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.34 107.98 5.95 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.07 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.95 86.73 0.73 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.778 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.45 -5.36 16.49 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.68 2.254 . . . . 0.0 111.699 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.521 ' O ' ' OE1' ' A' ' 7' ' ' GLN . 0.8 OUTLIER -76.34 6.07 6.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.49 179.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.47 117.53 15.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.444 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.842 ' H ' ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -87.44 148.06 25.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 179.932 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD22 ' A' ' 9' ' ' LEU . . . -66.8 175.73 2.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.277 -178.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -82.4 143.89 48.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.619 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -54.07 162.59 3.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.647 2.231 . . . . 0.0 112.351 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.923 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.9 tt -86.64 134.21 33.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.818 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.923 ' N ' HD23 ' A' ' 13' ' ' LEU . 19.6 mt -98.95 117.18 32.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.416 0.627 . . . . 0.0 110.408 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.951 HD11 HD21 ' A' ' 70' ' ' LEU . 2.0 tm? -128.56 132.33 48.23 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.718 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.869 ' N ' HD13 ' A' ' 15' ' ' LEU . 22.3 mt-30 -124.5 157.97 34.0 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.059 0.457 . . . . 0.0 111.36 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 ' CD2' HG22 ' A' ' 29' ' ' VAL . 16.2 tp -136.74 127.71 27.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.291 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.812 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 45.4 m-85 -97.88 121.77 40.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.861 178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 5.8 m -133.21 158.17 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.387 -179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.577 ' O ' ' OG1' ' A' ' 21' ' ' THR . 56.2 p30 -98.13 18.51 16.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.556 178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 8.9 p 73.37 2.79 4.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.659 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HE ' ' HG3' ' A' ' 68' ' ' PRO . 2.4 ptt180 -74.41 146.8 84.45 Favored Pre-proline 0 N--CA 1.463 0.189 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.3 Cg_endo -53.46 -36.09 78.41 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.567 2.178 . . . . 0.0 112.618 -179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.4 tp -54.38 -45.31 72.81 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.9 m -64.75 -42.61 95.04 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -64.41 -32.89 74.69 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.6 t-80 -62.68 -53.01 60.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.365 178.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 HD12 ' A' ' 86' ' ' LEU . 86.0 mt -63.89 -32.43 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.141 178.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 26.1 t -56.39 -45.58 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.859 179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 86.7 mm-40 -59.31 -43.16 92.69 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 59.5 mtt-85 -63.14 -39.55 95.0 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.928 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 28' ' ' ILE . 74.6 t -64.36 -52.01 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.992 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.179 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.6 m-20 -62.54 -46.08 90.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.888 -178.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.1 mt -69.03 -47.76 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.46 -179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.89 ' O ' HG12 ' A' ' 39' ' ' VAL . 94.1 mt -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.019 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.27 -16.81 63.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.09 -15.08 52.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.912 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.89 HG12 ' O ' ' A' ' 36' ' ' LEU . 3.7 p -84.98 -7.24 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.195 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 55.5 mm-40 41.46 -118.19 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.233 -179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 78.96 165.42 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.723 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 p -84.61 -4.83 59.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.3 m -121.45 80.55 38.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.096 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.89 155.35 33.44 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.116 1.877 . . . . 0.0 111.942 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.711 HG23 HD22 ' A' ' 13' ' ' LEU . 4.4 mp -104.14 143.24 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -100.78 130.99 46.89 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -108.59 130.1 55.31 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 0.0 111.346 -179.043 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.621 ' N ' HD23 ' A' ' 47' ' ' LEU . 3.0 mt-30 -129.67 129.82 44.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.428 178.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.11 135.27 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.901 0.381 . . . . 0.0 111.357 -179.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.812 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 26.7 mt -116.36 124.2 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.676 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 90.3 m-20 -85.13 107.5 17.24 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.207 -179.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 67' ' ' THR . 18.5 m -54.12 -21.5 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.039 0.447 . . . . 0.0 109.963 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.23 -20.24 60.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.525 179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -97.85 -38.54 9.4 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.747 -178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.68 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -139.16 75.13 34.9 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.346 0.593 . . . . 0.0 111.856 -178.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -74.07 -8.28 20.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.966 2.444 . . . . 0.0 111.407 178.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.83 -50.4 43.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.301 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.516 HD21 ' CG ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -73.49 -23.08 60.0 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.095 -179.813 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG22 ' CE2' ' A' ' 18' ' ' PHE . 43.8 t -60.88 -44.48 97.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.57 -34.35 75.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.928 178.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -55.42 -41.92 73.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.825 179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.9 m-85 -83.26 13.66 4.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.164 178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.3 mmm180 60.15 4.32 0.63 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -178.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.849 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.33 130.68 45.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.571 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.849 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -144.8 -9.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.853 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG23 ' OG ' ' A' ' 82' ' ' SER . 31.3 m -108.93 141.62 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.595 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 52' ' ' VAL . 32.2 p -136.31 147.3 59.66 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.083 179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.465 ' HG3' ' HE ' ' A' ' 22' ' ' ARG . 3.0 Cg_exo -73.33 156.36 99.57 Favored 'Cis proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.033 0.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.05 144.44 29.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.39 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.951 HD21 HD11 ' A' ' 15' ' ' LEU . 6.3 tt -119.43 135.41 54.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.084 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.812 HG22 HG13 ' A' ' 80' ' ' VAL . 26.0 t -131.18 129.1 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 77' ' ' SER . 0.6 OUTLIER -93.75 129.87 39.94 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.116 178.044 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.499 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.97 -24.38 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.383 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.33 -168.71 29.65 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.917 -1.135 . . . . 0.0 112.176 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.41 161.28 39.74 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.659 -1.809 . . . . 0.0 112.031 0.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.14 -170.55 21.67 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.505 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 4.5 t -66.23 159.48 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 111.24 -179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -91.29 142.2 27.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.437 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' NE1' ' A' ' 97' ' ' TRP . 52.9 mt-30 -142.4 150.23 40.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.026 179.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.812 HG13 HG22 ' A' ' 71' ' ' VAL . 36.9 t -121.04 125.56 74.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.176 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 70' ' ' LEU . 15.4 mt -114.72 128.94 56.59 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.678 ' OG ' HG23 ' A' ' 66' ' ' VAL . 32.5 t -156.22 172.21 18.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.413 0.625 . . . . 0.0 111.608 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.682 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 89.51 50.0 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.832 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 83' ' ' GLY . 26.4 pt 42.69 6.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.623 0.249 . . . . 0.0 111.666 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.682 ' N ' ' O ' ' A' ' 83' ' ' GLY . 47.2 p30 -96.52 11.07 36.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.266 0.555 . . . . 0.0 109.787 179.349 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD21 ' HA ' ' A' ' 82' ' ' SER . 70.7 mt -46.63 -50.38 17.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.852 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.6 p -66.57 -36.68 83.25 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.339 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -71.06 -49.69 41.99 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -69.0 -46.26 68.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.347 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.572 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 54.0 tp -56.51 -48.47 77.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.476 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.59 -36.51 74.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.371 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -80.43 -37.45 32.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.202 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.3 mm-40 -77.49 -34.63 54.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.889 -178.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD21 HG21 ' A' ' 39' ' ' VAL . 10.9 tp -52.45 -59.82 7.75 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.821 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.648 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -48.93 -43.64 34.86 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.109 1.873 . . . . 0.0 111.413 178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.18 -35.09 77.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.875 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.652 ' NE1' ' NE2' ' A' ' 79' ' ' GLN . 47.1 m0 -63.3 -41.44 98.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.118 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 101' ' ' GLN . 26.9 mt -68.17 -31.67 71.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.896 179.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 99' ' ' VAL . 81.4 t -72.55 3.06 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -81.74 20.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.162 -179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 98' ' ' LEU . 90.2 mm-40 -89.34 -4.74 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.612 ' OE1' ' O ' ' A' ' 99' ' ' VAL . 62.0 mp0 -99.37 172.16 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.596 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -52.44 -146.5 0.0 OUTLIER Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.7 mt -101.77 136.28 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.868 0.366 . . . . 0.0 110.753 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.532 179.911 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -82.82 -1.18 51.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.094 0.474 . . . . 0.0 110.213 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -179.34 101.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.802 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.74 -41.3 90.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.234 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -99.9 142.49 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.597 ' O ' ' CD2' ' A' ' 9' ' ' LEU . 2.6 Cg_endo -52.21 140.97 50.48 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.248 1.965 . . . . 0.0 111.696 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -103.33 -12.47 17.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.196 179.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -117.69 46.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.979 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.597 ' CD2' ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -82.3 134.52 35.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.038 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.83 -175.79 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.562 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -86.11 126.32 65.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.204 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.44 156.24 22.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.84 1.693 . . . . 0.0 111.386 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.912 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.2 tt -79.16 131.13 36.11 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.912 ' N ' HD23 ' A' ' 13' ' ' LEU . 30.1 mt -96.34 114.97 26.7 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.1 tm? -124.59 132.19 53.45 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.09 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.884 ' N ' HD13 ' A' ' 15' ' ' LEU . 87.4 mt-30 -129.05 155.23 45.76 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.093 0.473 . . . . 0.0 111.45 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.651 HD12 ' O ' ' A' ' 69' ' ' ALA . 17.0 tp -137.49 131.67 32.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.765 -179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 78.1 m-85 -95.57 126.64 40.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.027 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 25' ' ' SER . 18.0 m -131.49 155.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 111.981 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.604 ' C ' HG23 ' A' ' 21' ' ' THR . 43.8 p-10 -107.68 15.14 24.94 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.846 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 20' ' ' ASP . 4.9 p 76.41 5.09 3.61 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.242 -179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.511 HH11 ' HD3' ' A' ' 68' ' ' PRO . 11.1 ptm180 -74.88 147.29 83.84 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.555 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -52.62 -36.53 71.97 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.718 2.278 . . . . 0.0 112.277 -179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD21 HG22 ' A' ' 84' ' ' ILE . 11.9 tp -56.36 -41.86 76.84 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.857 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 1.003 ' O ' HG23 ' A' ' 29' ' ' VAL . 73.4 m -62.22 -45.47 93.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -63.72 -34.58 78.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.9 -55.72 17.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.922 179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 32' ' ' VAL . 74.1 mt -66.63 -35.12 74.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.542 178.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.003 HG23 ' O ' ' A' ' 25' ' ' SER . 55.5 t -56.27 -46.27 81.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.844 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.685 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 2.8 mm100 -59.58 -42.12 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -62.3 -38.99 91.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.434 178.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 28' ' ' ILE . 69.3 t -64.96 -51.75 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HE3' ' CG1' ' A' ' 29' ' ' VAL . 89.8 mttt -60.36 -44.33 95.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.596 178.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.685 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 80.6 m-20 -64.97 -47.62 76.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.085 -178.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.562 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 98.6 mt -69.36 -47.33 73.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.817 -179.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.706 ' O ' HG12 ' A' ' 39' ' ' VAL . 72.1 mt -57.88 -38.07 75.12 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.791 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.94 -11.03 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.546 178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -84.91 -17.24 38.44 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.851 -179.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.706 HG12 ' O ' ' A' ' 36' ' ' LEU . 6.0 p -86.95 -16.11 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.128 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' O ' ' O ' ' A' ' 41' ' ' ALA . 80.5 mt-10 35.0 -83.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.946 179.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' N ' ' O ' ' A' ' 39' ' ' VAL . . . 44.46 177.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.074 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.4 p -84.18 -6.88 59.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.851 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -120.81 84.01 37.33 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.461 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.32 149.56 69.86 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.77 2.313 . . . . 0.0 112.483 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.2 mp -101.75 147.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.847 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 t -97.19 122.16 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 48' ' ' GLN . 1.2 tm? -98.84 113.7 25.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.475 -178.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.517 ' N ' HD22 ' A' ' 47' ' ' LEU . 90.6 mt-30 -122.45 143.39 49.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.665 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -109.87 139.94 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.514 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 13.8 mt -116.32 123.0 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.584 ' O ' ' OE1' ' A' ' 55' ' ' GLN . 15.0 m120 -84.72 108.98 17.7 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.07 -27.37 31.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.996 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.45 -16.69 60.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -92.48 -25.95 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.104 -179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.691 ' NE2' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -164.89 83.71 1.16 Allowed Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.328 0.585 . . . . 0.0 111.3 179.803 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.75 -1.42 11.11 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.363 2.709 . . . . 0.0 111.878 179.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -66.03 -47.88 72.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.922 -177.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD12 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -75.11 -22.99 57.85 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.685 179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.721 ' H ' HD12 ' A' ' 58' ' ' LEU . 48.3 t -62.3 -47.46 92.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.08 -33.87 72.45 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.76 -42.02 71.16 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.84 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 64' ' ' LEU . 58.6 m-85 -85.45 15.68 4.31 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.516 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' O ' HG23 ' A' ' 65' ' ' VAL . 49.5 mtt180 56.86 5.46 0.23 Allowed 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -178.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.893 HD13 ' N ' ' A' ' 65' ' ' VAL . 1.2 tm? -63.09 133.4 54.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.187 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.893 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.3 t -145.51 -10.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.423 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.471 HG23 ' OG ' ' A' ' 82' ' ' SER . 23.7 m -104.01 140.69 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.039 0.447 . . . . 0.0 110.588 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.405 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 20.5 p -138.01 145.18 46.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.132 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD3' HH11 ' A' ' 22' ' ' ARG . 2.7 Cg_endo -74.56 161.15 95.22 Favored 'Cis proline' 0 C--N 1.308 -1.586 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.633 0.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.651 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.86 145.25 27.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.274 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.875 HD21 HD11 ' A' ' 15' ' ' LEU . 5.9 tt -116.06 129.29 56.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.922 179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.755 ' N ' HD23 ' A' ' 70' ' ' LEU . 42.5 t -125.81 126.08 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.564 -0.455 . . . . 0.0 112.115 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HE3' HD11 ' A' ' 13' ' ' LEU . 26.2 tttt -93.13 131.08 38.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.358 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.08 -19.9 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.44 -171.91 27.95 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.179 -1.01 . . . . 0.0 111.742 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.01 163.29 32.28 Favored 'Cis proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.996 -1.668 . . . . 0.0 112.392 -0.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.3 -171.28 29.38 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -65.04 161.3 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 111.141 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' NH1' ' HG2' ' A' ' 78' ' ' ARG . 39.3 ttp85 -85.38 143.39 28.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.628 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -140.52 153.54 46.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.246 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.616 HG13 HG22 ' A' ' 71' ' ' VAL . 67.6 t -133.37 123.39 46.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.556 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.775 HD21 ' HG3' ' A' ' 93' ' ' GLN . 18.9 mt -117.48 128.1 54.65 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 66' ' ' VAL . 30.8 t -158.31 171.28 20.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.346 0.593 . . . . 0.0 111.461 -179.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.704 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 90.15 58.37 1.58 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.722 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.475 HG22 HD21 ' A' ' 24' ' ' LEU . 25.4 pt 41.99 4.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 83' ' ' GLY . 48.5 p30 -103.51 11.08 36.77 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.185 0.516 . . . . 0.0 110.189 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 86' ' ' LEU . 6.8 mp -51.17 -50.09 59.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.525 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 52.1 p -64.34 -40.89 96.77 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -70.58 -47.91 57.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.728 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.447 ' HB3' HD22 ' A' ' 81' ' ' LEU . 1.1 tt0 -68.07 -42.18 80.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.228 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.513 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 58.2 tp -57.61 -48.26 79.92 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.437 179.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.544 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.89 -32.73 69.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -80.75 -36.33 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.775 ' HG3' HD21 ' A' ' 81' ' ' LEU . 96.5 mm-40 -77.05 -36.47 55.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.577 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 94' ' ' LEU . 3.9 tp -51.97 -60.01 7.03 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.553 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -49.87 -44.22 37.7 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.099 1.866 . . . . 0.0 111.198 178.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -61.67 -34.25 75.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.5 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 93' ' ' GLN . 46.5 m0 -61.19 -35.82 78.21 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.1 mt -76.96 -29.5 55.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.72 178.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.638 ' O ' HG12 ' A' ' 99' ' ' VAL . 17.9 t -102.06 30.82 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.008 -178.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.501 HE21 ' HA ' ' A' ' 97' ' ' TRP . 80.1 mm-40 -62.92 53.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.871 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.613 ' N ' ' O ' ' A' ' 99' ' ' VAL . 94.2 mt-30 -85.54 -0.44 55.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.472 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -101.39 140.14 36.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.062 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.06 -18.15 8.45 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.9 mt -109.97 136.43 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.664 0.269 . . . . 0.0 110.337 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.5 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.649 179.953 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.6 t -150.56 57.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.71 0.29 . . . . 0.0 110.644 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -69.53 -4.4 18.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.051 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 36.4 tp -102.06 131.24 48.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.622 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.4 p -123.03 80.81 51.03 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.221 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.92 -4.78 15.3 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 123.352 2.701 . . . . 0.0 113.3 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -67.71 124.77 24.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.659 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.81 130.44 34.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.28 158.63 20.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.378 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.94 136.34 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.365 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -91.38 145.75 32.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.076 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.53 173.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.205 1.936 . . . . 0.0 110.983 179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.906 HD23 ' N ' ' A' ' 14' ' ' LEU . 6.4 tt -79.33 136.47 37.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.906 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -91.12 104.87 17.39 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 16' ' ' GLN . 1.5 tm? -118.11 131.98 56.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.007 -178.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.872 ' N ' HD13 ' A' ' 15' ' ' LEU . 20.5 mt-30 -127.37 154.27 45.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.717 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' CD2' HG22 ' A' ' 29' ' ' VAL . 15.6 tp -137.93 127.45 24.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.24 -179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.445 ' HE1' HD13 ' A' ' 58' ' ' LEU . 83.2 m-85 -96.48 120.94 37.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.85 158.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.434 0.635 . . . . 0.0 112.239 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.61 ' O ' ' OG1' ' A' ' 21' ' ' THR . 37.9 p-10 -102.73 19.32 19.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.863 178.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 20' ' ' ASP . 25.1 p 68.54 7.1 5.82 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.264 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -72.31 147.25 90.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.2 Cg_endo -52.31 -39.63 72.16 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.412 2.075 . . . . 0.0 111.94 -179.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.63 -42.85 68.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 29' ' ' VAL . 83.4 p -66.24 -44.02 84.92 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -64.06 -33.82 76.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' PRO . 1.1 t-80 -64.55 -56.12 16.09 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.705 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.27 -32.67 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.638 179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 25' ' ' SER . 53.6 t -56.29 -42.33 73.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.683 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 95.2 mm-40 -60.25 -40.84 91.72 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -63.6 -42.4 98.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.014 178.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 54.0 t -61.76 -51.01 77.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.739 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 46.0 mttm -63.98 -43.78 94.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.997 179.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.683 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 87.4 m-20 -62.25 -44.24 97.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.046 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.92 -51.34 45.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.553 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 39' ' ' VAL . 88.6 mt -61.16 -42.05 97.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.019 0.437 . . . . 0.0 109.972 179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 33' ' ' LYS . . . -68.74 -13.16 62.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.04 -23.17 33.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 36' ' ' LEU . 1.4 p -88.85 -10.99 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.654 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 83.0 tt0 33.99 -108.13 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.045 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 80.25 165.94 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.087 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 81.2 p -76.7 -7.71 55.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.961 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.8 m -117.59 77.77 11.1 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.599 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -53.95 151.94 25.28 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 121.982 1.788 . . . . 0.0 111.658 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.803 HG23 ' HB3' ' A' ' 13' ' ' LEU . 5.2 mp -102.4 143.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.947 -179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 t -101.61 120.81 40.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -101.23 127.78 47.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.185 -178.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.609 ' N ' HD23 ' A' ' 47' ' ' LEU . 37.4 mt-30 -129.9 125.32 35.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.097 179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.02 134.52 40.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.842 HG23 ' NE2' ' A' ' 55' ' ' GLN . 13.1 mt -115.45 125.61 72.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -83.46 105.94 14.81 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.163 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.566 HG12 ' CG2' ' A' ' 59' ' ' VAL . 21.2 m -60.54 -23.67 29.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.02 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.84 -26.92 63.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.182 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -95.94 -19.5 19.47 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.59 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.842 ' NE2' HG23 ' A' ' 50' ' ' ILE . 22.8 pt20 -157.59 74.98 4.1 Favored Pre-proline 0 CA--C 1.53 0.206 0 C-N-CA 120.494 -0.483 . . . . 0.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.4 -6.76 18.17 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 123.506 2.804 . . . . 0.0 112.45 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -66.87 -41.37 87.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.226 -178.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.782 HD12 ' N ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.7 -22.65 59.86 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.646 -0.822 . . . . 0.0 109.579 179.755 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.782 ' N ' HD12 ' A' ' 58' ' ' LEU . 48.2 t -62.41 -43.89 98.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.01 -37.15 72.63 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.079 -0.509 . . . . 0.0 109.787 177.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -56.55 -42.17 78.07 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.963 179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.647 ' C ' ' H ' ' A' ' 64' ' ' LEU . 52.1 m-85 -83.45 12.32 5.73 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.467 179.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.6 mtm180 58.25 2.1 0.19 Allowed 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD13 ' N ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -61.84 130.68 46.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.319 -1.31 . . . . 0.0 108.174 178.816 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 64' ' ' LEU . 1.7 t -137.36 -8.85 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.156 -0.618 . . . . 0.0 112.275 -178.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.776 HG23 ' OG ' ' A' ' 82' ' ' SER . 18.4 m -117.18 142.53 30.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.152 -179.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HA ' ' C ' ' A' ' 68' ' ' PRO . 38.9 p -136.13 148.3 64.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.852 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 67' ' ' THR . 3.0 Cg_exo -70.69 155.94 95.57 Favored 'Cis proline' 0 C--N 1.308 -1.555 0 C-N-CA 123.574 -1.428 . . . . 0.0 112.021 0.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.547 ' HA ' HD21 ' A' ' 86' ' ' LEU . . . -147.97 151.83 36.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.003 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.797 HD23 ' N ' ' A' ' 71' ' ' VAL . 5.8 tt -126.57 132.48 51.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.248 -179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.797 ' N ' HD23 ' A' ' 70' ' ' LEU . 40.6 t -129.83 127.85 64.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.048 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.696 ' HE2' HD11 ' A' ' 13' ' ' LEU . 17.5 tttm -94.3 129.19 41.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.103 178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.494 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.8 -19.08 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.592 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' CA ' ' C ' ' A' ' 75' ' ' PRO . . . 149.25 -169.69 29.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.801 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.407 ' C ' ' CA ' ' A' ' 74' ' ' GLY . 3.0 Cg_endo -59.69 158.48 41.64 Favored 'Cis proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.643 -1.816 . . . . 0.0 112.063 0.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.23 -159.57 18.68 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 t -77.59 160.54 28.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.141 0.496 . . . . 0.0 111.571 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 72' ' ' LYS . 56.0 ttp180 -91.26 139.74 30.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.542 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 69.4 mt-30 -139.59 152.68 47.04 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 HG22 ' A' ' 71' ' ' VAL . 25.9 t -119.36 126.92 75.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.277 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD22 ' CD ' ' A' ' 89' ' ' GLN . 9.5 mt -118.36 126.33 51.87 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.776 ' OG ' HG23 ' A' ' 66' ' ' VAL . 45.3 t -156.89 168.68 26.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.743 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 87.03 57.31 2.04 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.489 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 83' ' ' GLY . 32.4 pt 43.18 4.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.686 ' N ' ' O ' ' A' ' 83' ' ' GLY . 51.0 p30 -99.78 5.89 45.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.971 0.415 . . . . 0.0 110.038 179.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.731 ' H ' HD12 ' A' ' 86' ' ' LEU . 1.7 mp -49.36 -46.8 47.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.1 p -67.36 -38.26 84.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.059 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -70.94 -47.44 59.03 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 93' ' ' GLN . 4.0 tt0 -68.81 -47.71 65.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.943 179.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 56.4 tp -55.83 -46.66 78.07 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 120.924 0.392 . . . . 0.0 110.243 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.624 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -57.69 -34.56 69.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.625 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -82.33 -38.04 24.85 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.032 179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 97' ' ' TRP . 99.3 mm-40 -76.63 -38.51 54.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.481 -178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 19.5 tp -52.96 -59.4 9.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.594 -179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CD ' ' O ' ' A' ' 91' ' ' ALA . 2.2 Cg_endo -47.99 -42.43 31.89 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.067 1.845 . . . . 0.0 111.136 178.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.59 -35.56 80.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.584 179.701 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.543 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 45.6 m0 -65.05 -41.98 94.68 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.4 mt -70.82 -36.23 72.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 95' ' ' PRO . 74.1 t -77.88 -41.29 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.544 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 102' ' ' GLU . 67.5 mm-40 64.11 63.65 0.78 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.815 0.34 . . . . 0.0 110.625 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -73.18 17.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.867 -179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 100' ' ' GLN . 95.5 mt-10 -53.18 144.81 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.988 0.423 . . . . 0.0 110.96 -179.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -127.26 176.91 17.68 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 104' ' ' ILE . 17.5 tt -112.26 125.94 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.509 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.4 ' CB ' ' O ' ' A' ' 104' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.504 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 3' ' ' SER . 19.5 t -106.56 138.37 42.87 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.666 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.586 ' C ' ' O ' ' A' ' 2' ' ' SER . 93.8 p 16.73 95.54 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.411 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 4' ' ' LEU . 4.5 tt -80.13 -6.89 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.424 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.32 80.8 71.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.274 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.24 149.75 64.3 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.877 2.385 . . . . 0.0 112.806 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 65.38 79.7 0.24 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.771 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.35 53.6 1.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.341 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -84.26 -169.97 2.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.359 -179.419 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.36 153.84 40.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.99 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -87.42 138.36 32.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.84 171.68 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.323 2.015 . . . . 0.0 111.577 179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 14' ' ' LEU . 5.7 tt -83.23 132.86 35.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.153 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.909 ' N ' HD23 ' A' ' 13' ' ' LEU . 13.4 mt -94.75 110.36 22.22 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.355 0.597 . . . . 0.0 110.485 -179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 70' ' ' LEU . 1.5 tm? -121.18 132.42 54.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.512 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.896 ' N ' HD13 ' A' ' 15' ' ' LEU . 88.3 mt-30 -129.41 158.58 38.77 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.126 0.489 . . . . 0.0 111.902 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 69' ' ' ALA . 12.8 tp -139.91 129.74 24.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.955 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 31.0 m-85 -97.43 123.06 41.15 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.76 157.31 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.747 -179.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.592 ' C ' HG23 ' A' ' 21' ' ' THR . 54.6 p30 -99.62 15.31 27.09 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.523 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 20' ' ' ASP . 5.1 p 76.45 5.42 3.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.567 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.474 HH22 ' CB ' ' A' ' 67' ' ' THR . 6.1 ptt180 -74.27 146.62 84.55 Favored Pre-proline 0 N--CA 1.464 0.264 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.144 179.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.4 Cg_endo -53.01 -38.23 79.81 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.396 2.064 . . . . 0.0 112.494 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -54.85 -43.77 73.38 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.45 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 29' ' ' VAL . 89.1 p -65.93 -42.19 90.38 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -64.06 -34.27 77.64 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 23' ' ' PRO . 2.0 t-80 -61.34 -53.48 56.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.132 -1.394 . . . . 0.0 108.529 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.698 HD12 ' HG2' ' A' ' 68' ' ' PRO . 67.3 mt -64.17 -33.84 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.132 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 25' ' ' SER . 36.9 t -56.04 -45.04 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.703 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 13.8 mm100 -59.62 -43.79 93.66 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -62.07 -41.24 97.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.649 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.02 -50.41 74.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.483 ' NZ ' ' CG1' ' A' ' 29' ' ' VAL . 33.0 mttt -61.75 -42.42 98.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.054 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.703 ' ND2' ' O ' ' A' ' 30' ' ' GLN . 85.1 m-20 -63.87 -45.65 88.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.006 -179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 95.4 mt -68.95 -51.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.799 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.2 mt -59.06 -40.89 86.56 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.341 -179.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.3 -15.22 62.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.888 178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 35' ' ' ILE . . . -83.52 -21.39 32.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.461 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.799 HG12 ' O ' ' A' ' 36' ' ' LEU . 14.2 p -88.52 -11.55 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.065 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.724 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 84.2 tt0 38.59 -110.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.382 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.724 ' HB3' ' O ' ' A' ' 40' ' ' GLU . . . 84.74 164.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.669 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.6 p -74.5 -6.9 51.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.296 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.97 82.04 65.26 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.584 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.99 151.63 64.45 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.144 1.896 . . . . 0.0 111.877 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.64 HG23 ' HB3' ' A' ' 13' ' ' LEU . 4.5 mp -102.88 143.92 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.7 t -103.38 127.28 50.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.823 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 48' ' ' GLN . 0.3 OUTLIER -103.86 128.35 51.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.487 -179.444 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.624 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -129.28 129.83 45.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.974 179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.76 132.83 45.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.936 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.9 HG22 ' NE2' ' A' ' 55' ' ' GLN . 24.8 mt -115.27 123.56 70.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.706 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 91.6 m-20 -81.85 108.6 15.5 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.379 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -52.44 -21.23 2.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.587 -178.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.67 -11.13 60.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.352 179.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -101.01 -41.54 6.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.093 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.9 ' NE2' HG22 ' A' ' 50' ' ' ILE . 2.7 pm0 -135.72 66.17 62.43 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 121.194 0.521 . . . . 0.0 111.359 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 55' ' ' GLN . 3.9 Cg_exo -67.97 -8.58 23.05 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 122.823 2.349 . . . . 0.0 111.88 179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -71.75 -47.29 54.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.723 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -71.76 -25.86 62.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.7 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 64' ' ' LEU . 86.4 t -62.67 -44.27 99.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.359 178.244 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.75 -34.53 77.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -56.18 -42.67 77.46 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' LEU . 36.1 m-85 -87.85 8.68 24.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.926 178.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.819 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.5 mtp85 58.75 10.0 1.34 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.727 0.775 . . . . 0.0 108.994 -178.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 1.3 tm? -61.09 63.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.923 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 63' ' ' ARG . 2.4 t -85.15 1.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG23 ' OG ' ' A' ' 82' ' ' SER . 16.0 m -109.26 139.29 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.017 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.474 ' CB ' HH22 ' A' ' 22' ' ' ARG . 19.1 p -140.05 147.11 49.34 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.986 178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.698 ' HG2' HD12 ' A' ' 28' ' ' ILE . 2.9 Cg_endo -74.6 166.82 81.89 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.454 -1.478 . . . . 0.0 111.604 0.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.835 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -148.57 152.82 37.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.963 0.411 . . . . 0.0 110.62 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 15' ' ' LEU . 5.2 tt -131.82 126.93 35.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.648 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.774 ' N ' HD23 ' A' ' 70' ' ' LEU . 26.4 t -129.34 128.79 66.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.264 -179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.603 ' NZ ' ' O ' ' A' ' 75' ' ' PRO . 11.6 tmtt? -92.71 124.79 36.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.003 178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -100.17 -22.15 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.2 -178.562 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 -178.82 28.63 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.798 -1.191 . . . . 0.0 112.465 178.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.603 ' O ' ' NZ ' ' A' ' 72' ' ' LYS . 3.5 Cg_exo -66.41 162.23 72.63 Favored 'Cis proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.809 -1.746 . . . . 0.0 112.072 0.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.28 -164.82 18.13 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.5 t -71.67 158.53 36.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.14 0.495 . . . . 0.0 111.338 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.7 ttm105 -94.33 140.36 29.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.097 179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.683 ' OE1' ' NE1' ' A' ' 97' ' ' TRP . 93.4 mt-30 -141.32 149.81 41.68 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 71' ' ' VAL . 46.1 t -120.98 123.83 70.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.037 0.446 . . . . 0.0 111.178 -179.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.7 mt -118.2 125.69 50.68 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.497 ' OG ' HG23 ' A' ' 66' ' ' VAL . 40.4 t -156.94 172.54 18.48 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.698 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 85' ' ' ASP . . . 85.97 56.27 2.36 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.053 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 83' ' ' GLY . 17.5 pt 43.19 5.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 83' ' ' GLY . 44.3 p30 -99.51 8.05 44.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.208 0.527 . . . . 0.0 109.644 179.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.808 ' H ' HD12 ' A' ' 86' ' ' LEU . 3.0 mp -48.12 -49.61 31.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.436 -179.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.2 p -67.01 -38.13 85.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.59 -178.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.87 -47.17 63.63 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.559 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' GLN . 1.9 tt0 -70.26 -48.25 57.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.739 178.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.557 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 59.7 tp -55.1 -49.14 72.47 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.957 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' O ' ' CD ' ' A' ' 95' ' ' PRO . . . -58.55 -36.85 74.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.944 0.402 . . . . 0.0 110.335 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.81 -36.98 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.745 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' GLN . 89.1 mm-40 -76.1 -32.73 59.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.175 -179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.481 ' N ' ' HD2' ' A' ' 95' ' ' PRO . 9.7 tp -52.48 -60.4 6.5 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.496 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.2 Cg_endo -49.61 -42.4 42.74 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.474 2.116 . . . . 0.0 111.517 178.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 100' ' ' GLN . 92.5 mt-30 -59.48 -34.79 73.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.634 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.683 ' NE1' ' OE1' ' A' ' 79' ' ' GLN . 36.4 m0 -65.87 -50.99 62.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.9 mt -73.02 -40.46 65.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 95' ' ' PRO . 65.4 t -70.7 -34.91 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.083 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 96' ' ' GLN . 95.2 mt-30 58.83 -163.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.94 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 54.87 81.67 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.353 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' O ' ' O ' ' A' ' 103' ' ' GLY . 96.4 mt-10 -49.62 144.62 5.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.869 0.366 . . . . 0.0 110.503 -179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.564 ' O ' ' O ' ' A' ' 102' ' ' GLU . . . -36.53 167.08 0.01 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.24 133.12 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 110.147 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.0 p90 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.621 -179.484 . . . . . . . . 0 0 . 1 stop_ save_